AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|COUNT|ICCC_GROUP|POPULATION|AGE|RACE|SEX|YEAR
142.2|148.4|145.3|8574|All ICCC Groups Combined|59151007|0-14|All Races|Male and Female|1999
43.4|46.8|45.1|2664|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59151007|0-14|All Races|Male and Female|1999
14.4|16.4|15.4|907|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59151007|0-14|All Races|Male and Female|1999
30.2|33.1|31.6|1871|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59151007|0-14|All Races|Male and Female|1999
2.6|3.5|3.0|177|IIIa Ependymomas and choroid plexus tumor|59151007|0-14|All Races|Male and Female|1999
13.4|15.4|14.4|850|IIIb Astrocytomas|59151007|0-14|All Races|Male and Female|1999
7.1|8.6|7.8|464|IIIc Intracranial and intraspinal embryonal tumors|59151007|0-14|All Races|Male and Female|1999
4.7|5.8|5.2|310|IIId Other gliomas|59151007|0-14|All Races|Male and Female|1999
0.3|0.7|0.5|30|IIIe Other specified intracranial and intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999
0.5|0.9|0.7|40|IIIf Unspecified intracranial and intraspinal neoplasms|59151007|0-14|All Races|Male and Female|1999
4.9|6.1|5.5|324|IIa Hodgkin lymphomas|59151007|0-14|All Races|Male and Female|1999
5.4|6.6|6.0|353|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59151007|0-14|All Races|Male and Female|1999
2.1|2.9|2.5|149|IIc Burkitt lymphoma|59151007|0-14|All Races|Male and Female|1999
0.7|1.2|0.9|54|IId Miscellaneous lymphoreticular neoplasms|59151007|0-14|All Races|Male and Female|1999
0.3|0.7|0.5|27|IIe Unspecified lymphomas|59151007|0-14|All Races|Male and Female|1999
9.8|11.5|10.7|626|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59151007|0-14|All Races|Male and Female|1999
9.7|11.4|10.5|616|IVa Neuroblastoma and ganglioneuroblastoma|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|IVb Other peripheral nervous cell tumors|59151007|0-14|All Races|Male and Female|1999
8.6|10.2|9.4|555|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59151007|0-14|All Races|Male and Female|1999
4.2|5.4|4.8|283|IXa Rhabdomyosarcomas|59151007|0-14|All Races|Male and Female|1999
0.7|1.2|0.9|55|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|IXc Kaposi sarcoma|59151007|0-14|All Races|Male and Female|1999
2.3|3.2|2.7|161|IXd Other specified soft tissue sarcomas|59151007|0-14|All Races|Male and Female|1999
0.7|1.2|0.9|55|IXe Unspecified soft tissue sarcomas|59151007|0-14|All Races|Male and Female|1999
33.9|37.0|35.4|2095|Ia Lymphoid leukemias|59151007|0-14|All Races|Male and Female|1999
6.9|8.4|7.6|449|Ib Acute myeloid leukemias|59151007|0-14|All Races|Male and Female|1999
0.4|0.9|0.6|37|Ic Chronic myeloproliferative diseases|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|59151007|0-14|All Races|Male and Female|1999
1.0|1.6|1.2|73|Ie Unspecified and other specified leukemias|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.3|19|Not classified by ICCC|59151007|0-14|All Races|Male and Female|1999
3.7|4.8|4.2|246|V RETINOBLASTOMA|59151007|0-14|All Races|Male and Female|1999
7.3|8.8|8.0|473|VI RENAL TUMORS|59151007|0-14|All Races|Male and Female|1999
1.8|2.6|2.2|129|VII HEPATIC TUMORS|59151007|0-14|All Races|Male and Female|1999
6.4|7.8|7.1|420|VIII MALIGNANT BONE TUMORS|59151007|0-14|All Races|Male and Female|1999
3.7|4.7|4.2|246|VIIIa Osteosarcomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIIIb Chondrosarcomas|59151007|0-14|All Races|Male and Female|1999
1.9|2.7|2.3|137|VIIIc Ewing tumor and related sarcomas of bone|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.3|19|VIIId Other specified malignant bone tumors|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIIIe Unspecified malignant bone tumors|59151007|0-14|All Races|Male and Female|1999
1.5|2.2|1.8|108|VIIa Hepatoblastoma and mesenchymal tumors of liver|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.4|21|VIIb Hepatic carcinomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59151007|0-14|All Races|Male and Female|1999
6.9|8.3|7.6|447|VIa Nephroblastoma and other non-epithelial renal tumors|59151007|0-14|All Races|Male and Female|1999
0.2|0.6|0.4|23|VIb Renal carcinomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|VIc Unspecified malignant renal tumors|59151007|0-14|All Races|Male and Female|1999
4.4|5.6|5.0|291|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59151007|0-14|All Races|Male and Female|1999
5.2|6.4|5.8|341|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59151007|0-14|All Races|Male and Female|1999
0.4|0.8|0.5|32|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|XIIa Other specified malignant tumors|59151007|0-14|All Races|Male and Female|1999
0.2|0.5|0.3|20|XIIb Other unspecified malignant tumors|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|XIa Adrenocortical carcinomas|59151007|0-14|All Races|Male and Female|1999
1.5|2.3|1.9|111|XIb Thyroid carcinomas|59151007|0-14|All Races|Male and Female|1999
0.2|0.6|0.4|23|XIc Nasopharyngeal carcinomas|59151007|0-14|All Races|Male and Female|1999
1.4|2.1|1.8|104|XId Malignant melanomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|XIe Skin carcinomas|59151007|0-14|All Races|Male and Female|1999
1.1|1.8|1.4|84|XIf Other and unspecified carcinomas|59151007|0-14|All Races|Male and Female|1999
1.0|1.6|1.3|76|Xa Intracranial and intraspinal germ cell tumors|59151007|0-14|All Races|Male and Female|1999
1.1|1.7|1.3|78|Xb Malignant extracranial and extragonadal germ cell tumors|59151007|0-14|All Races|Male and Female|1999
1.8|2.5|2.1|125|Xc Malignant gonadal germ cell tumors|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|Xd Gonadal carcinomas|59151007|0-14|All Races|Male and Female|1999
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59151007|0-14|All Races|Male and Female|1999
145.9|152.2|149.0|8843|All ICCC Groups Combined|59476204|0-14|All Races|Male and Female|2000
44.1|47.6|45.9|2716|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59476204|0-14|All Races|Male and Female|2000
15.5|17.6|16.6|987|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59476204|0-14|All Races|Male and Female|2000
31.1|34.1|32.6|1935|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59476204|0-14|All Races|Male and Female|2000
2.3|3.1|2.7|157|IIIa Ependymomas and choroid plexus tumor|59476204|0-14|All Races|Male and Female|2000
15.6|17.7|16.7|991|IIIb Astrocytomas|59476204|0-14|All Races|Male and Female|2000
6.7|8.2|7.4|441|IIIc Intracranial and intraspinal embryonal tumors|59476204|0-14|All Races|Male and Female|2000
4.1|5.2|4.6|276|IIId Other gliomas|59476204|0-14|All Races|Male and Female|2000
0.3|0.7|0.5|29|IIIe Other specified intracranial and intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000
0.5|0.9|0.7|41|IIIf Unspecified intracranial and intraspinal neoplasms|59476204|0-14|All Races|Male and Female|2000
5.2|6.5|5.8|349|IIa Hodgkin lymphomas|59476204|0-14|All Races|Male and Female|2000
5.4|6.6|6.0|356|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59476204|0-14|All Races|Male and Female|2000
2.4|3.3|2.8|168|IIc Burkitt lymphoma|59476204|0-14|All Races|Male and Female|2000
1.0|1.6|1.3|78|IId Miscellaneous lymphoreticular neoplasms|59476204|0-14|All Races|Male and Female|2000
0.4|0.8|0.6|36|IIe Unspecified lymphomas|59476204|0-14|All Races|Male and Female|2000
9.3|10.9|10.1|596|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59476204|0-14|All Races|Male and Female|2000
9.2|10.8|10.0|588|IVa Neuroblastoma and ganglioneuroblastoma|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|IVb Other peripheral nervous cell tumors|59476204|0-14|All Races|Male and Female|2000
9.5|11.1|10.3|612|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59476204|0-14|All Races|Male and Female|2000
4.5|5.7|5.1|302|IXa Rhabdomyosarcomas|59476204|0-14|All Races|Male and Female|2000
0.7|1.2|0.9|56|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|IXc Kaposi sarcoma|59476204|0-14|All Races|Male and Female|2000
2.8|3.7|3.2|192|IXd Other specified soft tissue sarcomas|59476204|0-14|All Races|Male and Female|2000
0.8|1.3|1.0|61|IXe Unspecified soft tissue sarcomas|59476204|0-14|All Races|Male and Female|2000
35.5|38.6|37.0|2191|Ia Lymphoid leukemias|59476204|0-14|All Races|Male and Female|2000
6.1|7.5|6.8|401|Ib Acute myeloid leukemias|59476204|0-14|All Races|Male and Female|2000
0.5|1.0|0.7|44|Ic Chronic myeloproliferative diseases|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|59476204|0-14|All Races|Male and Female|2000
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|59476204|0-14|All Races|Male and Female|2000
0.2|0.5|0.3|17|Not classified by ICCC|59476204|0-14|All Races|Male and Female|2000
3.8|4.9|4.4|257|V RETINOBLASTOMA|59476204|0-14|All Races|Male and Female|2000
8.0|9.5|8.8|517|VI RENAL TUMORS|59476204|0-14|All Races|Male and Female|2000
2.0|2.8|2.4|139|VII HEPATIC TUMORS|59476204|0-14|All Races|Male and Female|2000
5.9|7.2|6.5|390|VIII MALIGNANT BONE TUMORS|59476204|0-14|All Races|Male and Female|2000
3.1|4.1|3.6|213|VIIIa Osteosarcomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIIb Chondrosarcomas|59476204|0-14|All Races|Male and Female|2000
2.2|3.1|2.6|156|VIIIc Ewing tumor and related sarcomas of bone|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIId Other specified malignant bone tumors|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIIe Unspecified malignant bone tumors|59476204|0-14|All Races|Male and Female|2000
1.7|2.5|2.1|123|VIIa Hepatoblastoma and mesenchymal tumors of liver|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIb Hepatic carcinomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59476204|0-14|All Races|Male and Female|2000
7.6|9.1|8.4|493|VIa Nephroblastoma and other non-epithelial renal tumors|59476204|0-14|All Races|Male and Female|2000
0.2|0.6|0.4|23|VIb Renal carcinomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|VIc Unspecified malignant renal tumors|59476204|0-14|All Races|Male and Female|2000
4.4|5.5|4.9|294|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59476204|0-14|All Races|Male and Female|2000
5.1|6.3|5.7|340|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59476204|0-14|All Races|Male and Female|2000
0.5|1.0|0.7|43|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|XIIa Other specified malignant tumors|59476204|0-14|All Races|Male and Female|2000
0.3|0.7|0.5|30|XIIb Other unspecified malignant tumors|59476204|0-14|All Races|Male and Female|2000
0.2|0.5|0.3|18|XIa Adrenocortical carcinomas|59476204|0-14|All Races|Male and Female|2000
1.6|2.3|1.9|113|XIb Thyroid carcinomas|59476204|0-14|All Races|Male and Female|2000
0.2|0.5|0.3|20|XIc Nasopharyngeal carcinomas|59476204|0-14|All Races|Male and Female|2000
1.4|2.1|1.7|104|XId Malignant melanomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|XIe Skin carcinomas|59476204|0-14|All Races|Male and Female|2000
1.1|1.7|1.4|82|XIf Other and unspecified carcinomas|59476204|0-14|All Races|Male and Female|2000
1.2|1.8|1.5|87|Xa Intracranial and intraspinal germ cell tumors|59476204|0-14|All Races|Male and Female|2000
0.8|1.4|1.1|65|Xb Malignant extracranial and extragonadal germ cell tumors|59476204|0-14|All Races|Male and Female|2000
1.9|2.6|2.2|133|Xc Malignant gonadal germ cell tumors|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Xd Gonadal carcinomas|59476204|0-14|All Races|Male and Female|2000
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59476204|0-14|All Races|Male and Female|2000
152.8|159.1|155.9|9320|All ICCC Groups Combined|59815030|0-14|All Races|Male and Female|2001
48.6|52.2|50.4|2996|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59815030|0-14|All Races|Male and Female|2001
15.0|17.0|16.0|962|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59815030|0-14|All Races|Male and Female|2001
31.4|34.3|32.8|1958|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59815030|0-14|All Races|Male and Female|2001
2.3|3.2|2.7|164|IIIa Ependymomas and choroid plexus tumor|59815030|0-14|All Races|Male and Female|2001
15.3|17.4|16.3|973|IIIb Astrocytomas|59815030|0-14|All Races|Male and Female|2001
6.6|8.0|7.3|436|IIIc Intracranial and intraspinal embryonal tumors|59815030|0-14|All Races|Male and Female|2001
4.8|6.0|5.4|320|IIId Other gliomas|59815030|0-14|All Races|Male and Female|2001
0.5|0.9|0.7|42|IIIe Other specified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001
0.2|0.6|0.4|23|IIIf Unspecified intracranial and intraspinal neoplasms|59815030|0-14|All Races|Male and Female|2001
5.3|6.6|5.9|357|IIa Hodgkin lymphomas|59815030|0-14|All Races|Male and Female|2001
5.8|7.1|6.4|387|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59815030|0-14|All Races|Male and Female|2001
1.9|2.7|2.3|135|IIc Burkitt lymphoma|59815030|0-14|All Races|Male and Female|2001
0.8|1.3|1.0|60|IId Miscellaneous lymphoreticular neoplasms|59815030|0-14|All Races|Male and Female|2001
0.2|0.6|0.4|23|IIe Unspecified lymphomas|59815030|0-14|All Races|Male and Female|2001
10.7|12.5|11.6|694|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59815030|0-14|All Races|Male and Female|2001
10.6|12.3|11.4|684|IVa Neuroblastoma and ganglioneuroblastoma|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|IVb Other peripheral nervous cell tumors|59815030|0-14|All Races|Male and Female|2001
9.5|11.2|10.3|619|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59815030|0-14|All Races|Male and Female|2001
4.5|5.6|5.0|298|IXa Rhabdomyosarcomas|59815030|0-14|All Races|Male and Female|2001
1.0|1.6|1.3|76|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|IXc Kaposi sarcoma|59815030|0-14|All Races|Male and Female|2001
2.7|3.6|3.1|186|IXd Other specified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001
0.7|1.3|1.0|59|IXe Unspecified soft tissue sarcomas|59815030|0-14|All Races|Male and Female|2001
37.0|40.2|38.6|2289|Ia Lymphoid leukemias|59815030|0-14|All Races|Male and Female|2001
6.7|8.1|7.3|440|Ib Acute myeloid leukemias|59815030|0-14|All Races|Male and Female|2001
1.4|2.0|1.7|101|Ic Chronic myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001
1.3|2.0|1.6|96|Id Myelodysplastic syndrome and other myeloproliferative diseases|59815030|0-14|All Races|Male and Female|2001
0.9|1.5|1.2|70|Ie Unspecified and other specified leukemias|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|Not classified by ICCC|59815030|0-14|All Races|Male and Female|2001
3.9|5.0|4.4|266|V RETINOBLASTOMA|59815030|0-14|All Races|Male and Female|2001
7.9|9.4|8.6|511|VI RENAL TUMORS|59815030|0-14|All Races|Male and Female|2001
1.9|2.6|2.2|134|VII HEPATIC TUMORS|59815030|0-14|All Races|Male and Female|2001
6.4|7.7|7.0|424|VIII MALIGNANT BONE TUMORS|59815030|0-14|All Races|Male and Female|2001
3.4|4.4|3.8|232|VIIIa Osteosarcomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIIb Chondrosarcomas|59815030|0-14|All Races|Male and Female|2001
2.3|3.1|2.7|160|VIIIc Ewing tumor and related sarcomas of bone|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIId Other specified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIIe Unspecified malignant bone tumors|59815030|0-14|All Races|Male and Female|2001
1.5|2.2|1.8|108|VIIa Hepatoblastoma and mesenchymal tumors of liver|59815030|0-14|All Races|Male and Female|2001
0.3|0.6|0.4|25|VIIb Hepatic carcinomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59815030|0-14|All Races|Male and Female|2001
7.5|9.0|8.2|489|VIa Nephroblastoma and other non-epithelial renal tumors|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|20|VIb Renal carcinomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|VIc Unspecified malignant renal tumors|59815030|0-14|All Races|Male and Female|2001
4.5|5.6|5.0|303|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59815030|0-14|All Races|Male and Female|2001
6.0|7.3|6.6|399|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59815030|0-14|All Races|Male and Female|2001
0.5|1.0|0.7|43|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59815030|0-14|All Races|Male and Female|2001
0.2|0.6|0.4|23|XIIa Other specified malignant tumors|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|20|XIIb Other unspecified malignant tumors|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|17|XIa Adrenocortical carcinomas|59815030|0-14|All Races|Male and Female|2001
2.0|2.7|2.3|141|XIb Thyroid carcinomas|59815030|0-14|All Races|Male and Female|2001
0.2|0.5|0.3|19|XIc Nasopharyngeal carcinomas|59815030|0-14|All Races|Male and Female|2001
1.7|2.4|2.0|122|XId Malignant melanomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|XIe Skin carcinomas|59815030|0-14|All Races|Male and Female|2001
1.3|2.0|1.6|97|XIf Other and unspecified carcinomas|59815030|0-14|All Races|Male and Female|2001
1.0|1.6|1.3|79|Xa Intracranial and intraspinal germ cell tumors|59815030|0-14|All Races|Male and Female|2001
1.1|1.7|1.4|84|Xb Malignant extracranial and extragonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001
1.7|2.4|2.0|121|Xc Malignant gonadal germ cell tumors|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|Xd Gonadal carcinomas|59815030|0-14|All Races|Male and Female|2001
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59815030|0-14|All Races|Male and Female|2001
151.5|157.9|154.7|9269|All ICCC Groups Combined|59931314|0-14|All Races|Male and Female|2002
47.5|51.0|49.2|2938|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|59931314|0-14|All Races|Male and Female|2002
14.6|16.7|15.6|944|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|59931314|0-14|All Races|Male and Female|2002
33.0|36.0|34.5|2061|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|59931314|0-14|All Races|Male and Female|2002
3.1|4.1|3.6|215|IIIa Ependymomas and choroid plexus tumor|59931314|0-14|All Races|Male and Female|2002
15.5|17.6|16.5|986|IIIb Astrocytomas|59931314|0-14|All Races|Male and Female|2002
6.7|8.1|7.4|440|IIIc Intracranial and intraspinal embryonal tumors|59931314|0-14|All Races|Male and Female|2002
5.3|6.6|5.9|353|IIId Other gliomas|59931314|0-14|All Races|Male and Female|2002
0.5|1.0|0.7|43|IIIe Other specified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002
0.3|0.6|0.4|24|IIIf Unspecified intracranial and intraspinal neoplasms|59931314|0-14|All Races|Male and Female|2002
4.9|6.1|5.5|335|IIa Hodgkin lymphomas|59931314|0-14|All Races|Male and Female|2002
5.4|6.7|6.0|364|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|59931314|0-14|All Races|Male and Female|2002
2.3|3.2|2.7|163|IIc Burkitt lymphoma|59931314|0-14|All Races|Male and Female|2002
0.9|1.5|1.2|71|IId Miscellaneous lymphoreticular neoplasms|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|IIe Unspecified lymphomas|59931314|0-14|All Races|Male and Female|2002
10.2|11.9|11.1|662|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|59931314|0-14|All Races|Male and Female|2002
10.1|11.8|10.9|655|IVa Neuroblastoma and ganglioneuroblastoma|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|IVb Other peripheral nervous cell tumors|59931314|0-14|All Races|Male and Female|2002
9.9|11.6|10.7|644|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|59931314|0-14|All Races|Male and Female|2002
4.6|5.8|5.2|310|IXa Rhabdomyosarcomas|59931314|0-14|All Races|Male and Female|2002
0.9|1.4|1.1|69|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|IXc Kaposi sarcoma|59931314|0-14|All Races|Male and Female|2002
3.0|4.0|3.5|210|IXd Other specified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002
0.7|1.2|0.9|55|IXe Unspecified soft tissue sarcomas|59931314|0-14|All Races|Male and Female|2002
35.3|38.4|36.8|2191|Ia Lymphoid leukemias|59931314|0-14|All Races|Male and Female|2002
7.3|8.8|8.0|482|Ib Acute myeloid leukemias|59931314|0-14|All Races|Male and Female|2002
1.3|1.9|1.6|96|Ic Chronic myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002
1.3|2.0|1.6|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|59931314|0-14|All Races|Male and Female|2002
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|59931314|0-14|All Races|Male and Female|2002
0.2|0.5|0.3|19|Not classified by ICCC|59931314|0-14|All Races|Male and Female|2002
3.3|4.3|3.7|224|V RETINOBLASTOMA|59931314|0-14|All Races|Male and Female|2002
7.5|9.0|8.3|491|VI RENAL TUMORS|59931314|0-14|All Races|Male and Female|2002
1.8|2.5|2.1|126|VII HEPATIC TUMORS|59931314|0-14|All Races|Male and Female|2002
6.2|7.6|6.9|416|VIII MALIGNANT BONE TUMORS|59931314|0-14|All Races|Male and Female|2002
3.2|4.1|3.6|220|VIIIa Osteosarcomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIIIb Chondrosarcomas|59931314|0-14|All Races|Male and Female|2002
2.2|3.0|2.6|157|VIIIc Ewing tumor and related sarcomas of bone|59931314|0-14|All Races|Male and Female|2002
0.2|0.6|0.4|22|VIIId Other specified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIIIe Unspecified malignant bone tumors|59931314|0-14|All Races|Male and Female|2002
1.4|2.1|1.7|104|VIIa Hepatoblastoma and mesenchymal tumors of liver|59931314|0-14|All Races|Male and Female|2002
0.2|0.5|0.3|21|VIIb Hepatic carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIIc Unspecified malignant hepatic tumors|59931314|0-14|All Races|Male and Female|2002
7.3|8.8|8.0|477|VIa Nephroblastoma and other non-epithelial renal tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIb Renal carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|VIc Unspecified malignant renal tumors|59931314|0-14|All Races|Male and Female|2002
4.7|5.8|5.2|316|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|59931314|0-14|All Races|Male and Female|2002
5.8|7.1|6.4|392|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|59931314|0-14|All Races|Male and Female|2002
0.4|0.8|0.6|36|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|59931314|0-14|All Races|Male and Female|2002
0.2|0.6|0.4|22|XIIa Other specified malignant tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIIb Other unspecified malignant tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIa Adrenocortical carcinomas|59931314|0-14|All Races|Male and Female|2002
1.7|2.4|2.0|123|XIb Thyroid carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIc Nasopharyngeal carcinomas|59931314|0-14|All Races|Male and Female|2002
1.9|2.7|2.3|138|XId Malignant melanomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|XIe Skin carcinomas|59931314|0-14|All Races|Male and Female|2002
1.3|1.9|1.6|97|XIf Other and unspecified carcinomas|59931314|0-14|All Races|Male and Female|2002
1.1|1.7|1.4|84|Xa Intracranial and intraspinal germ cell tumors|59931314|0-14|All Races|Male and Female|2002
1.2|1.8|1.5|89|Xb Malignant extracranial and extragonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002
1.8|2.6|2.2|133|Xc Malignant gonadal germ cell tumors|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|Xd Gonadal carcinomas|59931314|0-14|All Races|Male and Female|2002
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|59931314|0-14|All Races|Male and Female|2002
148.8|155.0|151.9|9228|All ICCC Groups Combined|60628650|0-14|All Races|Male and Female|2003
45.7|49.2|47.4|2868|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60628650|0-14|All Races|Male and Female|2003
15.1|17.2|16.1|982|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60628650|0-14|All Races|Male and Female|2003
31.5|34.4|32.9|1990|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60628650|0-14|All Races|Male and Female|2003
2.1|2.9|2.5|149|IIIa Ependymomas and choroid plexus tumor|60628650|0-14|All Races|Male and Female|2003
15.5|17.5|16.5|998|IIIb Astrocytomas|60628650|0-14|All Races|Male and Female|2003
6.5|7.9|7.2|433|IIIc Intracranial and intraspinal embryonal tumors|60628650|0-14|All Races|Male and Female|2003
5.0|6.2|5.6|337|IIId Other gliomas|60628650|0-14|All Races|Male and Female|2003
0.6|1.1|0.9|52|IIIe Other specified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003
0.2|0.5|0.3|21|IIIf Unspecified intracranial and intraspinal neoplasms|60628650|0-14|All Races|Male and Female|2003
5.2|6.5|5.8|359|IIa Hodgkin lymphomas|60628650|0-14|All Races|Male and Female|2003
5.7|6.9|6.3|381|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60628650|0-14|All Races|Male and Female|2003
2.3|3.2|2.7|163|IIc Burkitt lymphoma|60628650|0-14|All Races|Male and Female|2003
0.9|1.5|1.2|73|IId Miscellaneous lymphoreticular neoplasms|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|IIe Unspecified lymphomas|60628650|0-14|All Races|Male and Female|2003
9.9|11.6|10.7|652|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60628650|0-14|All Races|Male and Female|2003
9.7|11.4|10.5|642|IVa Neuroblastoma and ganglioneuroblastoma|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|IVb Other peripheral nervous cell tumors|60628650|0-14|All Races|Male and Female|2003
9.7|11.3|10.5|639|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60628650|0-14|All Races|Male and Female|2003
4.3|5.5|4.9|295|IXa Rhabdomyosarcomas|60628650|0-14|All Races|Male and Female|2003
0.8|1.4|1.1|65|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|IXc Kaposi sarcoma|60628650|0-14|All Races|Male and Female|2003
3.1|4.1|3.6|219|IXd Other specified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003
0.7|1.2|0.9|58|IXe Unspecified soft tissue sarcomas|60628650|0-14|All Races|Male and Female|2003
34.3|37.3|35.8|2155|Ia Lymphoid leukemias|60628650|0-14|All Races|Male and Female|2003
6.9|8.3|7.6|462|Ib Acute myeloid leukemias|60628650|0-14|All Races|Male and Female|2003
1.2|1.8|1.5|91|Ic Chronic myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003
1.5|2.2|1.8|111|Id Myelodysplastic syndrome and other myeloproliferative diseases|60628650|0-14|All Races|Male and Female|2003
0.6|1.1|0.8|49|Ie Unspecified and other specified leukemias|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|Not classified by ICCC|60628650|0-14|All Races|Male and Female|2003
3.6|4.6|4.1|250|V RETINOBLASTOMA|60628650|0-14|All Races|Male and Female|2003
7.8|9.3|8.5|513|VI RENAL TUMORS|60628650|0-14|All Races|Male and Female|2003
2.3|3.1|2.7|163|VII HEPATIC TUMORS|60628650|0-14|All Races|Male and Female|2003
6.0|7.3|6.6|407|VIII MALIGNANT BONE TUMORS|60628650|0-14|All Races|Male and Female|2003
3.2|4.2|3.7|227|VIIIa Osteosarcomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIIIb Chondrosarcomas|60628650|0-14|All Races|Male and Female|2003
1.9|2.6|2.2|136|VIIIc Ewing tumor and related sarcomas of bone|60628650|0-14|All Races|Male and Female|2003
0.2|0.4|0.3|17|VIIId Other specified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIIIe Unspecified malignant bone tumors|60628650|0-14|All Races|Male and Female|2003
1.9|2.6|2.2|136|VIIa Hepatoblastoma and mesenchymal tumors of liver|60628650|0-14|All Races|Male and Female|2003
0.3|0.6|0.4|27|VIIb Hepatic carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60628650|0-14|All Races|Male and Female|2003
7.4|8.9|8.1|489|VIa Nephroblastoma and other non-epithelial renal tumors|60628650|0-14|All Races|Male and Female|2003
0.2|0.5|0.3|20|VIb Renal carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|VIc Unspecified malignant renal tumors|60628650|0-14|All Races|Male and Female|2003
4.5|5.7|5.1|312|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60628650|0-14|All Races|Male and Female|2003
5.7|6.9|6.3|388|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60628650|0-14|All Races|Male and Female|2003
0.6|1.1|0.8|52|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60628650|0-14|All Races|Male and Female|2003
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|60628650|0-14|All Races|Male and Female|2003
0.3|0.6|0.4|27|XIIb Other unspecified malignant tumors|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|XIa Adrenocortical carcinomas|60628650|0-14|All Races|Male and Female|2003
1.8|2.6|2.2|136|XIb Thyroid carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|XIc Nasopharyngeal carcinomas|60628650|0-14|All Races|Male and Female|2003
1.6|2.3|1.9|118|XId Malignant melanomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|XIe Skin carcinomas|60628650|0-14|All Races|Male and Female|2003
1.4|2.1|1.7|108|XIf Other and unspecified carcinomas|60628650|0-14|All Races|Male and Female|2003
0.9|1.5|1.2|72|Xa Intracranial and intraspinal germ cell tumors|60628650|0-14|All Races|Male and Female|2003
1.2|1.8|1.4|88|Xb Malignant extracranial and extragonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003
1.8|2.6|2.2|136|Xc Malignant gonadal germ cell tumors|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|Xd Gonadal carcinomas|60628650|0-14|All Races|Male and Female|2003
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60628650|0-14|All Races|Male and Female|2003
156.5|162.9|159.7|9725|All ICCC Groups Combined|60651802|0-14|All Races|Male and Female|2004
49.2|52.8|51.0|3093|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60651802|0-14|All Races|Male and Female|2004
15.1|17.1|16.1|983|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60651802|0-14|All Races|Male and Female|2004
33.6|36.6|35.1|2122|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60651802|0-14|All Races|Male and Female|2004
2.5|3.4|3.0|180|IIIa Ependymomas and choroid plexus tumor|60651802|0-14|All Races|Male and Female|2004
16.5|18.6|17.5|1061|IIIb Astrocytomas|60651802|0-14|All Races|Male and Female|2004
7.1|8.5|7.8|469|IIIc Intracranial and intraspinal embryonal tumors|60651802|0-14|All Races|Male and Female|2004
4.9|6.1|5.5|329|IIId Other gliomas|60651802|0-14|All Races|Male and Female|2004
0.6|1.1|0.8|49|IIIe Other specified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004
0.4|0.8|0.6|34|IIIf Unspecified intracranial and intraspinal neoplasms|60651802|0-14|All Races|Male and Female|2004
4.7|5.9|5.3|324|IIa Hodgkin lymphomas|60651802|0-14|All Races|Male and Female|2004
6.2|7.6|6.9|420|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60651802|0-14|All Races|Male and Female|2004
2.1|2.9|2.4|147|IIc Burkitt lymphoma|60651802|0-14|All Races|Male and Female|2004
1.0|1.6|1.3|80|IId Miscellaneous lymphoreticular neoplasms|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|IIe Unspecified lymphomas|60651802|0-14|All Races|Male and Female|2004
10.3|11.9|11.1|679|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60651802|0-14|All Races|Male and Female|2004
10.0|11.7|10.8|664|IVa Neuroblastoma and ganglioneuroblastoma|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|IVb Other peripheral nervous cell tumors|60651802|0-14|All Races|Male and Female|2004
9.6|11.3|10.4|638|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60651802|0-14|All Races|Male and Female|2004
4.0|5.1|4.5|275|IXa Rhabdomyosarcomas|60651802|0-14|All Races|Male and Female|2004
1.0|1.5|1.2|76|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|IXc Kaposi sarcoma|60651802|0-14|All Races|Male and Female|2004
3.2|4.1|3.6|223|IXd Other specified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004
0.8|1.3|1.0|62|IXe Unspecified soft tissue sarcomas|60651802|0-14|All Races|Male and Female|2004
37.1|40.2|38.6|2337|Ia Lymphoid leukemias|60651802|0-14|All Races|Male and Female|2004
7.3|8.7|8.0|489|Ib Acute myeloid leukemias|60651802|0-14|All Races|Male and Female|2004
1.3|1.9|1.6|97|Ic Chronic myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004
1.2|1.9|1.5|92|Id Myelodysplastic syndrome and other myeloproliferative diseases|60651802|0-14|All Races|Male and Female|2004
1.0|1.6|1.3|78|Ie Unspecified and other specified leukemias|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|Not classified by ICCC|60651802|0-14|All Races|Male and Female|2004
3.8|4.8|4.3|265|V RETINOBLASTOMA|60651802|0-14|All Races|Male and Female|2004
7.4|8.8|8.1|491|VI RENAL TUMORS|60651802|0-14|All Races|Male and Female|2004
2.4|3.3|2.8|174|VII HEPATIC TUMORS|60651802|0-14|All Races|Male and Female|2004
6.4|7.8|7.1|436|VIII MALIGNANT BONE TUMORS|60651802|0-14|All Races|Male and Female|2004
3.6|4.7|4.1|253|VIIIa Osteosarcomas|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.3|18|VIIIb Chondrosarcomas|60651802|0-14|All Races|Male and Female|2004
1.9|2.7|2.3|142|VIIIc Ewing tumor and related sarcomas of bone|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.3|18|VIIId Other specified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIIIe Unspecified malignant bone tumors|60651802|0-14|All Races|Male and Female|2004
2.1|3.0|2.5|155|VIIa Hepatoblastoma and mesenchymal tumors of liver|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIIb Hepatic carcinomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60651802|0-14|All Races|Male and Female|2004
7.0|8.4|7.7|468|VIa Nephroblastoma and other non-epithelial renal tumors|60651802|0-14|All Races|Male and Female|2004
0.2|0.6|0.4|23|VIb Renal carcinomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|VIc Unspecified malignant renal tumors|60651802|0-14|All Races|Male and Female|2004
5.1|6.3|5.6|349|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60651802|0-14|All Races|Male and Female|2004
6.4|7.8|7.1|436|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60651802|0-14|All Races|Male and Female|2004
0.5|1.0|0.7|45|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60651802|0-14|All Races|Male and Female|2004
0.2|0.5|0.4|22|XIIa Other specified malignant tumors|60651802|0-14|All Races|Male and Female|2004
0.2|0.6|0.4|23|XIIb Other unspecified malignant tumors|60651802|0-14|All Races|Male and Female|2004
0.2|0.4|0.3|16|XIa Adrenocortical carcinomas|60651802|0-14|All Races|Male and Female|2004
2.2|3.1|2.6|162|XIb Thyroid carcinomas|60651802|0-14|All Races|Male and Female|2004
0.2|0.6|0.4|24|XIc Nasopharyngeal carcinomas|60651802|0-14|All Races|Male and Female|2004
2.1|2.8|2.4|149|XId Malignant melanomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|XIe Skin carcinomas|60651802|0-14|All Races|Male and Female|2004
1.0|1.6|1.3|80|XIf Other and unspecified carcinomas|60651802|0-14|All Races|Male and Female|2004
1.3|1.9|1.6|96|Xa Intracranial and intraspinal germ cell tumors|60651802|0-14|All Races|Male and Female|2004
1.1|1.6|1.3|82|Xb Malignant extracranial and extragonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004
2.1|2.9|2.5|152|Xc Malignant gonadal germ cell tumors|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|Xd Gonadal carcinomas|60651802|0-14|All Races|Male and Female|2004
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60651802|0-14|All Races|Male and Female|2004
152.6|158.9|155.7|9476|All ICCC Groups Combined|60519046|0-14|All Races|Male and Female|2005
47.3|50.9|49.1|2982|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60519046|0-14|All Races|Male and Female|2005
15.6|17.6|16.6|1009|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60519046|0-14|All Races|Male and Female|2005
31.7|34.6|33.2|2003|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60519046|0-14|All Races|Male and Female|2005
2.9|3.8|3.3|201|IIIa Ependymomas and choroid plexus tumor|60519046|0-14|All Races|Male and Female|2005
15.8|17.8|16.8|1015|IIIb Astrocytomas|60519046|0-14|All Races|Male and Female|2005
6.3|7.6|6.9|419|IIIc Intracranial and intraspinal embryonal tumors|60519046|0-14|All Races|Male and Female|2005
4.5|5.7|5.1|306|IIId Other gliomas|60519046|0-14|All Races|Male and Female|2005
0.4|0.8|0.6|34|IIIe Other specified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005
0.3|0.7|0.5|28|IIIf Unspecified intracranial and intraspinal neoplasms|60519046|0-14|All Races|Male and Female|2005
5.3|6.5|5.9|360|IIa Hodgkin lymphomas|60519046|0-14|All Races|Male and Female|2005
5.7|7.0|6.4|386|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60519046|0-14|All Races|Male and Female|2005
2.2|3.0|2.6|155|IIc Burkitt lymphoma|60519046|0-14|All Races|Male and Female|2005
1.2|1.9|1.5|94|IId Miscellaneous lymphoreticular neoplasms|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|IIe Unspecified lymphomas|60519046|0-14|All Races|Male and Female|2005
11.0|12.7|11.8|729|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60519046|0-14|All Races|Male and Female|2005
10.9|12.6|11.7|720|IVa Neuroblastoma and ganglioneuroblastoma|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|IVb Other peripheral nervous cell tumors|60519046|0-14|All Races|Male and Female|2005
9.7|11.3|10.5|635|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60519046|0-14|All Races|Male and Female|2005
4.6|5.7|5.1|310|IXa Rhabdomyosarcomas|60519046|0-14|All Races|Male and Female|2005
0.9|1.4|1.1|70|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|IXc Kaposi sarcoma|60519046|0-14|All Races|Male and Female|2005
2.9|3.8|3.3|203|IXd Other specified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005
0.6|1.1|0.8|50|IXe Unspecified soft tissue sarcomas|60519046|0-14|All Races|Male and Female|2005
35.8|38.9|37.3|2264|Ia Lymphoid leukemias|60519046|0-14|All Races|Male and Female|2005
6.7|8.1|7.3|449|Ib Acute myeloid leukemias|60519046|0-14|All Races|Male and Female|2005
1.2|1.8|1.5|89|Ic Chronic myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005
1.3|2.0|1.6|100|Id Myelodysplastic syndrome and other myeloproliferative diseases|60519046|0-14|All Races|Male and Female|2005
1.0|1.6|1.3|80|Ie Unspecified and other specified leukemias|60519046|0-14|All Races|Male and Female|2005
0.1|0.4|0.3|16|Not classified by ICCC|60519046|0-14|All Races|Male and Female|2005
3.4|4.4|3.9|241|V RETINOBLASTOMA|60519046|0-14|All Races|Male and Female|2005
7.5|8.9|8.2|499|VI RENAL TUMORS|60519046|0-14|All Races|Male and Female|2005
2.1|2.9|2.5|155|VII HEPATIC TUMORS|60519046|0-14|All Races|Male and Female|2005
6.1|7.5|6.8|412|VIII MALIGNANT BONE TUMORS|60519046|0-14|All Races|Male and Female|2005
3.2|4.2|3.7|226|VIIIa Osteosarcomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIIIb Chondrosarcomas|60519046|0-14|All Races|Male and Female|2005
2.0|2.8|2.4|145|VIIIc Ewing tumor and related sarcomas of bone|60519046|0-14|All Races|Male and Female|2005
0.2|0.5|0.3|20|VIIId Other specified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIIIe Unspecified malignant bone tumors|60519046|0-14|All Races|Male and Female|2005
1.7|2.4|2.0|126|VIIa Hepatoblastoma and mesenchymal tumors of liver|60519046|0-14|All Races|Male and Female|2005
0.3|0.6|0.4|27|VIIb Hepatic carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60519046|0-14|All Races|Male and Female|2005
7.1|8.5|7.8|476|VIa Nephroblastoma and other non-epithelial renal tumors|60519046|0-14|All Races|Male and Female|2005
0.2|0.5|0.3|19|VIb Renal carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|VIc Unspecified malignant renal tumors|60519046|0-14|All Races|Male and Female|2005
4.9|6.1|5.5|338|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60519046|0-14|All Races|Male and Female|2005
6.1|7.4|6.8|414|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60519046|0-14|All Races|Male and Female|2005
0.5|1.0|0.7|43|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60519046|0-14|All Races|Male and Female|2005
0.3|0.6|0.4|26|XIIa Other specified malignant tumors|60519046|0-14|All Races|Male and Female|2005
0.2|0.5|0.3|17|XIIb Other unspecified malignant tumors|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|XIa Adrenocortical carcinomas|60519046|0-14|All Races|Male and Female|2005
1.9|2.7|2.3|139|XIb Thyroid carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|XIc Nasopharyngeal carcinomas|60519046|0-14|All Races|Male and Female|2005
2.0|2.8|2.4|144|XId Malignant melanomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|XIe Skin carcinomas|60519046|0-14|All Races|Male and Female|2005
1.4|2.1|1.8|108|XIf Other and unspecified carcinomas|60519046|0-14|All Races|Male and Female|2005
1.1|1.7|1.4|83|Xa Intracranial and intraspinal germ cell tumors|60519046|0-14|All Races|Male and Female|2005
1.3|2.0|1.6|100|Xb Malignant extracranial and extragonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005
1.9|2.6|2.2|138|Xc Malignant gonadal germ cell tumors|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|Xd Gonadal carcinomas|60519046|0-14|All Races|Male and Female|2005
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60519046|0-14|All Races|Male and Female|2005
155.8|162.2|159.0|9676|All ICCC Groups Combined|60516709|0-14|All Races|Male and Female|2006
49.7|53.4|51.5|3132|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60516709|0-14|All Races|Male and Female|2006
15.7|17.8|16.7|1014|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60516709|0-14|All Races|Male and Female|2006
32.8|35.7|34.2|2071|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60516709|0-14|All Races|Male and Female|2006
2.6|3.5|3.1|186|IIIa Ependymomas and choroid plexus tumor|60516709|0-14|All Races|Male and Female|2006
15.4|17.4|16.4|993|IIIb Astrocytomas|60516709|0-14|All Races|Male and Female|2006
7.1|8.5|7.7|469|IIIc Intracranial and intraspinal embryonal tumors|60516709|0-14|All Races|Male and Female|2006
5.2|6.5|5.8|350|IIId Other gliomas|60516709|0-14|All Races|Male and Female|2006
0.3|0.7|0.5|31|IIIe Other specified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006
0.5|0.9|0.7|42|IIIf Unspecified intracranial and intraspinal neoplasms|60516709|0-14|All Races|Male and Female|2006
5.5|6.8|6.1|372|IIa Hodgkin lymphomas|60516709|0-14|All Races|Male and Female|2006
5.8|7.1|6.4|389|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60516709|0-14|All Races|Male and Female|2006
2.1|2.9|2.5|150|IIc Burkitt lymphoma|60516709|0-14|All Races|Male and Female|2006
1.2|1.8|1.5|90|IId Miscellaneous lymphoreticular neoplasms|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|IIe Unspecified lymphomas|60516709|0-14|All Races|Male and Female|2006
9.5|11.1|10.3|635|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60516709|0-14|All Races|Male and Female|2006
9.4|11.0|10.2|627|IVa Neuroblastoma and ganglioneuroblastoma|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|IVb Other peripheral nervous cell tumors|60516709|0-14|All Races|Male and Female|2006
9.6|11.2|10.4|630|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60516709|0-14|All Races|Male and Female|2006
4.1|5.2|4.7|283|IXa Rhabdomyosarcomas|60516709|0-14|All Races|Male and Female|2006
0.9|1.4|1.1|68|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|IXc Kaposi sarcoma|60516709|0-14|All Races|Male and Female|2006
3.0|4.0|3.5|212|IXd Other specified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006
0.8|1.4|1.1|65|IXe Unspecified soft tissue sarcomas|60516709|0-14|All Races|Male and Female|2006
37.2|40.4|38.8|2353|Ia Lymphoid leukemias|60516709|0-14|All Races|Male and Female|2006
7.3|8.7|8.0|489|Ib Acute myeloid leukemias|60516709|0-14|All Races|Male and Female|2006
1.5|2.1|1.8|108|Ic Chronic myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006
1.5|2.2|1.8|110|Id Myelodysplastic syndrome and other myeloproliferative diseases|60516709|0-14|All Races|Male and Female|2006
0.9|1.5|1.2|72|Ie Unspecified and other specified leukemias|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|Not classified by ICCC|60516709|0-14|All Races|Male and Female|2006
3.6|4.6|4.1|253|V RETINOBLASTOMA|60516709|0-14|All Races|Male and Female|2006
7.5|9.0|8.2|502|VI RENAL TUMORS|60516709|0-14|All Races|Male and Female|2006
2.5|3.4|2.9|181|VII HEPATIC TUMORS|60516709|0-14|All Races|Male and Female|2006
6.4|7.7|7.0|424|VIII MALIGNANT BONE TUMORS|60516709|0-14|All Races|Male and Female|2006
3.5|4.5|4.0|242|VIIIa Osteosarcomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIIIb Chondrosarcomas|60516709|0-14|All Races|Male and Female|2006
2.0|2.9|2.4|146|VIIIc Ewing tumor and related sarcomas of bone|60516709|0-14|All Races|Male and Female|2006
0.2|0.5|0.3|18|VIIId Other specified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIIIe Unspecified malignant bone tumors|60516709|0-14|All Races|Male and Female|2006
2.1|2.9|2.5|153|VIIa Hepatoblastoma and mesenchymal tumors of liver|60516709|0-14|All Races|Male and Female|2006
0.3|0.6|0.4|24|VIIb Hepatic carcinomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60516709|0-14|All Races|Male and Female|2006
7.1|8.5|7.8|476|VIa Nephroblastoma and other non-epithelial renal tumors|60516709|0-14|All Races|Male and Female|2006
0.2|0.5|0.3|21|VIb Renal carcinomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|VIc Unspecified malignant renal tumors|60516709|0-14|All Races|Male and Female|2006
4.6|5.8|5.2|317|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60516709|0-14|All Races|Male and Female|2006
6.8|8.2|7.5|456|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60516709|0-14|All Races|Male and Female|2006
0.6|1.0|0.8|46|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60516709|0-14|All Races|Male and Female|2006
0.3|0.7|0.5|29|XIIa Other specified malignant tumors|60516709|0-14|All Races|Male and Female|2006
0.2|0.4|0.3|17|XIIb Other unspecified malignant tumors|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|XIa Adrenocortical carcinomas|60516709|0-14|All Races|Male and Female|2006
2.3|3.1|2.7|163|XIb Thyroid carcinomas|60516709|0-14|All Races|Male and Female|2006
0.2|0.5|0.3|18|XIc Nasopharyngeal carcinomas|60516709|0-14|All Races|Male and Female|2006
2.0|2.8|2.4|147|XId Malignant melanomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|XIe Skin carcinomas|60516709|0-14|All Races|Male and Female|2006
1.5|2.2|1.8|109|XIf Other and unspecified carcinomas|60516709|0-14|All Races|Male and Female|2006
1.0|1.6|1.3|78|Xa Intracranial and intraspinal germ cell tumors|60516709|0-14|All Races|Male and Female|2006
1.3|1.9|1.5|96|Xb Malignant extracranial and extragonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006
1.7|2.5|2.1|127|Xc Malignant gonadal germ cell tumors|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|Xd Gonadal carcinomas|60516709|0-14|All Races|Male and Female|2006
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60516709|0-14|All Races|Male and Female|2006
159.0|165.4|162.2|9913|All ICCC Groups Combined|60681615|0-14|All Races|Male and Female|2007
50.0|53.7|51.8|3164|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60681615|0-14|All Races|Male and Female|2007
15.6|17.7|16.6|1009|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60681615|0-14|All Races|Male and Female|2007
34.1|37.1|35.6|2161|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60681615|0-14|All Races|Male and Female|2007
2.5|3.4|2.9|179|IIIa Ependymomas and choroid plexus tumor|60681615|0-14|All Races|Male and Female|2007
16.2|18.3|17.2|1045|IIIb Astrocytomas|60681615|0-14|All Races|Male and Female|2007
7.0|8.4|7.6|465|IIIc Intracranial and intraspinal embryonal tumors|60681615|0-14|All Races|Male and Female|2007
5.9|7.2|6.5|396|IIId Other gliomas|60681615|0-14|All Races|Male and Female|2007
0.5|1.0|0.7|45|IIIe Other specified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007
0.3|0.7|0.5|31|IIIf Unspecified intracranial and intraspinal neoplasms|60681615|0-14|All Races|Male and Female|2007
4.9|6.1|5.5|332|IIa Hodgkin lymphomas|60681615|0-14|All Races|Male and Female|2007
6.4|7.7|7.0|425|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60681615|0-14|All Races|Male and Female|2007
2.2|3.1|2.6|159|IIc Burkitt lymphoma|60681615|0-14|All Races|Male and Female|2007
1.0|1.6|1.3|80|IId Miscellaneous lymphoreticular neoplasms|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|IIe Unspecified lymphomas|60681615|0-14|All Races|Male and Female|2007
10.9|12.7|11.8|735|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60681615|0-14|All Races|Male and Female|2007
10.7|12.5|11.6|723|IVa Neuroblastoma and ganglioneuroblastoma|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|IVb Other peripheral nervous cell tumors|60681615|0-14|All Races|Male and Female|2007
10.1|11.7|10.9|664|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60681615|0-14|All Races|Male and Female|2007
4.9|6.1|5.5|336|IXa Rhabdomyosarcomas|60681615|0-14|All Races|Male and Female|2007
0.9|1.5|1.2|73|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|IXc Kaposi sarcoma|60681615|0-14|All Races|Male and Female|2007
2.9|3.8|3.3|203|IXd Other specified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007
0.6|1.1|0.9|52|IXe Unspecified soft tissue sarcomas|60681615|0-14|All Races|Male and Female|2007
38.1|41.3|39.7|2419|Ia Lymphoid leukemias|60681615|0-14|All Races|Male and Female|2007
7.0|8.4|7.7|473|Ib Acute myeloid leukemias|60681615|0-14|All Races|Male and Female|2007
1.4|2.1|1.7|105|Ic Chronic myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007
1.3|1.9|1.6|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|60681615|0-14|All Races|Male and Female|2007
0.9|1.4|1.1|70|Ie Unspecified and other specified leukemias|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|Not classified by ICCC|60681615|0-14|All Races|Male and Female|2007
3.9|4.9|4.4|275|V RETINOBLASTOMA|60681615|0-14|All Races|Male and Female|2007
7.9|9.4|8.6|529|VI RENAL TUMORS|60681615|0-14|All Races|Male and Female|2007
2.3|3.2|2.7|169|VII HEPATIC TUMORS|60681615|0-14|All Races|Male and Female|2007
6.2|7.5|6.9|415|VIII MALIGNANT BONE TUMORS|60681615|0-14|All Races|Male and Female|2007
3.2|4.2|3.7|223|VIIIa Osteosarcomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIIIb Chondrosarcomas|60681615|0-14|All Races|Male and Female|2007
2.1|2.9|2.5|151|VIIIc Ewing tumor and related sarcomas of bone|60681615|0-14|All Races|Male and Female|2007
0.2|0.5|0.3|18|VIIId Other specified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIIIe Unspecified malignant bone tumors|60681615|0-14|All Races|Male and Female|2007
2.1|2.8|2.4|151|VIIa Hepatoblastoma and mesenchymal tumors of liver|60681615|0-14|All Races|Male and Female|2007
0.2|0.5|0.3|18|VIIb Hepatic carcinomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60681615|0-14|All Races|Male and Female|2007
7.5|8.9|8.2|502|VIa Nephroblastoma and other non-epithelial renal tumors|60681615|0-14|All Races|Male and Female|2007
0.3|0.6|0.4|26|VIb Renal carcinomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|VIc Unspecified malignant renal tumors|60681615|0-14|All Races|Male and Female|2007
4.9|6.1|5.5|336|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60681615|0-14|All Races|Male and Female|2007
6.0|7.3|6.6|401|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60681615|0-14|All Races|Male and Female|2007
0.5|0.9|0.7|42|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60681615|0-14|All Races|Male and Female|2007
0.3|0.6|0.4|24|XIIa Other specified malignant tumors|60681615|0-14|All Races|Male and Female|2007
0.2|0.5|0.3|18|XIIb Other unspecified malignant tumors|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|XIa Adrenocortical carcinomas|60681615|0-14|All Races|Male and Female|2007
2.0|2.8|2.3|143|XIb Thyroid carcinomas|60681615|0-14|All Races|Male and Female|2007
0.2|0.4|0.3|16|XIc Nasopharyngeal carcinomas|60681615|0-14|All Races|Male and Female|2007
1.8|2.5|2.1|128|XId Malignant melanomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|XIe Skin carcinomas|60681615|0-14|All Races|Male and Female|2007
1.3|2.0|1.6|98|XIf Other and unspecified carcinomas|60681615|0-14|All Races|Male and Female|2007
1.1|1.7|1.4|84|Xa Intracranial and intraspinal germ cell tumors|60681615|0-14|All Races|Male and Female|2007
1.0|1.6|1.3|82|Xb Malignant extracranial and extragonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007
2.2|3.0|2.6|157|Xc Malignant gonadal germ cell tumors|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|Xd Gonadal carcinomas|60681615|0-14|All Races|Male and Female|2007
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60681615|0-14|All Races|Male and Female|2007
161.6|168.0|164.8|10108|All ICCC Groups Combined|60907384|0-14|All Races|Male and Female|2008
51.9|55.6|53.8|3300|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60907384|0-14|All Races|Male and Female|2008
16.2|18.3|17.2|1045|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60907384|0-14|All Races|Male and Female|2008
34.2|37.2|35.7|2177|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60907384|0-14|All Races|Male and Female|2008
2.2|3.1|2.6|161|IIIa Ependymomas and choroid plexus tumor|60907384|0-14|All Races|Male and Female|2008
16.8|18.9|17.8|1086|IIIb Astrocytomas|60907384|0-14|All Races|Male and Female|2008
7.4|8.9|8.1|500|IIIc Intracranial and intraspinal embryonal tumors|60907384|0-14|All Races|Male and Female|2008
5.4|6.7|6.0|366|IIId Other gliomas|60907384|0-14|All Races|Male and Female|2008
0.5|0.9|0.7|43|IIIe Other specified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008
0.2|0.5|0.3|21|IIIf Unspecified intracranial and intraspinal neoplasms|60907384|0-14|All Races|Male and Female|2008
5.7|7.0|6.3|384|IIa Hodgkin lymphomas|60907384|0-14|All Races|Male and Female|2008
6.1|7.4|6.7|409|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60907384|0-14|All Races|Male and Female|2008
2.3|3.2|2.7|164|IIc Burkitt lymphoma|60907384|0-14|All Races|Male and Female|2008
0.9|1.5|1.2|74|IId Miscellaneous lymphoreticular neoplasms|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|IIe Unspecified lymphomas|60907384|0-14|All Races|Male and Female|2008
10.1|11.8|11.0|686|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60907384|0-14|All Races|Male and Female|2008
9.9|11.5|10.7|668|IVa Neuroblastoma and ganglioneuroblastoma|60907384|0-14|All Races|Male and Female|2008
0.2|0.5|0.3|18|IVb Other peripheral nervous cell tumors|60907384|0-14|All Races|Male and Female|2008
10.1|11.8|10.9|670|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60907384|0-14|All Races|Male and Female|2008
4.6|5.7|5.1|315|IXa Rhabdomyosarcomas|60907384|0-14|All Races|Male and Female|2008
0.8|1.3|1.0|64|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|IXc Kaposi sarcoma|60907384|0-14|All Races|Male and Female|2008
3.0|4.0|3.5|213|IXd Other specified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008
1.0|1.6|1.3|77|IXe Unspecified soft tissue sarcomas|60907384|0-14|All Races|Male and Female|2008
39.2|42.4|40.8|2500|Ia Lymphoid leukemias|60907384|0-14|All Races|Male and Female|2008
7.4|8.8|8.0|496|Ib Acute myeloid leukemias|60907384|0-14|All Races|Male and Female|2008
1.8|2.6|2.2|135|Ic Chronic myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008
1.4|2.1|1.7|106|Id Myelodysplastic syndrome and other myeloproliferative diseases|60907384|0-14|All Races|Male and Female|2008
0.8|1.3|1.0|63|Ie Unspecified and other specified leukemias|60907384|0-14|All Races|Male and Female|2008
0.2|0.5|0.3|18|Not classified by ICCC|60907384|0-14|All Races|Male and Female|2008
3.8|4.8|4.3|269|V RETINOBLASTOMA|60907384|0-14|All Races|Male and Female|2008
8.2|9.7|9.0|555|VI RENAL TUMORS|60907384|0-14|All Races|Male and Female|2008
2.4|3.2|2.8|174|VII HEPATIC TUMORS|60907384|0-14|All Races|Male and Female|2008
6.2|7.5|6.9|414|VIII MALIGNANT BONE TUMORS|60907384|0-14|All Races|Male and Female|2008
3.4|4.4|3.8|232|VIIIa Osteosarcomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIIb Chondrosarcomas|60907384|0-14|All Races|Male and Female|2008
2.1|2.9|2.4|148|VIIIc Ewing tumor and related sarcomas of bone|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIId Other specified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIIe Unspecified malignant bone tumors|60907384|0-14|All Races|Male and Female|2008
2.0|2.8|2.4|150|VIIa Hepatoblastoma and mesenchymal tumors of liver|60907384|0-14|All Races|Male and Female|2008
0.3|0.6|0.4|24|VIIb Hepatic carcinomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60907384|0-14|All Races|Male and Female|2008
7.8|9.3|8.6|531|VIa Nephroblastoma and other non-epithelial renal tumors|60907384|0-14|All Races|Male and Female|2008
0.2|0.6|0.4|23|VIb Renal carcinomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|VIc Unspecified malignant renal tumors|60907384|0-14|All Races|Male and Female|2008
4.7|5.9|5.3|326|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60907384|0-14|All Races|Male and Female|2008
6.5|7.9|7.2|436|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60907384|0-14|All Races|Male and Female|2008
0.4|0.8|0.6|38|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60907384|0-14|All Races|Male and Female|2008
0.2|0.6|0.4|24|XIIa Other specified malignant tumors|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|XIIb Other unspecified malignant tumors|60907384|0-14|All Races|Male and Female|2008
0.1|0.4|0.3|16|XIa Adrenocortical carcinomas|60907384|0-14|All Races|Male and Female|2008
2.2|3.1|2.6|159|XIb Thyroid carcinomas|60907384|0-14|All Races|Male and Female|2008
0.2|0.4|0.3|17|XIc Nasopharyngeal carcinomas|60907384|0-14|All Races|Male and Female|2008
1.9|2.6|2.2|136|XId Malignant melanomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|XIe Skin carcinomas|60907384|0-14|All Races|Male and Female|2008
1.4|2.1|1.7|105|XIf Other and unspecified carcinomas|60907384|0-14|All Races|Male and Female|2008
1.1|1.7|1.4|82|Xa Intracranial and intraspinal germ cell tumors|60907384|0-14|All Races|Male and Female|2008
1.1|1.7|1.4|90|Xb Malignant extracranial and extragonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008
1.9|2.7|2.3|141|Xc Malignant gonadal germ cell tumors|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|Xd Gonadal carcinomas|60907384|0-14|All Races|Male and Female|2008
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60907384|0-14|All Races|Male and Female|2008
160.4|166.8|163.6|10051|All ICCC Groups Combined|61087581|0-14|All Races|Male and Female|2009
50.8|54.4|52.6|3238|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61087581|0-14|All Races|Male and Female|2009
15.9|17.9|16.9|1028|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61087581|0-14|All Races|Male and Female|2009
34.3|37.3|35.8|2193|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61087581|0-14|All Races|Male and Female|2009
2.1|2.9|2.5|155|IIIa Ependymomas and choroid plexus tumor|61087581|0-14|All Races|Male and Female|2009
16.9|19.0|17.9|1096|IIIb Astrocytomas|61087581|0-14|All Races|Male and Female|2009
7.0|8.4|7.6|469|IIIc Intracranial and intraspinal embryonal tumors|61087581|0-14|All Races|Male and Female|2009
6.1|7.4|6.7|410|IIId Other gliomas|61087581|0-14|All Races|Male and Female|2009
0.4|0.8|0.6|34|IIIe Other specified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009
0.3|0.7|0.5|29|IIIf Unspecified intracranial and intraspinal neoplasms|61087581|0-14|All Races|Male and Female|2009
5.2|6.4|5.8|350|IIa Hodgkin lymphomas|61087581|0-14|All Races|Male and Female|2009
6.2|7.6|6.9|419|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61087581|0-14|All Races|Male and Female|2009
2.0|2.8|2.4|143|IIc Burkitt lymphoma|61087581|0-14|All Races|Male and Female|2009
1.4|2.0|1.7|104|IId Miscellaneous lymphoreticular neoplasms|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|IIe Unspecified lymphomas|61087581|0-14|All Races|Male and Female|2009
10.0|11.7|10.8|674|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61087581|0-14|All Races|Male and Female|2009
9.9|11.5|10.6|663|IVa Neuroblastoma and ganglioneuroblastoma|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|IVb Other peripheral nervous cell tumors|61087581|0-14|All Races|Male and Female|2009
9.8|11.4|10.6|648|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61087581|0-14|All Races|Male and Female|2009
3.9|5.0|4.4|271|IXa Rhabdomyosarcomas|61087581|0-14|All Races|Male and Female|2009
1.0|1.6|1.3|79|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|IXc Kaposi sarcoma|61087581|0-14|All Races|Male and Female|2009
3.2|4.2|3.7|224|IXd Other specified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009
1.0|1.5|1.2|74|IXe Unspecified soft tissue sarcomas|61087581|0-14|All Races|Male and Female|2009
39.4|42.6|41.0|2527|Ia Lymphoid leukemias|61087581|0-14|All Races|Male and Female|2009
6.6|8.0|7.3|450|Ib Acute myeloid leukemias|61087581|0-14|All Races|Male and Female|2009
1.3|2.0|1.6|100|Ic Chronic myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009
1.3|1.9|1.6|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|61087581|0-14|All Races|Male and Female|2009
0.8|1.3|1.0|64|Ie Unspecified and other specified leukemias|61087581|0-14|All Races|Male and Female|2009
0.2|0.5|0.3|19|Not classified by ICCC|61087581|0-14|All Races|Male and Female|2009
4.0|5.1|4.5|284|V RETINOBLASTOMA|61087581|0-14|All Races|Male and Female|2009
8.5|10.0|9.2|574|VI RENAL TUMORS|61087581|0-14|All Races|Male and Female|2009
2.0|2.8|2.4|150|VII HEPATIC TUMORS|61087581|0-14|All Races|Male and Female|2009
6.4|7.7|7.0|425|VIII MALIGNANT BONE TUMORS|61087581|0-14|All Races|Male and Female|2009
3.5|4.5|4.0|240|VIIIa Osteosarcomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIIIb Chondrosarcomas|61087581|0-14|All Races|Male and Female|2009
2.0|2.8|2.4|143|VIIIc Ewing tumor and related sarcomas of bone|61087581|0-14|All Races|Male and Female|2009
0.2|0.6|0.4|23|VIIId Other specified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIIIe Unspecified malignant bone tumors|61087581|0-14|All Races|Male and Female|2009
1.7|2.5|2.1|129|VIIa Hepatoblastoma and mesenchymal tumors of liver|61087581|0-14|All Races|Male and Female|2009
0.2|0.5|0.3|19|VIIb Hepatic carcinomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61087581|0-14|All Races|Male and Female|2009
7.9|9.4|8.6|537|VIa Nephroblastoma and other non-epithelial renal tumors|61087581|0-14|All Races|Male and Female|2009
0.4|0.8|0.6|36|VIb Renal carcinomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|VIc Unspecified malignant renal tumors|61087581|0-14|All Races|Male and Female|2009
4.9|6.1|5.4|333|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61087581|0-14|All Races|Male and Female|2009
6.4|7.8|7.1|430|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61087581|0-14|All Races|Male and Female|2009
0.7|1.2|0.9|55|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61087581|0-14|All Races|Male and Female|2009
0.3|0.7|0.5|28|XIIa Other specified malignant tumors|61087581|0-14|All Races|Male and Female|2009
0.3|0.6|0.4|27|XIIb Other unspecified malignant tumors|61087581|0-14|All Races|Male and Female|2009
0.1|0.4|0.3|16|XIa Adrenocortical carcinomas|61087581|0-14|All Races|Male and Female|2009
2.5|3.4|2.9|177|XIb Thyroid carcinomas|61087581|0-14|All Races|Male and Female|2009
0.3|0.6|0.4|25|XIc Nasopharyngeal carcinomas|61087581|0-14|All Races|Male and Female|2009
1.3|1.9|1.6|95|XId Malignant melanomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|XIe Skin carcinomas|61087581|0-14|All Races|Male and Female|2009
1.5|2.2|1.8|111|XIf Other and unspecified carcinomas|61087581|0-14|All Races|Male and Female|2009
1.1|1.7|1.4|85|Xa Intracranial and intraspinal germ cell tumors|61087581|0-14|All Races|Male and Female|2009
0.9|1.5|1.2|74|Xb Malignant extracranial and extragonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009
2.2|3.1|2.6|161|Xc Malignant gonadal germ cell tumors|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|Xd Gonadal carcinomas|61087581|0-14|All Races|Male and Female|2009
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61087581|0-14|All Races|Male and Female|2009
167.6|174.2|170.9|10511|All ICCC Groups Combined|61228770|0-14|All Races|Male and Female|2010
52.0|55.7|53.8|3319|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61228770|0-14|All Races|Male and Female|2010
19.5|21.8|20.6|1259|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61228770|0-14|All Races|Male and Female|2010
35.4|38.4|36.9|2263|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61228770|0-14|All Races|Male and Female|2010
2.9|3.8|3.3|205|IIIa Ependymomas and choroid plexus tumor|61228770|0-14|All Races|Male and Female|2010
17.9|20.1|19.0|1164|IIIb Astrocytomas|61228770|0-14|All Races|Male and Female|2010
6.7|8.1|7.4|455|IIIc Intracranial and intraspinal embryonal tumors|61228770|0-14|All Races|Male and Female|2010
5.6|6.8|6.2|378|IIId Other gliomas|61228770|0-14|All Races|Male and Female|2010
0.5|0.9|0.6|39|IIIe Other specified intracranial and intraspinal neoplasms|61228770|0-14|All Races|Male and Female|2010
0.2|0.5|0.4|22|IIIf Unspecified intracranial and intraspinal neoplasms|61228770|0-14|All Races|Male and Female|2010
4.7|5.9|5.3|323|IIa Hodgkin lymphomas|61228770|0-14|All Races|Male and Female|2010
7.0|8.4|7.6|466|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61228770|0-14|All Races|Male and Female|2010
2.1|2.9|2.4|149|IIc Burkitt lymphoma|61228770|0-14|All Races|Male and Female|2010
4.5|5.6|5.0|311|IId Miscellaneous lymphoreticular neoplasms|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|IIe Unspecified lymphomas|61228770|0-14|All Races|Male and Female|2010
10.5|12.1|11.3|700|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61228770|0-14|All Races|Male and Female|2010
10.3|11.9|11.1|688|IVa Neuroblastoma and ganglioneuroblastoma|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|IVb Other peripheral nervous cell tumors|61228770|0-14|All Races|Male and Female|2010
10.4|12.0|11.2|685|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61228770|0-14|All Races|Male and Female|2010
4.8|5.9|5.3|327|IXa Rhabdomyosarcomas|61228770|0-14|All Races|Male and Female|2010
0.6|1.1|0.8|50|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|IXc Kaposi sarcoma|61228770|0-14|All Races|Male and Female|2010
3.3|4.2|3.7|228|IXd Other specified soft tissue sarcomas|61228770|0-14|All Races|Male and Female|2010
1.0|1.6|1.3|80|IXe Unspecified soft tissue sarcomas|61228770|0-14|All Races|Male and Female|2010
39.4|42.6|41.0|2529|Ia Lymphoid leukemias|61228770|0-14|All Races|Male and Female|2010
7.2|8.6|7.9|487|Ib Acute myeloid leukemias|61228770|0-14|All Races|Male and Female|2010
1.6|2.4|2.0|121|Ic Chronic myeloproliferative diseases|61228770|0-14|All Races|Male and Female|2010
1.6|2.3|1.9|119|Id Myelodysplastic syndrome and other myeloproliferative diseases|61228770|0-14|All Races|Male and Female|2010
0.8|1.3|1.0|63|Ie Unspecified and other specified leukemias|61228770|0-14|All Races|Male and Female|2010
0.1|0.4|0.3|16|Not classified by ICCC|61228770|0-14|All Races|Male and Female|2010
4.0|5.1|4.5|282|V RETINOBLASTOMA|61228770|0-14|All Races|Male and Female|2010
7.7|9.2|8.4|523|VI RENAL TUMORS|61228770|0-14|All Races|Male and Female|2010
3.0|3.9|3.4|211|VII HEPATIC TUMORS|61228770|0-14|All Races|Male and Female|2010
6.1|7.5|6.8|412|VIII MALIGNANT BONE TUMORS|61228770|0-14|All Races|Male and Female|2010
3.3|4.2|3.7|226|VIIIa Osteosarcomas|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|VIIIb Chondrosarcomas|61228770|0-14|All Races|Male and Female|2010
2.0|2.8|2.4|144|VIIIc Ewing tumor and related sarcomas of bone|61228770|0-14|All Races|Male and Female|2010
0.2|0.5|0.3|21|VIIId Other specified malignant bone tumors|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|VIIIe Unspecified malignant bone tumors|61228770|0-14|All Races|Male and Female|2010
2.5|3.4|2.9|181|VIIa Hepatoblastoma and mesenchymal tumors of liver|61228770|0-14|All Races|Male and Female|2010
0.3|0.7|0.5|29|VIIb Hepatic carcinomas|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61228770|0-14|All Races|Male and Female|2010
7.4|8.8|8.1|503|VIa Nephroblastoma and other non-epithelial renal tumors|61228770|0-14|All Races|Male and Female|2010
0.2|0.5|0.3|19|VIb Renal carcinomas|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|VIc Unspecified malignant renal tumors|61228770|0-14|All Races|Male and Female|2010
5.5|6.8|6.1|376|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61228770|0-14|All Races|Male and Female|2010
6.3|7.6|6.9|421|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61228770|0-14|All Races|Male and Female|2010
0.5|1.0|0.7|44|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61228770|0-14|All Races|Male and Female|2010
0.3|0.7|0.5|30|XIIa Other specified malignant tumors|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|XIIb Other unspecified malignant tumors|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|XIa Adrenocortical carcinomas|61228770|0-14|All Races|Male and Female|2010
2.5|3.3|2.9|174|XIb Thyroid carcinomas|61228770|0-14|All Races|Male and Female|2010
0.2|0.4|0.3|16|XIc Nasopharyngeal carcinomas|61228770|0-14|All Races|Male and Female|2010
1.5|2.1|1.8|108|XId Malignant melanomas|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|XIe Skin carcinomas|61228770|0-14|All Races|Male and Female|2010
1.4|2.1|1.7|104|XIf Other and unspecified carcinomas|61228770|0-14|All Races|Male and Female|2010
1.5|2.2|1.8|111|Xa Intracranial and intraspinal germ cell tumors|61228770|0-14|All Races|Male and Female|2010
1.1|1.7|1.4|84|Xb Malignant extracranial and extragonadal germ cell tumors|61228770|0-14|All Races|Male and Female|2010
2.2|3.0|2.6|158|Xc Malignant gonadal germ cell tumors|61228770|0-14|All Races|Male and Female|2010
~|~|~|~|Xd Gonadal carcinomas|61228770|0-14|All Races|Male and Female|2010
0.1|0.4|0.3|16|Xe Other and unspecified malignant gonadal tumors|61228770|0-14|All Races|Male and Female|2010
167.1|173.7|170.4|10485|All ICCC Groups Combined|61309611|0-14|All Races|Male and Female|2011
51.9|55.6|53.7|3310|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61309611|0-14|All Races|Male and Female|2011
19.7|22.0|20.8|1276|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61309611|0-14|All Races|Male and Female|2011
34.7|37.7|36.2|2224|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61309611|0-14|All Races|Male and Female|2011
2.9|3.9|3.4|208|IIIa Ependymomas and choroid plexus tumor|61309611|0-14|All Races|Male and Female|2011
17.4|19.6|18.5|1136|IIIb Astrocytomas|61309611|0-14|All Races|Male and Female|2011
6.4|7.7|7.0|433|IIIc Intracranial and intraspinal embryonal tumors|61309611|0-14|All Races|Male and Female|2011
5.7|6.9|6.3|384|IIId Other gliomas|61309611|0-14|All Races|Male and Female|2011
0.4|0.8|0.6|35|IIIe Other specified intracranial and intraspinal neoplasms|61309611|0-14|All Races|Male and Female|2011
0.3|0.7|0.5|28|IIIf Unspecified intracranial and intraspinal neoplasms|61309611|0-14|All Races|Male and Female|2011
4.7|5.8|5.2|318|IIa Hodgkin lymphomas|61309611|0-14|All Races|Male and Female|2011
6.2|7.6|6.9|420|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61309611|0-14|All Races|Male and Female|2011
2.2|3.1|2.6|161|IIc Burkitt lymphoma|61309611|0-14|All Races|Male and Female|2011
5.3|6.6|5.9|364|IId Miscellaneous lymphoreticular neoplasms|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|IIe Unspecified lymphomas|61309611|0-14|All Races|Male and Female|2011
10.5|12.2|11.3|702|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61309611|0-14|All Races|Male and Female|2011
10.3|12.0|11.1|688|IVa Neuroblastoma and ganglioneuroblastoma|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|IVb Other peripheral nervous cell tumors|61309611|0-14|All Races|Male and Female|2011
9.9|11.5|10.7|657|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61309611|0-14|All Races|Male and Female|2011
4.4|5.5|4.9|304|IXa Rhabdomyosarcomas|61309611|0-14|All Races|Male and Female|2011
0.8|1.3|1.1|65|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|IXc Kaposi sarcoma|61309611|0-14|All Races|Male and Female|2011
3.1|4.1|3.6|220|IXd Other specified soft tissue sarcomas|61309611|0-14|All Races|Male and Female|2011
0.8|1.4|1.1|66|IXe Unspecified soft tissue sarcomas|61309611|0-14|All Races|Male and Female|2011
40.3|43.5|41.9|2582|Ia Lymphoid leukemias|61309611|0-14|All Races|Male and Female|2011
7.1|8.5|7.8|478|Ib Acute myeloid leukemias|61309611|0-14|All Races|Male and Female|2011
1.5|2.3|1.9|115|Ic Chronic myeloproliferative diseases|61309611|0-14|All Races|Male and Female|2011
1.1|1.7|1.3|83|Id Myelodysplastic syndrome and other myeloproliferative diseases|61309611|0-14|All Races|Male and Female|2011
0.6|1.1|0.8|52|Ie Unspecified and other specified leukemias|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|Not classified by ICCC|61309611|0-14|All Races|Male and Female|2011
3.7|4.7|4.2|260|V RETINOBLASTOMA|61309611|0-14|All Races|Male and Female|2011
8.2|9.7|9.0|556|VI RENAL TUMORS|61309611|0-14|All Races|Male and Female|2011
3.0|4.0|3.5|215|VII HEPATIC TUMORS|61309611|0-14|All Races|Male and Female|2011
6.7|8.1|7.4|451|VIII MALIGNANT BONE TUMORS|61309611|0-14|All Races|Male and Female|2011
3.6|4.6|4.1|249|VIIIa Osteosarcomas|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|VIIIb Chondrosarcomas|61309611|0-14|All Races|Male and Female|2011
2.4|3.2|2.8|170|VIIIc Ewing tumor and related sarcomas of bone|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|VIIId Other specified malignant bone tumors|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|VIIIe Unspecified malignant bone tumors|61309611|0-14|All Races|Male and Female|2011
2.6|3.5|3.0|187|VIIa Hepatoblastoma and mesenchymal tumors of liver|61309611|0-14|All Races|Male and Female|2011
0.3|0.6|0.4|25|VIIb Hepatic carcinomas|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61309611|0-14|All Races|Male and Female|2011
7.9|9.4|8.6|533|VIa Nephroblastoma and other non-epithelial renal tumors|61309611|0-14|All Races|Male and Female|2011
0.2|0.5|0.4|22|VIb Renal carcinomas|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|VIc Unspecified malignant renal tumors|61309611|0-14|All Races|Male and Female|2011
4.6|5.7|5.1|313|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61309611|0-14|All Races|Male and Female|2011
7.0|8.4|7.7|470|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61309611|0-14|All Races|Male and Female|2011
0.5|0.9|0.6|40|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61309611|0-14|All Races|Male and Female|2011
0.2|0.5|0.3|20|XIIa Other specified malignant tumors|61309611|0-14|All Races|Male and Female|2011
0.2|0.5|0.3|20|XIIb Other unspecified malignant tumors|61309611|0-14|All Races|Male and Female|2011
0.1|0.4|0.3|16|XIa Adrenocortical carcinomas|61309611|0-14|All Races|Male and Female|2011
2.9|3.8|3.3|204|XIb Thyroid carcinomas|61309611|0-14|All Races|Male and Female|2011
0.2|0.5|0.3|19|XIc Nasopharyngeal carcinomas|61309611|0-14|All Races|Male and Female|2011
1.7|2.4|2.0|124|XId Malignant melanomas|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|XIe Skin carcinomas|61309611|0-14|All Races|Male and Female|2011
1.4|2.1|1.7|105|XIf Other and unspecified carcinomas|61309611|0-14|All Races|Male and Female|2011
1.2|1.9|1.5|93|Xa Intracranial and intraspinal germ cell tumors|61309611|0-14|All Races|Male and Female|2011
1.0|1.5|1.2|75|Xb Malignant extracranial and extragonadal germ cell tumors|61309611|0-14|All Races|Male and Female|2011
1.8|2.6|2.2|133|Xc Malignant gonadal germ cell tumors|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|Xd Gonadal carcinomas|61309611|0-14|All Races|Male and Female|2011
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61309611|0-14|All Races|Male and Female|2011
166.2|172.8|169.5|10424|All ICCC Groups Combined|61367958|0-14|All Races|Male and Female|2012
50.0|53.6|51.8|3189|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61367958|0-14|All Races|Male and Female|2012
21.0|23.4|22.2|1361|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61367958|0-14|All Races|Male and Female|2012
34.2|37.2|35.7|2192|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61367958|0-14|All Races|Male and Female|2012
2.6|3.4|3.0|183|IIIa Ependymomas and choroid plexus tumor|61367958|0-14|All Races|Male and Female|2012
17.8|20.0|18.9|1162|IIIb Astrocytomas|61367958|0-14|All Races|Male and Female|2012
6.5|7.8|7.1|438|IIIc Intracranial and intraspinal embryonal tumors|61367958|0-14|All Races|Male and Female|2012
4.8|6.0|5.4|329|IIId Other gliomas|61367958|0-14|All Races|Male and Female|2012
0.4|0.8|0.6|36|IIIe Other specified intracranial and intraspinal neoplasms|61367958|0-14|All Races|Male and Female|2012
0.5|1.0|0.7|44|IIIf Unspecified intracranial and intraspinal neoplasms|61367958|0-14|All Races|Male and Female|2012
5.1|6.3|5.7|349|IIa Hodgkin lymphomas|61367958|0-14|All Races|Male and Female|2012
7.3|8.7|8.0|489|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61367958|0-14|All Races|Male and Female|2012
2.0|2.7|2.3|143|IIc Burkitt lymphoma|61367958|0-14|All Races|Male and Female|2012
5.2|6.4|5.8|356|IId Miscellaneous lymphoreticular neoplasms|61367958|0-14|All Races|Male and Female|2012
0.3|0.6|0.4|24|IIe Unspecified lymphomas|61367958|0-14|All Races|Male and Female|2012
10.6|12.3|11.4|704|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61367958|0-14|All Races|Male and Female|2012
10.4|12.1|11.2|690|IVa Neuroblastoma and ganglioneuroblastoma|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|IVb Other peripheral nervous cell tumors|61367958|0-14|All Races|Male and Female|2012
10.1|11.8|11.0|673|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61367958|0-14|All Races|Male and Female|2012
4.4|5.5|4.9|303|IXa Rhabdomyosarcomas|61367958|0-14|All Races|Male and Female|2012
0.9|1.5|1.2|71|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|IXc Kaposi sarcoma|61367958|0-14|All Races|Male and Female|2012
3.1|4.1|3.6|220|IXd Other specified soft tissue sarcomas|61367958|0-14|All Races|Male and Female|2012
1.0|1.6|1.3|77|IXe Unspecified soft tissue sarcomas|61367958|0-14|All Races|Male and Female|2012
38.6|41.7|40.1|2473|Ia Lymphoid leukemias|61367958|0-14|All Races|Male and Female|2012
6.5|7.9|7.2|442|Ib Acute myeloid leukemias|61367958|0-14|All Races|Male and Female|2012
1.5|2.1|1.8|109|Ic Chronic myeloproliferative diseases|61367958|0-14|All Races|Male and Female|2012
1.4|2.0|1.7|102|Id Myelodysplastic syndrome and other myeloproliferative diseases|61367958|0-14|All Races|Male and Female|2012
0.8|1.3|1.0|63|Ie Unspecified and other specified leukemias|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|Not classified by ICCC|61367958|0-14|All Races|Male and Female|2012
3.9|4.9|4.4|270|V RETINOBLASTOMA|61367958|0-14|All Races|Male and Female|2012
7.9|9.3|8.6|530|VI RENAL TUMORS|61367958|0-14|All Races|Male and Female|2012
3.1|4.0|3.5|217|VII HEPATIC TUMORS|61367958|0-14|All Races|Male and Female|2012
6.6|8.0|7.3|447|VIII MALIGNANT BONE TUMORS|61367958|0-14|All Races|Male and Female|2012
3.9|4.9|4.4|267|VIIIa Osteosarcomas|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|VIIIb Chondrosarcomas|61367958|0-14|All Races|Male and Female|2012
1.9|2.6|2.2|137|VIIIc Ewing tumor and related sarcomas of bone|61367958|0-14|All Races|Male and Female|2012
0.2|0.5|0.3|21|VIIId Other specified malignant bone tumors|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|VIIIe Unspecified malignant bone tumors|61367958|0-14|All Races|Male and Female|2012
2.6|3.5|3.0|187|VIIa Hepatoblastoma and mesenchymal tumors of liver|61367958|0-14|All Races|Male and Female|2012
0.3|0.7|0.5|28|VIIb Hepatic carcinomas|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61367958|0-14|All Races|Male and Female|2012
7.5|8.9|8.2|506|VIa Nephroblastoma and other non-epithelial renal tumors|61367958|0-14|All Races|Male and Female|2012
0.2|0.5|0.3|19|VIb Renal carcinomas|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|VIc Unspecified malignant renal tumors|61367958|0-14|All Races|Male and Female|2012
4.6|5.8|5.2|317|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61367958|0-14|All Races|Male and Female|2012
6.9|8.2|7.5|461|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61367958|0-14|All Races|Male and Female|2012
0.6|1.1|0.8|49|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61367958|0-14|All Races|Male and Female|2012
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|61367958|0-14|All Races|Male and Female|2012
0.3|0.6|0.4|24|XIIb Other unspecified malignant tumors|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|XIa Adrenocortical carcinomas|61367958|0-14|All Races|Male and Female|2012
2.8|3.7|3.2|199|XIb Thyroid carcinomas|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|XIc Nasopharyngeal carcinomas|61367958|0-14|All Races|Male and Female|2012
1.6|2.3|1.9|116|XId Malignant melanomas|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|XIe Skin carcinomas|61367958|0-14|All Races|Male and Female|2012
1.6|2.3|1.9|115|XIf Other and unspecified carcinomas|61367958|0-14|All Races|Male and Female|2012
1.1|1.7|1.3|82|Xa Intracranial and intraspinal germ cell tumors|61367958|0-14|All Races|Male and Female|2012
1.2|1.9|1.5|94|Xb Malignant extracranial and extragonadal germ cell tumors|61367958|0-14|All Races|Male and Female|2012
1.7|2.5|2.1|127|Xc Malignant gonadal germ cell tumors|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|Xd Gonadal carcinomas|61367958|0-14|All Races|Male and Female|2012
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61367958|0-14|All Races|Male and Female|2012
168.8|175.3|172.0|10575|All ICCC Groups Combined|61435794|0-14|All Races|Male and Female|2013
48.8|52.4|50.6|3112|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61435794|0-14|All Races|Male and Female|2013
21.2|23.6|22.3|1373|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61435794|0-14|All Races|Male and Female|2013
35.4|38.5|37.0|2271|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61435794|0-14|All Races|Male and Female|2013
2.7|3.6|3.1|192|IIIa Ependymomas and choroid plexus tumor|61435794|0-14|All Races|Male and Female|2013
18.4|20.6|19.5|1198|IIIb Astrocytomas|61435794|0-14|All Races|Male and Female|2013
6.3|7.6|6.9|425|IIIc Intracranial and intraspinal embryonal tumors|61435794|0-14|All Races|Male and Female|2013
5.6|6.9|6.2|381|IIId Other gliomas|61435794|0-14|All Races|Male and Female|2013
0.5|1.0|0.7|46|IIIe Other specified intracranial and intraspinal neoplasms|61435794|0-14|All Races|Male and Female|2013
0.3|0.7|0.5|29|IIIf Unspecified intracranial and intraspinal neoplasms|61435794|0-14|All Races|Male and Female|2013
5.0|6.2|5.5|340|IIa Hodgkin lymphomas|61435794|0-14|All Races|Male and Female|2013
7.2|8.6|7.9|485|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61435794|0-14|All Races|Male and Female|2013
1.9|2.7|2.3|142|IIc Burkitt lymphoma|61435794|0-14|All Races|Male and Female|2013
5.8|7.1|6.4|393|IId Miscellaneous lymphoreticular neoplasms|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|IIe Unspecified lymphomas|61435794|0-14|All Races|Male and Female|2013
11.4|13.1|12.2|752|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61435794|0-14|All Races|Male and Female|2013
11.1|12.8|11.9|732|IVa Neuroblastoma and ganglioneuroblastoma|61435794|0-14|All Races|Male and Female|2013
0.2|0.5|0.3|20|IVb Other peripheral nervous cell tumors|61435794|0-14|All Races|Male and Female|2013
10.1|11.7|10.9|668|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61435794|0-14|All Races|Male and Female|2013
4.5|5.6|5.1|311|IXa Rhabdomyosarcomas|61435794|0-14|All Races|Male and Female|2013
0.9|1.5|1.2|73|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|IXc Kaposi sarcoma|61435794|0-14|All Races|Male and Female|2013
3.2|4.1|3.6|222|IXd Other specified soft tissue sarcomas|61435794|0-14|All Races|Male and Female|2013
0.8|1.3|1.0|61|IXe Unspecified soft tissue sarcomas|61435794|0-14|All Races|Male and Female|2013
36.6|39.7|38.1|2346|Ia Lymphoid leukemias|61435794|0-14|All Races|Male and Female|2013
7.3|8.7|8.0|492|Ib Acute myeloid leukemias|61435794|0-14|All Races|Male and Female|2013
1.4|2.0|1.7|102|Ic Chronic myeloproliferative diseases|61435794|0-14|All Races|Male and Female|2013
1.3|1.9|1.5|95|Id Myelodysplastic syndrome and other myeloproliferative diseases|61435794|0-14|All Races|Male and Female|2013
1.0|1.6|1.3|77|Ie Unspecified and other specified leukemias|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|Not classified by ICCC|61435794|0-14|All Races|Male and Female|2013
3.8|4.8|4.3|264|V RETINOBLASTOMA|61435794|0-14|All Races|Male and Female|2013
8.2|9.7|8.9|549|VI RENAL TUMORS|61435794|0-14|All Races|Male and Female|2013
2.6|3.5|3.0|186|VII HEPATIC TUMORS|61435794|0-14|All Races|Male and Female|2013
6.7|8.0|7.3|450|VIII MALIGNANT BONE TUMORS|61435794|0-14|All Races|Male and Female|2013
3.3|4.3|3.8|231|VIIIa Osteosarcomas|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|VIIIb Chondrosarcomas|61435794|0-14|All Races|Male and Female|2013
2.4|3.3|2.8|174|VIIIc Ewing tumor and related sarcomas of bone|61435794|0-14|All Races|Male and Female|2013
0.3|0.6|0.4|27|VIIId Other specified malignant bone tumors|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|VIIIe Unspecified malignant bone tumors|61435794|0-14|All Races|Male and Female|2013
2.2|3.0|2.6|158|VIIa Hepatoblastoma and mesenchymal tumors of liver|61435794|0-14|All Races|Male and Female|2013
0.3|0.6|0.4|26|VIIb Hepatic carcinomas|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61435794|0-14|All Races|Male and Female|2013
7.8|9.2|8.5|522|VIa Nephroblastoma and other non-epithelial renal tumors|61435794|0-14|All Races|Male and Female|2013
0.3|0.6|0.4|24|VIb Renal carcinomas|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|VIc Unspecified malignant renal tumors|61435794|0-14|All Races|Male and Female|2013
5.1|6.4|5.7|352|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61435794|0-14|All Races|Male and Female|2013
8.0|9.5|8.7|537|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61435794|0-14|All Races|Male and Female|2013
0.5|1.0|0.7|46|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61435794|0-14|All Races|Male and Female|2013
0.3|0.7|0.5|30|XIIa Other specified malignant tumors|61435794|0-14|All Races|Male and Female|2013
0.1|0.4|0.3|16|XIIb Other unspecified malignant tumors|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|XIa Adrenocortical carcinomas|61435794|0-14|All Races|Male and Female|2013
3.1|4.1|3.6|221|XIb Thyroid carcinomas|61435794|0-14|All Races|Male and Female|2013
0.2|0.5|0.4|22|XIc Nasopharyngeal carcinomas|61435794|0-14|All Races|Male and Female|2013
1.8|2.5|2.1|132|XId Malignant melanomas|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|XIe Skin carcinomas|61435794|0-14|All Races|Male and Female|2013
2.1|2.8|2.4|149|XIf Other and unspecified carcinomas|61435794|0-14|All Races|Male and Female|2013
1.4|2.0|1.7|103|Xa Intracranial and intraspinal germ cell tumors|61435794|0-14|All Races|Male and Female|2013
1.1|1.6|1.3|81|Xb Malignant extracranial and extragonadal germ cell tumors|61435794|0-14|All Races|Male and Female|2013
2.0|2.8|2.4|147|Xc Malignant gonadal germ cell tumors|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|Xd Gonadal carcinomas|61435794|0-14|All Races|Male and Female|2013
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61435794|0-14|All Races|Male and Female|2013
172.2|178.8|175.5|10805|All ICCC Groups Combined|61534687|0-14|All Races|Male and Female|2014
49.7|53.3|51.5|3172|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61534687|0-14|All Races|Male and Female|2014
22.7|25.1|23.9|1469|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61534687|0-14|All Races|Male and Female|2014
35.4|38.4|36.9|2269|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61534687|0-14|All Races|Male and Female|2014
2.9|3.8|3.3|205|IIIa Ependymomas and choroid plexus tumor|61534687|0-14|All Races|Male and Female|2014
18.0|20.2|19.1|1173|IIIb Astrocytomas|61534687|0-14|All Races|Male and Female|2014
6.7|8.1|7.4|453|IIIc Intracranial and intraspinal embryonal tumors|61534687|0-14|All Races|Male and Female|2014
5.2|6.4|5.8|355|IIId Other gliomas|61534687|0-14|All Races|Male and Female|2014
0.6|1.1|0.8|51|IIIe Other specified intracranial and intraspinal neoplasms|61534687|0-14|All Races|Male and Female|2014
0.4|0.7|0.5|32|IIIf Unspecified intracranial and intraspinal neoplasms|61534687|0-14|All Races|Male and Female|2014
4.9|6.1|5.5|337|IIa Hodgkin lymphomas|61534687|0-14|All Races|Male and Female|2014
8.1|9.6|8.8|542|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61534687|0-14|All Races|Male and Female|2014
2.4|3.2|2.8|171|IIc Burkitt lymphoma|61534687|0-14|All Races|Male and Female|2014
5.9|7.2|6.5|401|IId Miscellaneous lymphoreticular neoplasms|61534687|0-14|All Races|Male and Female|2014
0.2|0.5|0.3|18|IIe Unspecified lymphomas|61534687|0-14|All Races|Male and Female|2014
11.2|12.9|12.0|741|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61534687|0-14|All Races|Male and Female|2014
11.0|12.7|11.8|728|IVa Neuroblastoma and ganglioneuroblastoma|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|IVb Other peripheral nervous cell tumors|61534687|0-14|All Races|Male and Female|2014
10.0|11.7|10.8|666|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61534687|0-14|All Races|Male and Female|2014
4.2|5.3|4.7|291|IXa Rhabdomyosarcomas|61534687|0-14|All Races|Male and Female|2014
0.9|1.5|1.2|74|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|IXc Kaposi sarcoma|61534687|0-14|All Races|Male and Female|2014
3.2|4.2|3.7|228|IXd Other specified soft tissue sarcomas|61534687|0-14|All Races|Male and Female|2014
0.9|1.5|1.2|72|IXe Unspecified soft tissue sarcomas|61534687|0-14|All Races|Male and Female|2014
37.4|40.6|39.0|2400|Ia Lymphoid leukemias|61534687|0-14|All Races|Male and Female|2014
7.3|8.7|8.0|491|Ib Acute myeloid leukemias|61534687|0-14|All Races|Male and Female|2014
1.3|2.0|1.6|101|Ic Chronic myeloproliferative diseases|61534687|0-14|All Races|Male and Female|2014
1.3|2.0|1.6|100|Id Myelodysplastic syndrome and other myeloproliferative diseases|61534687|0-14|All Races|Male and Female|2014
1.0|1.6|1.3|80|Ie Unspecified and other specified leukemias|61534687|0-14|All Races|Male and Female|2014
0.2|0.6|0.4|24|Not classified by ICCC|61534687|0-14|All Races|Male and Female|2014
3.8|4.9|4.3|265|V RETINOBLASTOMA|61534687|0-14|All Races|Male and Female|2014
8.4|9.9|9.1|560|VI RENAL TUMORS|61534687|0-14|All Races|Male and Female|2014
2.8|3.8|3.3|202|VII HEPATIC TUMORS|61534687|0-14|All Races|Male and Female|2014
7.1|8.5|7.8|480|VIII MALIGNANT BONE TUMORS|61534687|0-14|All Races|Male and Female|2014
3.8|4.8|4.3|265|VIIIa Osteosarcomas|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|VIIIb Chondrosarcomas|61534687|0-14|All Races|Male and Female|2014
2.3|3.1|2.7|165|VIIIc Ewing tumor and related sarcomas of bone|61534687|0-14|All Races|Male and Female|2014
0.3|0.7|0.5|29|VIIId Other specified malignant bone tumors|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|VIIIe Unspecified malignant bone tumors|61534687|0-14|All Races|Male and Female|2014
2.5|3.3|2.9|178|VIIa Hepatoblastoma and mesenchymal tumors of liver|61534687|0-14|All Races|Male and Female|2014
0.2|0.6|0.4|24|VIIb Hepatic carcinomas|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61534687|0-14|All Races|Male and Female|2014
7.9|9.4|8.6|532|VIa Nephroblastoma and other non-epithelial renal tumors|61534687|0-14|All Races|Male and Female|2014
0.3|0.6|0.4|26|VIb Renal carcinomas|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|VIc Unspecified malignant renal tumors|61534687|0-14|All Races|Male and Female|2014
5.1|6.3|5.7|350|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61534687|0-14|All Races|Male and Female|2014
8.4|9.9|9.1|563|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61534687|0-14|All Races|Male and Female|2014
0.5|1.0|0.7|44|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61534687|0-14|All Races|Male and Female|2014
0.3|0.7|0.5|29|XIIa Other specified malignant tumors|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|XIIb Other unspecified malignant tumors|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|XIa Adrenocortical carcinomas|61534687|0-14|All Races|Male and Female|2014
3.5|4.5|3.9|243|XIb Thyroid carcinomas|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|XIc Nasopharyngeal carcinomas|61534687|0-14|All Races|Male and Female|2014
1.8|2.6|2.2|134|XId Malignant melanomas|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|XIe Skin carcinomas|61534687|0-14|All Races|Male and Female|2014
2.2|3.0|2.6|160|XIf Other and unspecified carcinomas|61534687|0-14|All Races|Male and Female|2014
1.2|1.8|1.5|90|Xa Intracranial and intraspinal germ cell tumors|61534687|0-14|All Races|Male and Female|2014
1.3|2.0|1.6|101|Xb Malignant extracranial and extragonadal germ cell tumors|61534687|0-14|All Races|Male and Female|2014
1.9|2.6|2.2|138|Xc Malignant gonadal germ cell tumors|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|Xd Gonadal carcinomas|61534687|0-14|All Races|Male and Female|2014
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61534687|0-14|All Races|Male and Female|2014
174.9|181.5|178.2|10987|All ICCC Groups Combined|61594394|0-14|All Races|Male and Female|2015
52.2|55.9|54.0|3331|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61594394|0-14|All Races|Male and Female|2015
22.7|25.1|23.9|1471|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61594394|0-14|All Races|Male and Female|2015
34.1|37.1|35.6|2191|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61594394|0-14|All Races|Male and Female|2015
2.7|3.6|3.1|192|IIIa Ependymomas and choroid plexus tumor|61594394|0-14|All Races|Male and Female|2015
17.1|19.2|18.1|1116|IIIb Astrocytomas|61594394|0-14|All Races|Male and Female|2015
6.6|8.0|7.3|449|IIIc Intracranial and intraspinal embryonal tumors|61594394|0-14|All Races|Male and Female|2015
5.4|6.6|6.0|366|IIId Other gliomas|61594394|0-14|All Races|Male and Female|2015
0.5|0.9|0.7|43|IIIe Other specified intracranial and intraspinal neoplasms|61594394|0-14|All Races|Male and Female|2015
0.3|0.6|0.4|25|IIIf Unspecified intracranial and intraspinal neoplasms|61594394|0-14|All Races|Male and Female|2015
5.3|6.5|5.8|361|IIa Hodgkin lymphomas|61594394|0-14|All Races|Male and Female|2015
7.5|8.9|8.2|503|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61594394|0-14|All Races|Male and Female|2015
2.2|3.0|2.5|156|IIc Burkitt lymphoma|61594394|0-14|All Races|Male and Female|2015
6.4|7.7|7.0|434|IId Miscellaneous lymphoreticular neoplasms|61594394|0-14|All Races|Male and Female|2015
0.2|0.4|0.3|17|IIe Unspecified lymphomas|61594394|0-14|All Races|Male and Female|2015
11.4|13.2|12.3|758|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61594394|0-14|All Races|Male and Female|2015
11.2|13.0|12.1|745|IVa Neuroblastoma and ganglioneuroblastoma|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|IVb Other peripheral nervous cell tumors|61594394|0-14|All Races|Male and Female|2015
10.0|11.6|10.8|666|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61594394|0-14|All Races|Male and Female|2015
4.3|5.5|4.9|301|IXa Rhabdomyosarcomas|61594394|0-14|All Races|Male and Female|2015
0.8|1.4|1.1|67|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|IXc Kaposi sarcoma|61594394|0-14|All Races|Male and Female|2015
3.2|4.1|3.6|223|IXd Other specified soft tissue sarcomas|61594394|0-14|All Races|Male and Female|2015
0.9|1.5|1.2|74|IXe Unspecified soft tissue sarcomas|61594394|0-14|All Races|Male and Female|2015
39.8|43.0|41.4|2550|Ia Lymphoid leukemias|61594394|0-14|All Races|Male and Female|2015
7.3|8.8|8.0|496|Ib Acute myeloid leukemias|61594394|0-14|All Races|Male and Female|2015
1.6|2.4|2.0|122|Ic Chronic myeloproliferative diseases|61594394|0-14|All Races|Male and Female|2015
1.2|1.8|1.5|93|Id Myelodysplastic syndrome and other myeloproliferative diseases|61594394|0-14|All Races|Male and Female|2015
0.9|1.4|1.1|70|Ie Unspecified and other specified leukemias|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|Not classified by ICCC|61594394|0-14|All Races|Male and Female|2015
4.4|5.5|4.9|306|V RETINOBLASTOMA|61594394|0-14|All Races|Male and Female|2015
9.0|10.6|9.8|603|VI RENAL TUMORS|61594394|0-14|All Races|Male and Female|2015
3.2|4.1|3.6|223|VII HEPATIC TUMORS|61594394|0-14|All Races|Male and Female|2015
6.8|8.2|7.4|459|VIII MALIGNANT BONE TUMORS|61594394|0-14|All Races|Male and Female|2015
3.4|4.4|3.8|237|VIIIa Osteosarcomas|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|VIIIb Chondrosarcomas|61594394|0-14|All Races|Male and Female|2015
2.3|3.1|2.7|166|VIIIc Ewing tumor and related sarcomas of bone|61594394|0-14|All Races|Male and Female|2015
0.4|0.7|0.5|32|VIIId Other specified malignant bone tumors|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|VIIIe Unspecified malignant bone tumors|61594394|0-14|All Races|Male and Female|2015
2.7|3.6|3.2|196|VIIa Hepatoblastoma and mesenchymal tumors of liver|61594394|0-14|All Races|Male and Female|2015
0.3|0.6|0.4|26|VIIb Hepatic carcinomas|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61594394|0-14|All Races|Male and Female|2015
8.6|10.2|9.4|577|VIa Nephroblastoma and other non-epithelial renal tumors|61594394|0-14|All Races|Male and Female|2015
0.2|0.6|0.4|24|VIb Renal carcinomas|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|VIc Unspecified malignant renal tumors|61594394|0-14|All Races|Male and Female|2015
4.9|6.1|5.5|338|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61594394|0-14|All Races|Male and Female|2015
8.7|10.2|9.4|583|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61594394|0-14|All Races|Male and Female|2015
0.6|1.0|0.8|47|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61594394|0-14|All Races|Male and Female|2015
0.4|0.8|0.5|34|XIIa Other specified malignant tumors|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|XIIb Other unspecified malignant tumors|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|XIa Adrenocortical carcinomas|61594394|0-14|All Races|Male and Female|2015
3.0|4.0|3.5|214|XIb Thyroid carcinomas|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|XIc Nasopharyngeal carcinomas|61594394|0-14|All Races|Male and Female|2015
1.7|2.5|2.1|128|XId Malignant melanomas|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|XIe Skin carcinomas|61594394|0-14|All Races|Male and Female|2015
3.1|4.1|3.6|220|XIf Other and unspecified carcinomas|61594394|0-14|All Races|Male and Female|2015
1.3|2.0|1.6|100|Xa Intracranial and intraspinal germ cell tumors|61594394|0-14|All Races|Male and Female|2015
1.1|1.7|1.4|85|Xb Malignant extracranial and extragonadal germ cell tumors|61594394|0-14|All Races|Male and Female|2015
1.9|2.6|2.2|137|Xc Malignant gonadal germ cell tumors|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|Xd Gonadal carcinomas|61594394|0-14|All Races|Male and Female|2015
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61594394|0-14|All Races|Male and Female|2015
172.8|179.5|176.1|10878|All ICCC Groups Combined|61696945|0-14|All Races|Male and Female|2016
52.7|56.4|54.5|3368|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61696945|0-14|All Races|Male and Female|2016
21.5|23.9|22.7|1400|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61696945|0-14|All Races|Male and Female|2016
34.1|37.1|35.6|2195|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61696945|0-14|All Races|Male and Female|2016
2.4|3.3|2.8|175|IIIa Ependymomas and choroid plexus tumor|61696945|0-14|All Races|Male and Female|2016
16.5|18.6|17.6|1083|IIIb Astrocytomas|61696945|0-14|All Races|Male and Female|2016
6.1|7.4|6.7|415|IIIc Intracranial and intraspinal embryonal tumors|61696945|0-14|All Races|Male and Female|2016
6.4|7.7|7.0|431|IIId Other gliomas|61696945|0-14|All Races|Male and Female|2016
0.7|1.1|0.9|54|IIIe Other specified intracranial and intraspinal neoplasms|61696945|0-14|All Races|Male and Female|2016
0.4|0.8|0.6|37|IIIf Unspecified intracranial and intraspinal neoplasms|61696945|0-14|All Races|Male and Female|2016
5.1|6.3|5.7|352|IIa Hodgkin lymphomas|61696945|0-14|All Races|Male and Female|2016
8.1|9.6|8.9|547|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61696945|0-14|All Races|Male and Female|2016
2.0|2.8|2.4|147|IIc Burkitt lymphoma|61696945|0-14|All Races|Male and Female|2016
5.0|6.2|5.5|342|IId Miscellaneous lymphoreticular neoplasms|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|IIe Unspecified lymphomas|61696945|0-14|All Races|Male and Female|2016
10.8|12.5|11.6|715|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61696945|0-14|All Races|Male and Female|2016
10.6|12.3|11.4|706|IVa Neuroblastoma and ganglioneuroblastoma|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|IVb Other peripheral nervous cell tumors|61696945|0-14|All Races|Male and Female|2016
10.1|11.7|10.9|671|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61696945|0-14|All Races|Male and Female|2016
4.9|6.1|5.5|337|IXa Rhabdomyosarcomas|61696945|0-14|All Races|Male and Female|2016
0.8|1.3|1.0|61|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|IXc Kaposi sarcoma|61696945|0-14|All Races|Male and Female|2016
2.9|3.8|3.4|208|IXd Other specified soft tissue sarcomas|61696945|0-14|All Races|Male and Female|2016
0.8|1.3|1.0|64|IXe Unspecified soft tissue sarcomas|61696945|0-14|All Races|Male and Female|2016
39.9|43.2|41.5|2564|Ia Lymphoid leukemias|61696945|0-14|All Races|Male and Female|2016
7.5|9.0|8.2|508|Ib Acute myeloid leukemias|61696945|0-14|All Races|Male and Female|2016
1.8|2.5|2.1|131|Ic Chronic myeloproliferative diseases|61696945|0-14|All Races|Male and Female|2016
1.2|1.8|1.5|91|Id Myelodysplastic syndrome and other myeloproliferative diseases|61696945|0-14|All Races|Male and Female|2016
0.9|1.5|1.2|74|Ie Unspecified and other specified leukemias|61696945|0-14|All Races|Male and Female|2016
0.2|0.4|0.3|17|Not classified by ICCC|61696945|0-14|All Races|Male and Female|2016
3.7|4.8|4.2|260|V RETINOBLASTOMA|61696945|0-14|All Races|Male and Female|2016
7.8|9.3|8.6|528|VI RENAL TUMORS|61696945|0-14|All Races|Male and Female|2016
3.0|4.0|3.5|214|VII HEPATIC TUMORS|61696945|0-14|All Races|Male and Female|2016
7.3|8.7|8.0|494|VIII MALIGNANT BONE TUMORS|61696945|0-14|All Races|Male and Female|2016
3.8|4.8|4.3|265|VIIIa Osteosarcomas|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|VIIIb Chondrosarcomas|61696945|0-14|All Races|Male and Female|2016
2.5|3.4|2.9|181|VIIIc Ewing tumor and related sarcomas of bone|61696945|0-14|All Races|Male and Female|2016
0.3|0.7|0.5|30|VIIId Other specified malignant bone tumors|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|VIIIe Unspecified malignant bone tumors|61696945|0-14|All Races|Male and Female|2016
2.8|3.7|3.2|197|VIIa Hepatoblastoma and mesenchymal tumors of liver|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|VIIb Hepatic carcinomas|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61696945|0-14|All Races|Male and Female|2016
7.4|8.8|8.1|497|VIa Nephroblastoma and other non-epithelial renal tumors|61696945|0-14|All Races|Male and Female|2016
0.3|0.7|0.5|29|VIb Renal carcinomas|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|VIc Unspecified malignant renal tumors|61696945|0-14|All Races|Male and Female|2016
5.2|6.4|5.8|359|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61696945|0-14|All Races|Male and Female|2016
8.9|10.5|9.7|600|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61696945|0-14|All Races|Male and Female|2016
0.7|1.2|0.9|57|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61696945|0-14|All Races|Male and Female|2016
0.4|0.9|0.6|39|XIIa Other specified malignant tumors|61696945|0-14|All Races|Male and Female|2016
0.2|0.5|0.3|18|XIIb Other unspecified malignant tumors|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|XIa Adrenocortical carcinomas|61696945|0-14|All Races|Male and Female|2016
3.0|3.9|3.4|211|XIb Thyroid carcinomas|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|XIc Nasopharyngeal carcinomas|61696945|0-14|All Races|Male and Female|2016
1.5|2.2|1.8|112|XId Malignant melanomas|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|XIe Skin carcinomas|61696945|0-14|All Races|Male and Female|2016
3.6|4.6|4.1|252|XIf Other and unspecified carcinomas|61696945|0-14|All Races|Male and Female|2016
1.5|2.2|1.9|115|Xa Intracranial and intraspinal germ cell tumors|61696945|0-14|All Races|Male and Female|2016
1.0|1.6|1.3|78|Xb Malignant extracranial and extragonadal germ cell tumors|61696945|0-14|All Races|Male and Female|2016
2.0|2.8|2.4|150|Xc Malignant gonadal germ cell tumors|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|Xd Gonadal carcinomas|61696945|0-14|All Races|Male and Female|2016
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61696945|0-14|All Races|Male and Female|2016
169.3|175.9|172.6|10671|All ICCC Groups Combined|61799838|0-14|All Races|Male and Female|2017
49.5|53.0|51.2|3167|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61799838|0-14|All Races|Male and Female|2017
22.0|24.5|23.2|1439|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61799838|0-14|All Races|Male and Female|2017
35.8|38.9|37.3|2303|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61799838|0-14|All Races|Male and Female|2017
3.0|3.9|3.4|210|IIIa Ependymomas and choroid plexus tumor|61799838|0-14|All Races|Male and Female|2017
18.0|20.2|19.1|1178|IIIb Astrocytomas|61799838|0-14|All Races|Male and Female|2017
6.2|7.5|6.8|419|IIIc Intracranial and intraspinal embryonal tumors|61799838|0-14|All Races|Male and Female|2017
6.2|7.6|6.9|425|IIId Other gliomas|61799838|0-14|All Races|Male and Female|2017
0.4|0.8|0.6|36|IIIe Other specified intracranial and intraspinal neoplasms|61799838|0-14|All Races|Male and Female|2017
0.4|0.8|0.6|35|IIIf Unspecified intracranial and intraspinal neoplasms|61799838|0-14|All Races|Male and Female|2017
5.1|6.3|5.7|355|IIa Hodgkin lymphomas|61799838|0-14|All Races|Male and Female|2017
7.4|8.8|8.1|500|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61799838|0-14|All Races|Male and Female|2017
2.2|3.0|2.6|160|IIc Burkitt lymphoma|61799838|0-14|All Races|Male and Female|2017
6.1|7.4|6.8|416|IId Miscellaneous lymphoreticular neoplasms|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|IIe Unspecified lymphomas|61799838|0-14|All Races|Male and Female|2017
10.1|11.8|10.9|669|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61799838|0-14|All Races|Male and Female|2017
10.0|11.6|10.8|661|IVa Neuroblastoma and ganglioneuroblastoma|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|IVb Other peripheral nervous cell tumors|61799838|0-14|All Races|Male and Female|2017
9.8|11.5|10.6|658|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61799838|0-14|All Races|Male and Female|2017
4.4|5.6|5.0|307|IXa Rhabdomyosarcomas|61799838|0-14|All Races|Male and Female|2017
0.7|1.2|0.9|55|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|IXc Kaposi sarcoma|61799838|0-14|All Races|Male and Female|2017
2.8|3.7|3.2|197|IXd Other specified soft tissue sarcomas|61799838|0-14|All Races|Male and Female|2017
1.3|1.9|1.6|99|IXe Unspecified soft tissue sarcomas|61799838|0-14|All Races|Male and Female|2017
37.9|41.1|39.5|2441|Ia Lymphoid leukemias|61799838|0-14|All Races|Male and Female|2017
7.0|8.4|7.6|472|Ib Acute myeloid leukemias|61799838|0-14|All Races|Male and Female|2017
1.4|2.1|1.7|106|Ic Chronic myeloproliferative diseases|61799838|0-14|All Races|Male and Female|2017
1.1|1.7|1.3|82|Id Myelodysplastic syndrome and other myeloproliferative diseases|61799838|0-14|All Races|Male and Female|2017
0.8|1.4|1.1|66|Ie Unspecified and other specified leukemias|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|Not classified by ICCC|61799838|0-14|All Races|Male and Female|2017
3.6|4.7|4.1|252|V RETINOBLASTOMA|61799838|0-14|All Races|Male and Female|2017
7.7|9.2|8.5|521|VI RENAL TUMORS|61799838|0-14|All Races|Male and Female|2017
2.7|3.6|3.1|190|VII HEPATIC TUMORS|61799838|0-14|All Races|Male and Female|2017
6.7|8.1|7.4|459|VIII MALIGNANT BONE TUMORS|61799838|0-14|All Races|Male and Female|2017
3.8|4.9|4.3|270|VIIIa Osteosarcomas|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|VIIIb Chondrosarcomas|61799838|0-14|All Races|Male and Female|2017
2.0|2.8|2.3|146|VIIIc Ewing tumor and related sarcomas of bone|61799838|0-14|All Races|Male and Female|2017
0.2|0.5|0.3|21|VIIId Other specified malignant bone tumors|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|VIIIe Unspecified malignant bone tumors|61799838|0-14|All Races|Male and Female|2017
2.3|3.1|2.7|166|VIIa Hepatoblastoma and mesenchymal tumors of liver|61799838|0-14|All Races|Male and Female|2017
0.2|0.5|0.3|20|VIIb Hepatic carcinomas|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61799838|0-14|All Races|Male and Female|2017
7.3|8.7|8.0|492|VIa Nephroblastoma and other non-epithelial renal tumors|61799838|0-14|All Races|Male and Female|2017
0.3|0.6|0.4|27|VIb Renal carcinomas|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|VIc Unspecified malignant renal tumors|61799838|0-14|All Races|Male and Female|2017
5.5|6.8|6.1|380|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61799838|0-14|All Races|Male and Female|2017
8.2|9.7|8.9|557|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61799838|0-14|All Races|Male and Female|2017
0.8|1.3|1.1|65|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61799838|0-14|All Races|Male and Female|2017
0.5|0.9|0.7|42|XIIa Other specified malignant tumors|61799838|0-14|All Races|Male and Female|2017
0.2|0.6|0.4|23|XIIb Other unspecified malignant tumors|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|XIa Adrenocortical carcinomas|61799838|0-14|All Races|Male and Female|2017
2.8|3.7|3.2|201|XIb Thyroid carcinomas|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|XIc Nasopharyngeal carcinomas|61799838|0-14|All Races|Male and Female|2017
1.0|1.6|1.3|81|XId Malignant melanomas|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|XIe Skin carcinomas|61799838|0-14|All Races|Male and Female|2017
3.5|4.5|4.0|248|XIf Other and unspecified carcinomas|61799838|0-14|All Races|Male and Female|2017
1.5|2.2|1.9|116|Xa Intracranial and intraspinal germ cell tumors|61799838|0-14|All Races|Male and Female|2017
1.2|1.8|1.5|91|Xb Malignant extracranial and extragonadal germ cell tumors|61799838|0-14|All Races|Male and Female|2017
2.0|2.8|2.3|146|Xc Malignant gonadal germ cell tumors|61799838|0-14|All Races|Male and Female|2017
~|~|~|~|Xd Gonadal carcinomas|61799838|0-14|All Races|Male and Female|2017
0.2|0.5|0.4|22|Xe Other and unspecified malignant gonadal tumors|61799838|0-14|All Races|Male and Female|2017
169.7|176.3|173.0|10688|All ICCC Groups Combined|61786818|0-14|All Races|Male and Female|2018
51.3|55.0|53.1|3277|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61786818|0-14|All Races|Male and Female|2018
21.6|24.0|22.8|1417|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61786818|0-14|All Races|Male and Female|2018
31.9|34.8|33.3|2058|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61786818|0-14|All Races|Male and Female|2018
2.4|3.3|2.8|174|IIIa Ependymomas and choroid plexus tumor|61786818|0-14|All Races|Male and Female|2018
14.9|16.9|15.8|978|IIIb Astrocytomas|61786818|0-14|All Races|Male and Female|2018
6.1|7.4|6.7|412|IIIc Intracranial and intraspinal embryonal tumors|61786818|0-14|All Races|Male and Female|2018
6.2|7.5|6.8|420|IIId Other gliomas|61786818|0-14|All Races|Male and Female|2018
0.5|0.9|0.6|40|IIIe Other specified intracranial and intraspinal neoplasms|61786818|0-14|All Races|Male and Female|2018
0.4|0.8|0.6|34|IIIf Unspecified intracranial and intraspinal neoplasms|61786818|0-14|All Races|Male and Female|2018
5.3|6.5|5.9|370|IIa Hodgkin lymphomas|61786818|0-14|All Races|Male and Female|2018
8.1|9.6|8.8|546|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61786818|0-14|All Races|Male and Female|2018
1.8|2.6|2.2|136|IIc Burkitt lymphoma|61786818|0-14|All Races|Male and Female|2018
5.2|6.4|5.8|355|IId Miscellaneous lymphoreticular neoplasms|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|IIe Unspecified lymphomas|61786818|0-14|All Races|Male and Female|2018
10.9|12.7|11.8|718|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61786818|0-14|All Races|Male and Female|2018
10.8|12.5|11.6|706|IVa Neuroblastoma and ganglioneuroblastoma|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|IVb Other peripheral nervous cell tumors|61786818|0-14|All Races|Male and Female|2018
9.8|11.5|10.6|659|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61786818|0-14|All Races|Male and Female|2018
4.1|5.2|4.7|288|IXa Rhabdomyosarcomas|61786818|0-14|All Races|Male and Female|2018
0.9|1.4|1.1|69|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|IXc Kaposi sarcoma|61786818|0-14|All Races|Male and Female|2018
3.2|4.2|3.7|229|IXd Other specified soft tissue sarcomas|61786818|0-14|All Races|Male and Female|2018
0.9|1.4|1.1|71|IXe Unspecified soft tissue sarcomas|61786818|0-14|All Races|Male and Female|2018
39.8|43.0|41.4|2553|Ia Lymphoid leukemias|61786818|0-14|All Races|Male and Female|2018
7.1|8.5|7.8|483|Ib Acute myeloid leukemias|61786818|0-14|All Races|Male and Female|2018
1.0|1.6|1.3|80|Ic Chronic myeloproliferative diseases|61786818|0-14|All Races|Male and Female|2018
1.0|1.5|1.2|74|Id Myelodysplastic syndrome and other myeloproliferative diseases|61786818|0-14|All Races|Male and Female|2018
1.1|1.7|1.4|87|Ie Unspecified and other specified leukemias|61786818|0-14|All Races|Male and Female|2018
0.2|0.4|0.3|17|Not classified by ICCC|61786818|0-14|All Races|Male and Female|2018
3.6|4.7|4.1|251|V RETINOBLASTOMA|61786818|0-14|All Races|Male and Female|2018
7.9|9.4|8.6|529|VI RENAL TUMORS|61786818|0-14|All Races|Male and Female|2018
2.9|3.8|3.4|205|VII HEPATIC TUMORS|61786818|0-14|All Races|Male and Female|2018
7.3|8.7|8.0|498|VIII MALIGNANT BONE TUMORS|61786818|0-14|All Races|Male and Female|2018
3.7|4.7|4.1|260|VIIIa Osteosarcomas|61786818|0-14|All Races|Male and Female|2018
0.2|0.4|0.3|17|VIIIb Chondrosarcomas|61786818|0-14|All Races|Male and Female|2018
2.5|3.4|2.9|182|VIIIc Ewing tumor and related sarcomas of bone|61786818|0-14|All Races|Male and Female|2018
0.3|0.6|0.4|25|VIIId Other specified malignant bone tumors|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|VIIIe Unspecified malignant bone tumors|61786818|0-14|All Races|Male and Female|2018
2.5|3.4|2.9|179|VIIa Hepatoblastoma and mesenchymal tumors of liver|61786818|0-14|All Races|Male and Female|2018
0.2|0.6|0.4|24|VIIb Hepatic carcinomas|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61786818|0-14|All Races|Male and Female|2018
7.4|8.9|8.1|498|VIa Nephroblastoma and other non-epithelial renal tumors|61786818|0-14|All Races|Male and Female|2018
0.3|0.6|0.4|27|VIb Renal carcinomas|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|VIc Unspecified malignant renal tumors|61786818|0-14|All Races|Male and Female|2018
5.1|6.3|5.7|355|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61786818|0-14|All Races|Male and Female|2018
9.6|11.2|10.3|651|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61786818|0-14|All Races|Male and Female|2018
0.6|1.1|0.9|53|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61786818|0-14|All Races|Male and Female|2018
0.3|0.6|0.4|27|XIIa Other specified malignant tumors|61786818|0-14|All Races|Male and Female|2018
0.3|0.6|0.4|26|XIIb Other unspecified malignant tumors|61786818|0-14|All Races|Male and Female|2018
0.2|0.5|0.4|22|XIa Adrenocortical carcinomas|61786818|0-14|All Races|Male and Female|2018
3.6|4.7|4.1|261|XIb Thyroid carcinomas|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|XIc Nasopharyngeal carcinomas|61786818|0-14|All Races|Male and Female|2018
1.3|2.0|1.6|103|XId Malignant melanomas|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|XIe Skin carcinomas|61786818|0-14|All Races|Male and Female|2018
3.5|4.5|4.0|250|XIf Other and unspecified carcinomas|61786818|0-14|All Races|Male and Female|2018
1.1|1.7|1.4|88|Xa Intracranial and intraspinal germ cell tumors|61786818|0-14|All Races|Male and Female|2018
1.1|1.8|1.4|86|Xb Malignant extracranial and extragonadal germ cell tumors|61786818|0-14|All Races|Male and Female|2018
2.2|3.0|2.5|159|Xc Malignant gonadal germ cell tumors|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|Xd Gonadal carcinomas|61786818|0-14|All Races|Male and Female|2018
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61786818|0-14|All Races|Male and Female|2018
164.9|167.8|166.3|50645|All ICCC Groups Combined|305444197|0-14|All Races|Male and Female|2018-2022
50.8|52.4|51.6|15684|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|305444197|0-14|All Races|Male and Female|2018-2022
20.1|21.1|20.6|6344|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|305444197|0-14|All Races|Male and Female|2018-2022
31.2|32.4|31.8|9682|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|305444197|0-14|All Races|Male and Female|2018-2022
2.6|2.9|2.8|834|IIIa Ependymomas and choroid plexus tumor|305444197|0-14|All Races|Male and Female|2018-2022
13.5|14.3|13.9|4240|IIIb Astrocytomas|305444197|0-14|All Races|Male and Female|2018-2022
6.2|6.8|6.5|1955|IIIc Intracranial and intraspinal embryonal tumors|305444197|0-14|All Races|Male and Female|2018-2022
7.2|7.9|7.5|2306|IIId Other gliomas|305444197|0-14|All Races|Male and Female|2018-2022
0.5|0.7|0.6|172|IIIe Other specified intracranial and intraspinal neoplasms|305444197|0-14|All Races|Male and Female|2018-2022
0.5|0.7|0.6|175|IIIf Unspecified intracranial and intraspinal neoplasms|305444197|0-14|All Races|Male and Female|2018-2022
5.3|5.8|5.5|1734|IIa Hodgkin lymphomas|305444197|0-14|All Races|Male and Female|2018-2022
7.9|8.6|8.2|2537|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|305444197|0-14|All Races|Male and Female|2018-2022
2.6|2.9|2.7|840|IIc Burkitt lymphoma|305444197|0-14|All Races|Male and Female|2018-2022
3.7|4.2|3.9|1182|IId Miscellaneous lymphoreticular neoplasms|305444197|0-14|All Races|Male and Female|2018-2022
0.1|0.2|0.2|51|IIe Unspecified lymphomas|305444197|0-14|All Races|Male and Female|2018-2022
11.3|12.1|11.7|3488|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|305444197|0-14|All Races|Male and Female|2018-2022
11.1|11.8|11.4|3403|IVa Neuroblastoma and ganglioneuroblastoma|305444197|0-14|All Races|Male and Female|2018-2022
0.2|0.3|0.3|85|IVb Other peripheral nervous cell tumors|305444197|0-14|All Races|Male and Female|2018-2022
10.5|11.2|10.8|3310|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|305444197|0-14|All Races|Male and Female|2018-2022
4.7|5.3|5.0|1517|IXa Rhabdomyosarcomas|305444197|0-14|All Races|Male and Female|2018-2022
0.8|1.0|0.9|277|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|305444197|0-14|All Races|Male and Female|2018-2022
~|~|~|~|IXc Kaposi sarcoma|305444197|0-14|All Races|Male and Female|2018-2022
3.3|3.7|3.5|1076|IXd Other specified soft tissue sarcomas|305444197|0-14|All Races|Male and Female|2018-2022
1.3|1.6|1.4|436|IXe Unspecified soft tissue sarcomas|305444197|0-14|All Races|Male and Female|2018-2022
39.9|41.3|40.6|12336|Ia Lymphoid leukemias|305444197|0-14|All Races|Male and Female|2018-2022
7.2|7.8|7.5|2269|Ib Acute myeloid leukemias|305444197|0-14|All Races|Male and Female|2018-2022
1.0|1.2|1.1|342|Ic Chronic myeloproliferative diseases|305444197|0-14|All Races|Male and Female|2018-2022
1.2|1.4|1.3|385|Id Myelodysplastic syndrome and other myeloproliferative diseases|305444197|0-14|All Races|Male and Female|2018-2022
1.0|1.3|1.2|352|Ie Unspecified and other specified leukemias|305444197|0-14|All Races|Male and Female|2018-2022
0.2|0.3|0.2|74|Not classified by ICCC|305444197|0-14|All Races|Male and Female|2018-2022
3.7|4.2|3.9|1165|V RETINOBLASTOMA|305444197|0-14|All Races|Male and Female|2018-2022
8.2|8.9|8.5|2569|VI RENAL TUMORS|305444197|0-14|All Races|Male and Female|2018-2022
3.4|3.8|3.6|1074|VII HEPATIC TUMORS|305444197|0-14|All Races|Male and Female|2018-2022
7.1|7.7|7.4|2311|VIII MALIGNANT BONE TUMORS|305444197|0-14|All Races|Male and Female|2018-2022
4.0|4.4|4.2|1312|VIIIa Osteosarcomas|305444197|0-14|All Races|Male and Female|2018-2022
0.1|0.2|0.2|56|VIIIb Chondrosarcomas|305444197|0-14|All Races|Male and Female|2018-2022
2.3|2.6|2.5|761|VIIIc Ewing tumor and related sarcomas of bone|305444197|0-14|All Races|Male and Female|2018-2022
0.3|0.4|0.4|112|VIIId Other specified malignant bone tumors|305444197|0-14|All Races|Male and Female|2018-2022
0.2|0.3|0.2|70|VIIIe Unspecified malignant bone tumors|305444197|0-14|All Races|Male and Female|2018-2022
2.9|3.3|3.1|921|VIIa Hepatoblastoma and mesenchymal tumors of liver|305444197|0-14|All Races|Male and Female|2018-2022
0.4|0.5|0.5|143|VIIb Hepatic carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
~|~|~|~|VIIc Unspecified malignant hepatic tumors|305444197|0-14|All Races|Male and Female|2018-2022
7.8|8.4|8.1|2431|VIa Nephroblastoma and other non-epithelial renal tumors|305444197|0-14|All Races|Male and Female|2018-2022
0.3|0.5|0.4|124|VIb Renal carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
~|~|~|~|VIc Unspecified malignant renal tumors|305444197|0-14|All Races|Male and Female|2018-2022
5.3|5.8|5.5|1691|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|305444197|0-14|All Races|Male and Female|2018-2022
9.2|9.9|9.6|2983|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|305444197|0-14|All Races|Male and Female|2018-2022
0.8|1.0|0.9|270|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|305444197|0-14|All Races|Male and Female|2018-2022
0.4|0.6|0.5|143|XIIa Other specified malignant tumors|305444197|0-14|All Races|Male and Female|2018-2022
0.4|0.5|0.4|127|XIIb Other unspecified malignant tumors|305444197|0-14|All Races|Male and Female|2018-2022
0.2|0.3|0.2|72|XIa Adrenocortical carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
3.1|3.5|3.3|1026|XIb Thyroid carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
0.1|0.2|0.2|48|XIc Nasopharyngeal carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
1.4|1.6|1.5|456|XId Malignant melanomas|305444197|0-14|All Races|Male and Female|2018-2022
0.0|0.1|0.1|21|XIe Skin carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
4.1|4.6|4.3|1360|XIf Other and unspecified carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
1.3|1.6|1.4|442|Xa Intracranial and intraspinal germ cell tumors|305444197|0-14|All Races|Male and Female|2018-2022
1.2|1.5|1.4|397|Xb Malignant extracranial and extragonadal germ cell tumors|305444197|0-14|All Races|Male and Female|2018-2022
2.2|2.6|2.4|747|Xc Malignant gonadal germ cell tumors|305444197|0-14|All Races|Male and Female|2018-2022
0.1|0.1|0.1|33|Xd Gonadal carcinomas|305444197|0-14|All Races|Male and Female|2018-2022
0.2|0.3|0.2|72|Xe Other and unspecified malignant gonadal tumors|305444197|0-14|All Races|Male and Female|2018-2022
164.4|170.9|167.6|10314|All ICCC Groups Combined|61633127|0-14|All Races|Male and Female|2019
49.1|52.7|50.9|3128|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61633127|0-14|All Races|Male and Female|2019
20.3|22.7|21.5|1331|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61633127|0-14|All Races|Male and Female|2019
30.6|33.4|32.0|1965|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61633127|0-14|All Races|Male and Female|2019
2.5|3.4|2.9|178|IIIa Ependymomas and choroid plexus tumor|61633127|0-14|All Races|Male and Female|2019
14.0|15.9|14.9|921|IIIb Astrocytomas|61633127|0-14|All Races|Male and Female|2019
5.6|6.8|6.2|377|IIIc Intracranial and intraspinal embryonal tumors|61633127|0-14|All Races|Male and Female|2019
6.3|7.6|6.9|425|IIId Other gliomas|61633127|0-14|All Races|Male and Female|2019
0.4|0.8|0.6|36|IIIe Other specified intracranial and intraspinal neoplasms|61633127|0-14|All Races|Male and Female|2019
0.3|0.7|0.5|28|IIIf Unspecified intracranial and intraspinal neoplasms|61633127|0-14|All Races|Male and Female|2019
4.9|6.1|5.5|344|IIa Hodgkin lymphomas|61633127|0-14|All Races|Male and Female|2019
7.4|8.8|8.1|500|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61633127|0-14|All Races|Male and Female|2019
1.9|2.7|2.3|143|IIc Burkitt lymphoma|61633127|0-14|All Races|Male and Female|2019
4.9|6.1|5.5|334|IId Miscellaneous lymphoreticular neoplasms|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|IIe Unspecified lymphomas|61633127|0-14|All Races|Male and Female|2019
11.1|12.9|12.0|724|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61633127|0-14|All Races|Male and Female|2019
11.0|12.8|11.9|716|IVa Neuroblastoma and ganglioneuroblastoma|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|IVb Other peripheral nervous cell tumors|61633127|0-14|All Races|Male and Female|2019
10.4|12.1|11.2|690|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61633127|0-14|All Races|Male and Female|2019
4.3|5.4|4.8|295|IXa Rhabdomyosarcomas|61633127|0-14|All Races|Male and Female|2019
0.8|1.4|1.1|65|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|IXc Kaposi sarcoma|61633127|0-14|All Races|Male and Female|2019
3.3|4.3|3.8|236|IXd Other specified soft tissue sarcomas|61633127|0-14|All Races|Male and Female|2019
1.2|1.9|1.5|94|IXe Unspecified soft tissue sarcomas|61633127|0-14|All Races|Male and Female|2019
37.9|41.1|39.5|2425|Ia Lymphoid leukemias|61633127|0-14|All Races|Male and Female|2019
7.1|8.5|7.8|481|Ib Acute myeloid leukemias|61633127|0-14|All Races|Male and Female|2019
1.0|1.5|1.2|75|Ic Chronic myeloproliferative diseases|61633127|0-14|All Races|Male and Female|2019
1.0|1.6|1.3|77|Id Myelodysplastic syndrome and other myeloproliferative diseases|61633127|0-14|All Races|Male and Female|2019
0.9|1.4|1.1|70|Ie Unspecified and other specified leukemias|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|Not classified by ICCC|61633127|0-14|All Races|Male and Female|2019
3.5|4.6|4.0|242|V RETINOBLASTOMA|61633127|0-14|All Races|Male and Female|2019
7.3|8.8|8.0|488|VI RENAL TUMORS|61633127|0-14|All Races|Male and Female|2019
3.1|4.1|3.5|215|VII HEPATIC TUMORS|61633127|0-14|All Races|Male and Female|2019
7.0|8.4|7.7|481|VIII MALIGNANT BONE TUMORS|61633127|0-14|All Races|Male and Female|2019
3.9|5.0|4.4|277|VIIIa Osteosarcomas|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|VIIIb Chondrosarcomas|61633127|0-14|All Races|Male and Female|2019
2.0|2.8|2.4|151|VIIIc Ewing tumor and related sarcomas of bone|61633127|0-14|All Races|Male and Female|2019
0.2|0.6|0.4|24|VIIId Other specified malignant bone tumors|61633127|0-14|All Races|Male and Female|2019
0.2|0.5|0.3|21|VIIIe Unspecified malignant bone tumors|61633127|0-14|All Races|Male and Female|2019
2.6|3.5|3.0|184|VIIa Hepatoblastoma and mesenchymal tumors of liver|61633127|0-14|All Races|Male and Female|2019
0.3|0.6|0.4|27|VIIb Hepatic carcinomas|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61633127|0-14|All Races|Male and Female|2019
6.9|8.3|7.6|463|VIa Nephroblastoma and other non-epithelial renal tumors|61633127|0-14|All Races|Male and Female|2019
0.2|0.6|0.4|24|VIb Renal carcinomas|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|VIc Unspecified malignant renal tumors|61633127|0-14|All Races|Male and Female|2019
4.9|6.1|5.4|335|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61633127|0-14|All Races|Male and Female|2019
9.6|11.2|10.3|651|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61633127|0-14|All Races|Male and Female|2019
0.6|1.1|0.8|49|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61633127|0-14|All Races|Male and Female|2019
0.3|0.7|0.5|31|XIIa Other specified malignant tumors|61633127|0-14|All Races|Male and Female|2019
0.2|0.5|0.3|18|XIIb Other unspecified malignant tumors|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|XIa Adrenocortical carcinomas|61633127|0-14|All Races|Male and Female|2019
3.4|4.4|3.9|246|XIb Thyroid carcinomas|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|XIc Nasopharyngeal carcinomas|61633127|0-14|All Races|Male and Female|2019
1.4|2.1|1.7|107|XId Malignant melanomas|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|XIe Skin carcinomas|61633127|0-14|All Races|Male and Female|2019
3.9|4.9|4.4|276|XIf Other and unspecified carcinomas|61633127|0-14|All Races|Male and Female|2019
1.2|1.8|1.5|92|Xa Intracranial and intraspinal germ cell tumors|61633127|0-14|All Races|Male and Female|2019
1.1|1.7|1.3|79|Xb Malignant extracranial and extragonadal germ cell tumors|61633127|0-14|All Races|Male and Female|2019
1.9|2.7|2.3|141|Xc Malignant gonadal germ cell tumors|61633127|0-14|All Races|Male and Female|2019
~|~|~|~|Xd Gonadal carcinomas|61633127|0-14|All Races|Male and Female|2019
0.2|0.5|0.3|19|Xe Other and unspecified malignant gonadal tumors|61633127|0-14|All Races|Male and Female|2019
160.0|166.4|163.2|9968|All ICCC Groups Combined|61331347|0-14|All Races|Male and Female|2020
50.4|54.0|52.2|3182|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|61331347|0-14|All Races|Male and Female|2020
19.5|21.8|20.6|1272|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|61331347|0-14|All Races|Male and Female|2020
29.0|31.7|30.3|1853|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|61331347|0-14|All Races|Male and Female|2020
2.2|3.0|2.6|155|IIIa Ependymomas and choroid plexus tumor|61331347|0-14|All Races|Male and Female|2020
12.1|13.9|13.0|797|IIIb Astrocytomas|61331347|0-14|All Races|Male and Female|2020
6.1|7.4|6.7|406|IIIc Intracranial and intraspinal embryonal tumors|61331347|0-14|All Races|Male and Female|2020
6.2|7.5|6.9|421|IIId Other gliomas|61331347|0-14|All Races|Male and Female|2020
0.4|0.8|0.6|36|IIIe Other specified intracranial and intraspinal neoplasms|61331347|0-14|All Races|Male and Female|2020
0.4|0.9|0.6|38|IIIf Unspecified intracranial and intraspinal neoplasms|61331347|0-14|All Races|Male and Female|2020
4.7|5.8|5.2|328|IIa Hodgkin lymphomas|61331347|0-14|All Races|Male and Female|2020
7.5|8.9|8.2|507|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|61331347|0-14|All Races|Male and Female|2020
2.0|2.8|2.4|148|IIc Burkitt lymphoma|61331347|0-14|All Races|Male and Female|2020
4.1|5.2|4.6|280|IId Miscellaneous lymphoreticular neoplasms|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|IIe Unspecified lymphomas|61331347|0-14|All Races|Male and Female|2020
10.9|12.6|11.7|698|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|61331347|0-14|All Races|Male and Female|2020
10.7|12.5|11.6|689|IVa Neuroblastoma and ganglioneuroblastoma|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|IVb Other peripheral nervous cell tumors|61331347|0-14|All Races|Male and Female|2020
9.9|11.5|10.7|654|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|61331347|0-14|All Races|Male and Female|2020
4.5|5.7|5.1|309|IXa Rhabdomyosarcomas|61331347|0-14|All Races|Male and Female|2020
0.6|1.1|0.9|52|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|IXc Kaposi sarcoma|61331347|0-14|All Races|Male and Female|2020
2.8|3.7|3.2|202|IXd Other specified soft tissue sarcomas|61331347|0-14|All Races|Male and Female|2020
1.2|1.8|1.5|90|IXe Unspecified soft tissue sarcomas|61331347|0-14|All Races|Male and Female|2020
39.7|43.0|41.3|2520|Ia Lymphoid leukemias|61331347|0-14|All Races|Male and Female|2020
6.6|8.0|7.3|445|Ib Acute myeloid leukemias|61331347|0-14|All Races|Male and Female|2020
0.9|1.4|1.1|70|Ic Chronic myeloproliferative diseases|61331347|0-14|All Races|Male and Female|2020
0.9|1.5|1.2|73|Id Myelodysplastic syndrome and other myeloproliferative diseases|61331347|0-14|All Races|Male and Female|2020
1.0|1.5|1.2|74|Ie Unspecified and other specified leukemias|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|Not classified by ICCC|61331347|0-14|All Races|Male and Female|2020
3.4|4.5|3.9|232|V RETINOBLASTOMA|61331347|0-14|All Races|Male and Female|2020
8.3|9.8|9.0|543|VI RENAL TUMORS|61331347|0-14|All Races|Male and Female|2020
3.0|4.0|3.5|209|VII HEPATIC TUMORS|61331347|0-14|All Races|Male and Female|2020
5.8|7.1|6.4|400|VIII MALIGNANT BONE TUMORS|61331347|0-14|All Races|Male and Female|2020
3.3|4.3|3.8|239|VIIIa Osteosarcomas|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|VIIIb Chondrosarcomas|61331347|0-14|All Races|Male and Female|2020
1.9|2.6|2.2|138|VIIIc Ewing tumor and related sarcomas of bone|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|VIIId Other specified malignant bone tumors|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|VIIIe Unspecified malignant bone tumors|61331347|0-14|All Races|Male and Female|2020
2.6|3.5|3.0|179|VIIa Hepatoblastoma and mesenchymal tumors of liver|61331347|0-14|All Races|Male and Female|2020
0.3|0.7|0.5|29|VIIb Hepatic carcinomas|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|VIIc Unspecified malignant hepatic tumors|61331347|0-14|All Races|Male and Female|2020
7.8|9.3|8.6|516|VIa Nephroblastoma and other non-epithelial renal tumors|61331347|0-14|All Races|Male and Female|2020
0.3|0.6|0.4|25|VIb Renal carcinomas|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|VIc Unspecified malignant renal tumors|61331347|0-14|All Races|Male and Female|2020
4.8|6.0|5.4|330|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|61331347|0-14|All Races|Male and Female|2020
7.7|9.2|8.4|531|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|61331347|0-14|All Races|Male and Female|2020
0.6|1.1|0.8|50|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|61331347|0-14|All Races|Male and Female|2020
0.3|0.6|0.4|25|XIIa Other specified malignant tumors|61331347|0-14|All Races|Male and Female|2020
0.3|0.6|0.4|25|XIIb Other unspecified malignant tumors|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|XIa Adrenocortical carcinomas|61331347|0-14|All Races|Male and Female|2020
2.4|3.2|2.8|176|XIb Thyroid carcinomas|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|XIc Nasopharyngeal carcinomas|61331347|0-14|All Races|Male and Female|2020
1.0|1.6|1.3|78|XId Malignant melanomas|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|XIe Skin carcinomas|61331347|0-14|All Races|Male and Female|2020
3.4|4.4|3.9|247|XIf Other and unspecified carcinomas|61331347|0-14|All Races|Male and Female|2020
1.1|1.7|1.4|85|Xa Intracranial and intraspinal germ cell tumors|61331347|0-14|All Races|Male and Female|2020
0.9|1.5|1.2|68|Xb Malignant extracranial and extragonadal germ cell tumors|61331347|0-14|All Races|Male and Female|2020
2.1|2.9|2.5|154|Xc Malignant gonadal germ cell tumors|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|Xd Gonadal carcinomas|61331347|0-14|All Races|Male and Female|2020
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|61331347|0-14|All Races|Male and Female|2020
162.5|169.0|165.7|9991|All ICCC Groups Combined|60622548|0-14|All Races|Male and Female|2021
49.5|53.1|51.3|3088|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60622548|0-14|All Races|Male and Female|2021
17.9|20.1|19.0|1160|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60622548|0-14|All Races|Male and Female|2021
30.8|33.7|32.2|1946|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60622548|0-14|All Races|Male and Female|2021
2.2|3.0|2.6|155|IIIa Ependymomas and choroid plexus tumor|60622548|0-14|All Races|Male and Female|2021
12.9|14.8|13.9|839|IIIb Astrocytomas|60622548|0-14|All Races|Male and Female|2021
6.1|7.4|6.7|401|IIIc Intracranial and intraspinal embryonal tumors|60622548|0-14|All Races|Male and Female|2021
7.4|8.8|8.1|491|IIId Other gliomas|60622548|0-14|All Races|Male and Female|2021
0.3|0.7|0.5|28|IIIe Other specified intracranial and intraspinal neoplasms|60622548|0-14|All Races|Male and Female|2021
0.4|0.7|0.5|32|IIIf Unspecified intracranial and intraspinal neoplasms|60622548|0-14|All Races|Male and Female|2021
4.7|5.8|5.2|327|IIa Hodgkin lymphomas|60622548|0-14|All Races|Male and Female|2021
7.4|8.8|8.1|494|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60622548|0-14|All Races|Male and Female|2021
3.2|4.2|3.7|221|IIc Burkitt lymphoma|60622548|0-14|All Races|Male and Female|2021
1.5|2.3|1.9|111|IId Miscellaneous lymphoreticular neoplasms|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|IIe Unspecified lymphomas|60622548|0-14|All Races|Male and Female|2021
11.1|12.8|11.9|697|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60622548|0-14|All Races|Male and Female|2021
10.5|12.3|11.4|665|IVa Neuroblastoma and ganglioneuroblastoma|60622548|0-14|All Races|Male and Female|2021
0.4|0.7|0.5|32|IVb Other peripheral nervous cell tumors|60622548|0-14|All Races|Male and Female|2021
10.2|11.9|11.1|668|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60622548|0-14|All Races|Male and Female|2021
4.7|5.9|5.3|317|IXa Rhabdomyosarcomas|60622548|0-14|All Races|Male and Female|2021
0.7|1.2|0.9|52|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|IXc Kaposi sarcoma|60622548|0-14|All Races|Male and Female|2021
2.9|3.8|3.3|203|IXd Other specified soft tissue sarcomas|60622548|0-14|All Races|Male and Female|2021
1.3|1.9|1.6|96|IXe Unspecified soft tissue sarcomas|60622548|0-14|All Races|Male and Female|2021
38.9|42.1|40.4|2436|Ia Lymphoid leukemias|60622548|0-14|All Races|Male and Female|2021
6.5|7.9|7.2|434|Ib Acute myeloid leukemias|60622548|0-14|All Races|Male and Female|2021
0.8|1.3|1.1|64|Ic Chronic myeloproliferative diseases|60622548|0-14|All Races|Male and Female|2021
1.2|1.9|1.5|92|Id Myelodysplastic syndrome and other myeloproliferative diseases|60622548|0-14|All Races|Male and Female|2021
0.8|1.3|1.0|62|Ie Unspecified and other specified leukemias|60622548|0-14|All Races|Male and Female|2021
0.2|0.5|0.3|18|Not classified by ICCC|60622548|0-14|All Races|Male and Female|2021
3.3|4.3|3.8|218|V RETINOBLASTOMA|60622548|0-14|All Races|Male and Female|2021
8.1|9.7|8.9|527|VI RENAL TUMORS|60622548|0-14|All Races|Male and Female|2021
3.4|4.4|3.8|225|VII HEPATIC TUMORS|60622548|0-14|All Races|Male and Female|2021
6.5|7.9|7.2|445|VIII MALIGNANT BONE TUMORS|60622548|0-14|All Races|Male and Female|2021
3.4|4.4|3.9|242|VIIIa Osteosarcomas|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|VIIIb Chondrosarcomas|60622548|0-14|All Races|Male and Female|2021
2.0|2.8|2.4|148|VIIIc Ewing tumor and related sarcomas of bone|60622548|0-14|All Races|Male and Female|2021
0.3|0.6|0.4|27|VIIId Other specified malignant bone tumors|60622548|0-14|All Races|Male and Female|2021
0.2|0.5|0.3|19|VIIIe Unspecified malignant bone tumors|60622548|0-14|All Races|Male and Female|2021
2.9|3.8|3.3|193|VIIa Hepatoblastoma and mesenchymal tumors of liver|60622548|0-14|All Races|Male and Female|2021
0.3|0.7|0.5|30|VIIb Hepatic carcinomas|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60622548|0-14|All Races|Male and Female|2021
7.7|9.3|8.5|502|VIa Nephroblastoma and other non-epithelial renal tumors|60622548|0-14|All Races|Male and Female|2021
0.2|0.6|0.4|23|VIb Renal carcinomas|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|VIc Unspecified malignant renal tumors|60622548|0-14|All Races|Male and Female|2021
5.1|6.4|5.7|345|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60622548|0-14|All Races|Male and Female|2021
8.8|10.4|9.6|595|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60622548|0-14|All Races|Male and Female|2021
0.8|1.3|1.0|59|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60622548|0-14|All Races|Male and Female|2021
0.4|0.8|0.5|33|XIIa Other specified malignant tumors|60622548|0-14|All Races|Male and Female|2021
0.3|0.6|0.4|26|XIIb Other unspecified malignant tumors|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|XIa Adrenocortical carcinomas|60622548|0-14|All Races|Male and Female|2021
2.5|3.3|2.9|181|XIb Thyroid carcinomas|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|XIc Nasopharyngeal carcinomas|60622548|0-14|All Races|Male and Female|2021
1.1|1.7|1.4|82|XId Malignant melanomas|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|XIe Skin carcinomas|60622548|0-14|All Races|Male and Female|2021
4.3|5.4|4.8|301|XIf Other and unspecified carcinomas|60622548|0-14|All Races|Male and Female|2021
1.2|1.8|1.5|93|Xa Intracranial and intraspinal germ cell tumors|60622548|0-14|All Races|Male and Female|2021
1.3|2.0|1.6|94|Xb Malignant extracranial and extragonadal germ cell tumors|60622548|0-14|All Races|Male and Female|2021
1.9|2.7|2.3|141|Xc Malignant gonadal germ cell tumors|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|Xd Gonadal carcinomas|60622548|0-14|All Races|Male and Female|2021
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|60622548|0-14|All Races|Male and Female|2021
158.8|165.2|162.0|9684|All ICCC Groups Combined|60070357|0-14|All Races|Male and Female|2022
48.7|52.4|50.5|3009|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|60070357|0-14|All Races|Male and Female|2022
18.1|20.3|19.2|1164|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|60070357|0-14|All Races|Male and Female|2022
29.7|32.6|31.1|1860|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|60070357|0-14|All Races|Male and Female|2022
2.5|3.4|2.9|172|IIIa Ependymomas and choroid plexus tumor|60070357|0-14|All Races|Male and Female|2022
10.9|12.7|11.8|705|IIIb Astrocytomas|60070357|0-14|All Races|Male and Female|2022
5.4|6.7|6.1|359|IIIc Intracranial and intraspinal embryonal tumors|60070357|0-14|All Races|Male and Female|2022
8.4|9.9|9.1|549|IIId Other gliomas|60070357|0-14|All Races|Male and Female|2022
0.4|0.8|0.5|32|IIIe Other specified intracranial and intraspinal neoplasms|60070357|0-14|All Races|Male and Female|2022
0.5|1.0|0.7|43|IIIf Unspecified intracranial and intraspinal neoplasms|60070357|0-14|All Races|Male and Female|2022
5.3|6.6|5.9|365|IIa Hodgkin lymphomas|60070357|0-14|All Races|Male and Female|2022
7.4|8.8|8.1|490|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|60070357|0-14|All Races|Male and Female|2022
2.8|3.7|3.2|192|IIc Burkitt lymphoma|60070357|0-14|All Races|Male and Female|2022
1.4|2.1|1.7|102|IId Miscellaneous lymphoreticular neoplasms|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|IIe Unspecified lymphomas|60070357|0-14|All Races|Male and Female|2022
10.3|12.1|11.2|651|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|60070357|0-14|All Races|Male and Female|2022
10.0|11.7|10.8|627|IVa Neuroblastoma and ganglioneuroblastoma|60070357|0-14|All Races|Male and Female|2022
0.2|0.6|0.4|24|IVb Other peripheral nervous cell tumors|60070357|0-14|All Races|Male and Female|2022
9.8|11.5|10.6|639|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|60070357|0-14|All Races|Male and Female|2022
4.6|5.8|5.2|308|IXa Rhabdomyosarcomas|60070357|0-14|All Races|Male and Female|2022
0.5|0.9|0.7|39|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|IXc Kaposi sarcoma|60070357|0-14|All Races|Male and Female|2022
2.9|3.9|3.4|206|IXd Other specified soft tissue sarcomas|60070357|0-14|All Races|Male and Female|2022
1.1|1.7|1.4|85|IXe Unspecified soft tissue sarcomas|60070357|0-14|All Races|Male and Female|2022
38.8|42.0|40.4|2402|Ia Lymphoid leukemias|60070357|0-14|All Races|Male and Female|2022
6.5|7.8|7.1|426|Ib Acute myeloid leukemias|60070357|0-14|All Races|Male and Female|2022
0.7|1.1|0.9|53|Ic Chronic myeloproliferative diseases|60070357|0-14|All Races|Male and Female|2022
0.9|1.5|1.2|69|Id Myelodysplastic syndrome and other myeloproliferative diseases|60070357|0-14|All Races|Male and Female|2022
0.7|1.3|1.0|59|Ie Unspecified and other specified leukemias|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|Not classified by ICCC|60070357|0-14|All Races|Male and Female|2022
3.4|4.4|3.8|222|V RETINOBLASTOMA|60070357|0-14|All Races|Male and Female|2022
7.5|9.0|8.2|482|VI RENAL TUMORS|60070357|0-14|All Races|Male and Female|2022
3.3|4.3|3.8|220|VII HEPATIC TUMORS|60070357|0-14|All Races|Male and Female|2022
7.2|8.7|7.9|487|VIII MALIGNANT BONE TUMORS|60070357|0-14|All Races|Male and Female|2022
4.2|5.4|4.8|294|VIIIa Osteosarcomas|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|VIIIb Chondrosarcomas|60070357|0-14|All Races|Male and Female|2022
2.0|2.7|2.3|142|VIIIc Ewing tumor and related sarcomas of bone|60070357|0-14|All Races|Male and Female|2022
0.3|0.7|0.5|29|VIIId Other specified malignant bone tumors|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|VIIIe Unspecified malignant bone tumors|60070357|0-14|All Races|Male and Female|2022
2.8|3.7|3.2|186|VIIa Hepatoblastoma and mesenchymal tumors of liver|60070357|0-14|All Races|Male and Female|2022
0.4|0.8|0.5|33|VIIb Hepatic carcinomas|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|VIIc Unspecified malignant hepatic tumors|60070357|0-14|All Races|Male and Female|2022
7.0|8.4|7.7|452|VIa Nephroblastoma and other non-epithelial renal tumors|60070357|0-14|All Races|Male and Female|2022
0.3|0.6|0.4|25|VIb Renal carcinomas|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|VIc Unspecified malignant renal tumors|60070357|0-14|All Races|Male and Female|2022
4.8|6.0|5.4|326|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|60070357|0-14|All Races|Male and Female|2022
8.3|9.8|9.1|555|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|60070357|0-14|All Races|Male and Female|2022
0.8|1.3|1.0|59|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|60070357|0-14|All Races|Male and Female|2022
0.3|0.7|0.5|27|XIIa Other specified malignant tumors|60070357|0-14|All Races|Male and Female|2022
0.4|0.8|0.5|32|XIIb Other unspecified malignant tumors|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|XIa Adrenocortical carcinomas|60070357|0-14|All Races|Male and Female|2022
2.2|3.1|2.6|162|XIb Thyroid carcinomas|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|XIc Nasopharyngeal carcinomas|60070357|0-14|All Races|Male and Female|2022
1.1|1.8|1.4|86|XId Malignant melanomas|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|XIe Skin carcinomas|60070357|0-14|All Races|Male and Female|2022
4.1|5.2|4.7|286|XIf Other and unspecified carcinomas|60070357|0-14|All Races|Male and Female|2022
1.1|1.7|1.4|84|Xa Intracranial and intraspinal germ cell tumors|60070357|0-14|All Races|Male and Female|2022
0.9|1.5|1.2|70|Xb Malignant extracranial and extragonadal germ cell tumors|60070357|0-14|All Races|Male and Female|2022
2.1|2.9|2.5|152|Xc Malignant gonadal germ cell tumors|60070357|0-14|All Races|Male and Female|2022
~|~|~|~|Xd Gonadal carcinomas|60070357|0-14|All Races|Male and Female|2022
0.1|0.4|0.3|16|Xe Other and unspecified malignant gonadal tumors|60070357|0-14|All Races|Male and Female|2022
155.4|160.9|158.1|12459|All ICCC Groups Combined|78936986|0-19|All Races|Male and Female|1999
39.0|41.9|40.4|3190|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|78936986|0-19|All Races|Male and Female|1999
22.2|24.3|23.2|1829|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|78936986|0-19|All Races|Male and Female|1999
27.4|29.8|28.6|2259|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|78936986|0-19|All Races|Male and Female|1999
2.3|3.0|2.6|207|IIIa Ependymomas and choroid plexus tumor|78936986|0-19|All Races|Male and Female|1999
12.7|14.4|13.5|1068|IIIb Astrocytomas|78936986|0-19|All Races|Male and Female|1999
6.1|7.2|6.6|523|IIIc Intracranial and intraspinal embryonal tumors|78936986|0-19|All Races|Male and Female|1999
4.3|5.2|4.7|375|IIId Other gliomas|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|40|IIIe Other specified intracranial and intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999
0.4|0.8|0.6|46|IIIf Unspecified intracranial and intraspinal neoplasms|78936986|0-19|All Races|Male and Female|1999
11.1|12.7|11.9|934|IIa Hodgkin lymphomas|78936986|0-19|All Races|Male and Female|1999
7.0|8.3|7.6|601|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|78936986|0-19|All Races|Male and Female|1999
2.1|2.8|2.4|189|IIc Burkitt lymphoma|78936986|0-19|All Races|Male and Female|1999
0.5|0.9|0.7|56|IId Miscellaneous lymphoreticular neoplasms|78936986|0-19|All Races|Male and Female|1999
0.5|0.8|0.6|49|IIe Unspecified lymphomas|78936986|0-19|All Races|Male and Female|1999
7.6|8.9|8.3|648|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|78936986|0-19|All Races|Male and Female|1999
7.4|8.6|8.0|625|IVa Neuroblastoma and ganglioneuroblastoma|78936986|0-19|All Races|Male and Female|1999
0.2|0.4|0.3|23|IVb Other peripheral nervous cell tumors|78936986|0-19|All Races|Male and Female|1999
10.1|11.6|10.8|852|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|78936986|0-19|All Races|Male and Female|1999
3.9|4.9|4.4|347|IXa Rhabdomyosarcomas|78936986|0-19|All Races|Male and Female|1999
0.9|1.4|1.1|88|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|IXc Kaposi sarcoma|78936986|0-19|All Races|Male and Female|1999
3.6|4.5|4.0|315|IXd Other specified soft tissue sarcomas|78936986|0-19|All Races|Male and Female|1999
1.0|1.5|1.3|99|IXe Unspecified soft tissue sarcomas|78936986|0-19|All Races|Male and Female|1999
28.8|31.2|30.0|2369|Ia Lymphoid leukemias|78936986|0-19|All Races|Male and Female|1999
7.5|8.8|8.1|638|Ib Acute myeloid leukemias|78936986|0-19|All Races|Male and Female|1999
0.8|1.3|1.0|81|Ic Chronic myeloproliferative diseases|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|78936986|0-19|All Races|Male and Female|1999
0.9|1.4|1.2|91|Ie Unspecified and other specified leukemias|78936986|0-19|All Races|Male and Female|1999
0.3|0.6|0.4|34|Not classified by ICCC|78936986|0-19|All Races|Male and Female|1999
2.8|3.6|3.2|247|V RETINOBLASTOMA|78936986|0-19|All Races|Male and Female|1999
5.8|6.9|6.3|500|VI RENAL TUMORS|78936986|0-19|All Races|Male and Female|1999
1.8|2.4|2.1|163|VII HEPATIC TUMORS|78936986|0-19|All Races|Male and Female|1999
8.2|9.5|8.8|694|VIII MALIGNANT BONE TUMORS|78936986|0-19|All Races|Male and Female|1999
4.6|5.6|5.1|400|VIIIa Osteosarcomas|78936986|0-19|All Races|Male and Female|1999
0.3|0.5|0.4|30|VIIIb Chondrosarcomas|78936986|0-19|All Races|Male and Female|1999
2.3|3.1|2.7|212|VIIIc Ewing tumor and related sarcomas of bone|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|40|VIIId Other specified malignant bone tumors|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|VIIIe Unspecified malignant bone tumors|78936986|0-19|All Races|Male and Female|1999
1.2|1.7|1.4|111|VIIa Hepatoblastoma and mesenchymal tumors of liver|78936986|0-19|All Races|Male and Female|1999
0.5|0.9|0.6|51|VIIb Hepatic carcinomas|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|VIIc Unspecified malignant hepatic tumors|78936986|0-19|All Races|Male and Female|1999
5.3|6.3|5.8|456|VIa Nephroblastoma and other non-epithelial renal tumors|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|40|VIb Renal carcinomas|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|VIc Unspecified malignant renal tumors|78936986|0-19|All Races|Male and Female|1999
9.3|10.7|10.0|787|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|78936986|0-19|All Races|Male and Female|1999
14.3|16.0|15.1|1190|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|78936986|0-19|All Races|Male and Female|1999
0.6|1.1|0.8|66|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|78936986|0-19|All Races|Male and Female|1999
0.1|0.4|0.2|19|XIIa Other specified malignant tumors|78936986|0-19|All Races|Male and Female|1999
0.4|0.8|0.6|47|XIIb Other unspecified malignant tumors|78936986|0-19|All Races|Male and Female|1999
0.1|0.4|0.2|19|XIa Adrenocortical carcinomas|78936986|0-19|All Races|Male and Female|1999
5.4|6.4|5.9|463|XIb Thyroid carcinomas|78936986|0-19|All Races|Male and Female|1999
0.4|0.7|0.5|42|XIc Nasopharyngeal carcinomas|78936986|0-19|All Races|Male and Female|1999
4.3|5.2|4.7|371|XId Malignant melanomas|78936986|0-19|All Races|Male and Female|1999
~|~|~|~|XIe Skin carcinomas|78936986|0-19|All Races|Male and Female|1999
3.2|4.1|3.6|286|XIf Other and unspecified carcinomas|78936986|0-19|All Races|Male and Female|1999
1.1|1.7|1.4|110|Xa Intracranial and intraspinal germ cell tumors|78936986|0-19|All Races|Male and Female|1999
1.1|1.6|1.4|106|Xb Malignant extracranial and extragonadal germ cell tumors|78936986|0-19|All Races|Male and Female|1999
6.1|7.2|6.6|522|Xc Malignant gonadal germ cell tumors|78936986|0-19|All Races|Male and Female|1999
0.3|0.5|0.4|30|Xd Gonadal carcinomas|78936986|0-19|All Races|Male and Female|1999
0.1|0.4|0.2|19|Xe Other and unspecified malignant gonadal tumors|78936986|0-19|All Races|Male and Female|1999
160.4|166.1|163.2|12952|All ICCC Groups Combined|79474943|0-19|All Races|Male and Female|2000
39.8|42.7|41.2|3265|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|79474943|0-19|All Races|Male and Female|2000
23.8|26.0|24.9|1979|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|79474943|0-19|All Races|Male and Female|2000
28.5|30.9|29.7|2360|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|79474943|0-19|All Races|Male and Female|2000
2.0|2.7|2.3|184|IIIa Ependymomas and choroid plexus tumor|79474943|0-19|All Races|Male and Female|2000
14.5|16.3|15.4|1223|IIIb Astrocytomas|79474943|0-19|All Races|Male and Female|2000
5.8|6.9|6.4|504|IIIc Intracranial and intraspinal embryonal tumors|79474943|0-19|All Races|Male and Female|2000
4.1|5.0|4.5|360|IIId Other gliomas|79474943|0-19|All Races|Male and Female|2000
0.3|0.6|0.5|37|IIIe Other specified intracranial and intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000
0.5|0.9|0.7|52|IIIf Unspecified intracranial and intraspinal neoplasms|79474943|0-19|All Races|Male and Female|2000
11.6|13.1|12.3|983|IIa Hodgkin lymphomas|79474943|0-19|All Races|Male and Female|2000
7.6|8.8|8.2|650|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|79474943|0-19|All Races|Male and Female|2000
2.3|3.1|2.7|213|IIc Burkitt lymphoma|79474943|0-19|All Races|Male and Female|2000
0.8|1.3|1.0|81|IId Miscellaneous lymphoreticular neoplasms|79474943|0-19|All Races|Male and Female|2000
0.5|0.9|0.7|52|IIe Unspecified lymphomas|79474943|0-19|All Races|Male and Female|2000
7.1|8.3|7.7|608|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|79474943|0-19|All Races|Male and Female|2000
7.0|8.2|7.6|596|IVa Neuroblastoma and ganglioneuroblastoma|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|IVb Other peripheral nervous cell tumors|79474943|0-19|All Races|Male and Female|2000
11.2|12.7|11.9|947|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|79474943|0-19|All Races|Male and Female|2000
4.3|5.2|4.7|376|IXa Rhabdomyosarcomas|79474943|0-19|All Races|Male and Female|2000
1.0|1.4|1.2|94|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|IXc Kaposi sarcoma|79474943|0-19|All Races|Male and Female|2000
4.2|5.1|4.6|368|IXd Other specified soft tissue sarcomas|79474943|0-19|All Races|Male and Female|2000
1.1|1.6|1.3|105|IXe Unspecified soft tissue sarcomas|79474943|0-19|All Races|Male and Female|2000
30.5|33.0|31.7|2512|Ia Lymphoid leukemias|79474943|0-19|All Races|Male and Female|2000
6.7|7.9|7.3|581|Ib Acute myeloid leukemias|79474943|0-19|All Races|Male and Female|2000
0.7|1.1|0.9|71|Ic Chronic myeloproliferative diseases|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|Id Myelodysplastic syndrome and other myeloproliferative diseases|79474943|0-19|All Races|Male and Female|2000
0.9|1.4|1.2|92|Ie Unspecified and other specified leukemias|79474943|0-19|All Races|Male and Female|2000
0.3|0.6|0.4|33|Not classified by ICCC|79474943|0-19|All Races|Male and Female|2000
2.9|3.7|3.3|258|V RETINOBLASTOMA|79474943|0-19|All Races|Male and Female|2000
6.3|7.4|6.8|540|VI RENAL TUMORS|79474943|0-19|All Races|Male and Female|2000
1.7|2.3|2.0|156|VII HEPATIC TUMORS|79474943|0-19|All Races|Male and Female|2000
7.7|9.0|8.4|666|VIII MALIGNANT BONE TUMORS|79474943|0-19|All Races|Male and Female|2000
4.2|5.2|4.7|373|VIIIa Osteosarcomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|VIIIb Chondrosarcomas|79474943|0-19|All Races|Male and Female|2000
2.7|3.4|3.0|241|VIIIc Ewing tumor and related sarcomas of bone|79474943|0-19|All Races|Male and Female|2000
0.2|0.4|0.3|20|VIIId Other specified malignant bone tumors|79474943|0-19|All Races|Male and Female|2000
0.1|0.3|0.2|17|VIIIe Unspecified malignant bone tumors|79474943|0-19|All Races|Male and Female|2000
1.3|1.9|1.6|124|VIIa Hepatoblastoma and mesenchymal tumors of liver|79474943|0-19|All Races|Male and Female|2000
0.3|0.5|0.4|30|VIIb Hepatic carcinomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|VIIc Unspecified malignant hepatic tumors|79474943|0-19|All Races|Male and Female|2000
5.8|6.9|6.3|499|VIa Nephroblastoma and other non-epithelial renal tumors|79474943|0-19|All Races|Male and Female|2000
0.3|0.7|0.5|39|VIb Renal carcinomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|VIc Unspecified malignant renal tumors|79474943|0-19|All Races|Male and Female|2000
10.0|11.5|10.7|854|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|79474943|0-19|All Races|Male and Female|2000
14.5|16.3|15.4|1223|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|79474943|0-19|All Races|Male and Female|2000
0.6|1.0|0.8|63|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|XIIa Other specified malignant tumors|79474943|0-19|All Races|Male and Female|2000
0.4|0.8|0.6|48|XIIb Other unspecified malignant tumors|79474943|0-19|All Races|Male and Female|2000
0.2|0.5|0.3|25|XIa Adrenocortical carcinomas|79474943|0-19|All Races|Male and Female|2000
5.2|6.2|5.7|451|XIb Thyroid carcinomas|79474943|0-19|All Races|Male and Female|2000
0.4|0.7|0.5|41|XIc Nasopharyngeal carcinomas|79474943|0-19|All Races|Male and Female|2000
4.7|5.7|5.2|411|XId Malignant melanomas|79474943|0-19|All Races|Male and Female|2000
~|~|~|~|XIe Skin carcinomas|79474943|0-19|All Races|Male and Female|2000
3.2|4.1|3.6|289|XIf Other and unspecified carcinomas|79474943|0-19|All Races|Male and Female|2000
1.4|2.0|1.7|133|Xa Intracranial and intraspinal germ cell tumors|79474943|0-19|All Races|Male and Female|2000
1.1|1.6|1.4|107|Xb Malignant extracranial and extragonadal germ cell tumors|79474943|0-19|All Races|Male and Female|2000
6.5|7.6|7.0|560|Xc Malignant gonadal germ cell tumors|79474943|0-19|All Races|Male and Female|2000
0.3|0.6|0.5|36|Xd Gonadal carcinomas|79474943|0-19|All Races|Male and Female|2000
0.1|0.4|0.2|18|Xe Other and unspecified malignant gonadal tumors|79474943|0-19|All Races|Male and Female|2000
167.5|173.2|170.4|13635|All ICCC Groups Combined|80042731|0-19|All Races|Male and Female|2001
44.1|47.1|45.6|3630|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|80042731|0-19|All Races|Male and Female|2001
23.5|25.7|24.6|1977|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|80042731|0-19|All Races|Male and Female|2001
28.9|31.3|30.1|2400|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|80042731|0-19|All Races|Male and Female|2001
2.1|2.8|2.4|194|IIIa Ependymomas and choroid plexus tumor|80042731|0-19|All Races|Male and Female|2001
14.2|15.9|15.0|1201|IIIb Astrocytomas|80042731|0-19|All Races|Male and Female|2001
6.0|7.1|6.5|520|IIIc Intracranial and intraspinal embryonal tumors|80042731|0-19|All Races|Male and Female|2001
4.6|5.6|5.1|405|IIId Other gliomas|80042731|0-19|All Races|Male and Female|2001
0.5|0.8|0.6|49|IIIe Other specified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001
0.3|0.5|0.4|31|IIIf Unspecified intracranial and intraspinal neoplasms|80042731|0-19|All Races|Male and Female|2001
11.7|13.3|12.5|1007|IIa Hodgkin lymphomas|80042731|0-19|All Races|Male and Female|2001
8.0|9.3|8.6|694|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|80042731|0-19|All Races|Male and Female|2001
1.9|2.5|2.2|174|IIc Burkitt lymphoma|80042731|0-19|All Races|Male and Female|2001
0.6|1.0|0.8|64|IId Miscellaneous lymphoreticular neoplasms|80042731|0-19|All Races|Male and Female|2001
0.3|0.7|0.5|38|IIe Unspecified lymphomas|80042731|0-19|All Races|Male and Female|2001
8.2|9.5|8.9|709|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|80042731|0-19|All Races|Male and Female|2001
8.0|9.3|8.7|692|IVa Neuroblastoma and ganglioneuroblastoma|80042731|0-19|All Races|Male and Female|2001
0.1|0.3|0.2|17|IVb Other peripheral nervous cell tumors|80042731|0-19|All Races|Male and Female|2001
11.0|12.5|11.8|943|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|80042731|0-19|All Races|Male and Female|2001
4.4|5.4|4.9|388|IXa Rhabdomyosarcomas|80042731|0-19|All Races|Male and Female|2001
1.2|1.7|1.4|115|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|IXc Kaposi sarcoma|80042731|0-19|All Races|Male and Female|2001
3.7|4.6|4.2|335|IXd Other specified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001
1.0|1.5|1.3|102|IXe Unspecified soft tissue sarcomas|80042731|0-19|All Races|Male and Female|2001
31.6|34.1|32.8|2606|Ia Lymphoid leukemias|80042731|0-19|All Races|Male and Female|2001
7.2|8.4|7.8|624|Ib Acute myeloid leukemias|80042731|0-19|All Races|Male and Female|2001
2.0|2.7|2.3|186|Ic Chronic myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001
1.2|1.8|1.5|117|Id Myelodysplastic syndrome and other myeloproliferative diseases|80042731|0-19|All Races|Male and Female|2001
1.0|1.5|1.2|97|Ie Unspecified and other specified leukemias|80042731|0-19|All Races|Male and Female|2001
0.3|0.5|0.4|31|Not classified by ICCC|80042731|0-19|All Races|Male and Female|2001
2.9|3.7|3.3|266|V RETINOBLASTOMA|80042731|0-19|All Races|Male and Female|2001
6.2|7.4|6.8|539|VI RENAL TUMORS|80042731|0-19|All Races|Male and Female|2001
1.7|2.3|2.0|158|VII HEPATIC TUMORS|80042731|0-19|All Races|Male and Female|2001
8.9|10.3|9.6|771|VIII MALIGNANT BONE TUMORS|80042731|0-19|All Races|Male and Female|2001
4.7|5.7|5.2|420|VIIIa Osteosarcomas|80042731|0-19|All Races|Male and Female|2001
0.3|0.5|0.4|30|VIIIb Chondrosarcomas|80042731|0-19|All Races|Male and Female|2001
3.0|3.8|3.4|274|VIIIc Ewing tumor and related sarcomas of bone|80042731|0-19|All Races|Male and Female|2001
0.3|0.6|0.4|36|VIIId Other specified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|VIIIe Unspecified malignant bone tumors|80042731|0-19|All Races|Male and Female|2001
1.2|1.7|1.4|114|VIIa Hepatoblastoma and mesenchymal tumors of liver|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|43|VIIb Hepatic carcinomas|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|VIIc Unspecified malignant hepatic tumors|80042731|0-19|All Races|Male and Female|2001
5.7|6.8|6.2|493|VIa Nephroblastoma and other non-epithelial renal tumors|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|43|VIb Renal carcinomas|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|VIc Unspecified malignant renal tumors|80042731|0-19|All Races|Male and Female|2001
9.6|11.0|10.3|830|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|80042731|0-19|All Races|Male and Female|2001
15.4|17.1|16.2|1307|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|80042731|0-19|All Races|Male and Female|2001
0.7|1.2|0.9|74|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|80042731|0-19|All Races|Male and Female|2001
0.3|0.6|0.4|32|XIIa Other specified malignant tumors|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|80042731|0-19|All Races|Male and Female|2001
0.1|0.4|0.2|18|XIa Adrenocortical carcinomas|80042731|0-19|All Races|Male and Female|2001
5.3|6.4|5.8|468|XIb Thyroid carcinomas|80042731|0-19|All Races|Male and Female|2001
0.4|0.7|0.5|43|XIc Nasopharyngeal carcinomas|80042731|0-19|All Races|Male and Female|2001
5.2|6.3|5.8|463|XId Malignant melanomas|80042731|0-19|All Races|Male and Female|2001
~|~|~|~|XIe Skin carcinomas|80042731|0-19|All Races|Male and Female|2001
3.4|4.3|3.8|308|XIf Other and unspecified carcinomas|80042731|0-19|All Races|Male and Female|2001
1.3|1.9|1.6|128|Xa Intracranial and intraspinal germ cell tumors|80042731|0-19|All Races|Male and Female|2001
1.3|1.9|1.6|126|Xb Malignant extracranial and extragonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001
6.0|7.1|6.5|525|Xc Malignant gonadal germ cell tumors|80042731|0-19|All Races|Male and Female|2001
0.2|0.5|0.3|27|Xd Gonadal carcinomas|80042731|0-19|All Races|Male and Female|2001
0.2|0.4|0.3|24|Xe Other and unspecified malignant gonadal tumors|80042731|0-19|All Races|Male and Female|2001
167.6|173.3|170.4|13699|All ICCC Groups Combined|80317363|0-19|All Races|Male and Female|2002
43.2|46.1|44.6|3567|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|80317363|0-19|All Races|Male and Female|2002
23.5|25.7|24.6|1989|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|80317363|0-19|All Races|Male and Female|2002
30.2|32.7|31.4|2513|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|80317363|0-19|All Races|Male and Female|2002
2.6|3.3|2.9|236|IIIa Ependymomas and choroid plexus tumor|80317363|0-19|All Races|Male and Female|2002
14.6|16.3|15.4|1237|IIIb Astrocytomas|80317363|0-19|All Races|Male and Female|2002
5.8|6.9|6.3|505|IIIc Intracranial and intraspinal embryonal tumors|80317363|0-19|All Races|Male and Female|2002
5.1|6.1|5.6|444|IIId Other gliomas|80317363|0-19|All Races|Male and Female|2002
0.5|0.9|0.7|58|IIIe Other specified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.4|33|IIIf Unspecified intracranial and intraspinal neoplasms|80317363|0-19|All Races|Male and Female|2002
11.6|13.1|12.4|1003|IIa Hodgkin lymphomas|80317363|0-19|All Races|Male and Female|2002
7.6|8.9|8.2|664|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|80317363|0-19|All Races|Male and Female|2002
2.4|3.1|2.7|220|IIc Burkitt lymphoma|80317363|0-19|All Races|Male and Female|2002
0.7|1.2|0.9|74|IId Miscellaneous lymphoreticular neoplasms|80317363|0-19|All Races|Male and Female|2002
0.2|0.5|0.3|28|IIe Unspecified lymphomas|80317363|0-19|All Races|Male and Female|2002
7.8|9.1|8.5|678|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|80317363|0-19|All Races|Male and Female|2002
7.6|8.9|8.3|660|IVa Neuroblastoma and ganglioneuroblastoma|80317363|0-19|All Races|Male and Female|2002
0.1|0.4|0.2|18|IVb Other peripheral nervous cell tumors|80317363|0-19|All Races|Male and Female|2002
11.0|12.5|11.7|941|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|80317363|0-19|All Races|Male and Female|2002
4.3|5.2|4.7|378|IXa Rhabdomyosarcomas|80317363|0-19|All Races|Male and Female|2002
1.0|1.4|1.2|95|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|IXc Kaposi sarcoma|80317363|0-19|All Races|Male and Female|2002
4.3|5.3|4.8|389|IXd Other specified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002
0.8|1.2|1.0|79|IXe Unspecified soft tissue sarcomas|80317363|0-19|All Races|Male and Female|2002
30.4|32.9|31.7|2524|Ia Lymphoid leukemias|80317363|0-19|All Races|Male and Female|2002
7.6|8.9|8.2|662|Ib Acute myeloid leukemias|80317363|0-19|All Races|Male and Female|2002
1.8|2.4|2.1|170|Ic Chronic myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002
1.3|1.8|1.5|122|Id Myelodysplastic syndrome and other myeloproliferative diseases|80317363|0-19|All Races|Male and Female|2002
0.9|1.4|1.1|89|Ie Unspecified and other specified leukemias|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.4|35|Not classified by ICCC|80317363|0-19|All Races|Male and Female|2002
2.4|3.2|2.8|224|V RETINOBLASTOMA|80317363|0-19|All Races|Male and Female|2002
5.9|7.1|6.5|517|VI RENAL TUMORS|80317363|0-19|All Races|Male and Female|2002
1.6|2.2|1.9|150|VII HEPATIC TUMORS|80317363|0-19|All Races|Male and Female|2002
8.5|9.8|9.1|740|VIII MALIGNANT BONE TUMORS|80317363|0-19|All Races|Male and Female|2002
4.4|5.4|4.9|397|VIIIa Osteosarcomas|80317363|0-19|All Races|Male and Female|2002
0.4|0.7|0.5|41|VIIIb Chondrosarcomas|80317363|0-19|All Races|Male and Female|2002
2.7|3.5|3.1|248|VIIIc Ewing tumor and related sarcomas of bone|80317363|0-19|All Races|Male and Female|2002
0.4|0.7|0.5|43|VIIId Other specified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|VIIIe Unspecified malignant bone tumors|80317363|0-19|All Races|Male and Female|2002
1.1|1.6|1.3|107|VIIa Hepatoblastoma and mesenchymal tumors of liver|80317363|0-19|All Races|Male and Female|2002
0.4|0.7|0.5|42|VIIb Hepatic carcinomas|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|VIIc Unspecified malignant hepatic tumors|80317363|0-19|All Races|Male and Female|2002
5.5|6.6|6.0|479|VIa Nephroblastoma and other non-epithelial renal tumors|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.5|37|VIb Renal carcinomas|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|VIc Unspecified malignant renal tumors|80317363|0-19|All Races|Male and Female|2002
10.3|11.7|11.0|888|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|80317363|0-19|All Races|Male and Female|2002
16.2|18.0|17.1|1384|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|80317363|0-19|All Races|Male and Female|2002
0.7|1.1|0.9|73|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.5|38|XIIa Other specified malignant tumors|80317363|0-19|All Races|Male and Female|2002
0.3|0.6|0.4|35|XIIb Other unspecified malignant tumors|80317363|0-19|All Races|Male and Female|2002
0.1|0.4|0.2|19|XIa Adrenocortical carcinomas|80317363|0-19|All Races|Male and Female|2002
5.3|6.4|5.9|476|XIb Thyroid carcinomas|80317363|0-19|All Races|Male and Female|2002
0.4|0.8|0.6|49|XIc Nasopharyngeal carcinomas|80317363|0-19|All Races|Male and Female|2002
5.9|7.0|6.5|523|XId Malignant melanomas|80317363|0-19|All Races|Male and Female|2002
~|~|~|~|XIe Skin carcinomas|80317363|0-19|All Races|Male and Female|2002
3.4|4.2|3.8|308|XIf Other and unspecified carcinomas|80317363|0-19|All Races|Male and Female|2002
1.4|1.9|1.6|131|Xa Intracranial and intraspinal germ cell tumors|80317363|0-19|All Races|Male and Female|2002
1.3|1.9|1.6|126|Xb Malignant extracranial and extragonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002
6.6|7.8|7.2|580|Xc Malignant gonadal germ cell tumors|80317363|0-19|All Races|Male and Female|2002
0.2|0.5|0.3|28|Xd Gonadal carcinomas|80317363|0-19|All Races|Male and Female|2002
0.2|0.4|0.3|23|Xe Other and unspecified malignant gonadal tumors|80317363|0-19|All Races|Male and Female|2002
164.7|170.3|167.5|13675|All ICCC Groups Combined|81425816|0-19|All Races|Male and Female|2003
41.8|44.7|43.3|3508|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|81425816|0-19|All Races|Male and Female|2003
23.1|25.3|24.2|1984|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|81425816|0-19|All Races|Male and Female|2003
29.0|31.4|30.2|2448|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|81425816|0-19|All Races|Male and Female|2003
2.0|2.6|2.3|186|IIIa Ependymomas and choroid plexus tumor|81425816|0-19|All Races|Male and Female|2003
14.5|16.3|15.4|1250|IIIb Astrocytomas|81425816|0-19|All Races|Male and Female|2003
5.6|6.7|6.1|492|IIIc Intracranial and intraspinal embryonal tumors|81425816|0-19|All Races|Male and Female|2003
4.7|5.7|5.2|422|IIId Other gliomas|81425816|0-19|All Races|Male and Female|2003
0.7|1.1|0.8|68|IIIe Other specified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.4|30|IIIf Unspecified intracranial and intraspinal neoplasms|81425816|0-19|All Races|Male and Female|2003
11.6|13.2|12.4|1023|IIa Hodgkin lymphomas|81425816|0-19|All Races|Male and Female|2003
7.4|8.7|8.0|657|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|81425816|0-19|All Races|Male and Female|2003
2.3|3.0|2.6|212|IIc Burkitt lymphoma|81425816|0-19|All Races|Male and Female|2003
0.7|1.2|0.9|76|IId Miscellaneous lymphoreticular neoplasms|81425816|0-19|All Races|Male and Female|2003
0.1|0.3|0.2|16|IIe Unspecified lymphomas|81425816|0-19|All Races|Male and Female|2003
7.6|8.8|8.2|668|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|81425816|0-19|All Races|Male and Female|2003
7.4|8.7|8.0|653|IVa Neuroblastoma and ganglioneuroblastoma|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|IVb Other peripheral nervous cell tumors|81425816|0-19|All Races|Male and Female|2003
11.3|12.8|12.0|984|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|81425816|0-19|All Races|Male and Female|2003
4.2|5.1|4.6|376|IXa Rhabdomyosarcomas|81425816|0-19|All Races|Male and Female|2003
1.2|1.8|1.5|120|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|IXc Kaposi sarcoma|81425816|0-19|All Races|Male and Female|2003
4.2|5.1|4.6|382|IXd Other specified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003
1.0|1.5|1.2|103|IXe Unspecified soft tissue sarcomas|81425816|0-19|All Races|Male and Female|2003
29.3|31.7|30.5|2461|Ia Lymphoid leukemias|81425816|0-19|All Races|Male and Female|2003
7.3|8.5|7.8|642|Ib Acute myeloid leukemias|81425816|0-19|All Races|Male and Female|2003
2.1|2.7|2.4|195|Ic Chronic myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003
1.4|2.0|1.7|137|Id Myelodysplastic syndrome and other myeloproliferative diseases|81425816|0-19|All Races|Male and Female|2003
0.7|1.1|0.9|73|Ie Unspecified and other specified leukemias|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.4|29|Not classified by ICCC|81425816|0-19|All Races|Male and Female|2003
2.7|3.5|3.1|251|V RETINOBLASTOMA|81425816|0-19|All Races|Male and Female|2003
6.1|7.3|6.7|539|VI RENAL TUMORS|81425816|0-19|All Races|Male and Female|2003
2.0|2.6|2.3|187|VII HEPATIC TUMORS|81425816|0-19|All Races|Male and Female|2003
8.1|9.4|8.7|717|VIII MALIGNANT BONE TUMORS|81425816|0-19|All Races|Male and Female|2003
4.8|5.8|5.3|436|VIIIa Osteosarcomas|81425816|0-19|All Races|Male and Female|2003
0.2|0.4|0.3|25|VIIIb Chondrosarcomas|81425816|0-19|All Races|Male and Female|2003
2.2|2.9|2.6|211|VIIIc Ewing tumor and related sarcomas of bone|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.3|28|VIIId Other specified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003
0.1|0.3|0.2|17|VIIIe Unspecified malignant bone tumors|81425816|0-19|All Races|Male and Female|2003
1.4|2.0|1.7|138|VIIa Hepatoblastoma and mesenchymal tumors of liver|81425816|0-19|All Races|Male and Female|2003
0.4|0.8|0.6|49|VIIb Hepatic carcinomas|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|VIIc Unspecified malignant hepatic tumors|81425816|0-19|All Races|Male and Female|2003
5.6|6.7|6.1|491|VIa Nephroblastoma and other non-epithelial renal tumors|81425816|0-19|All Races|Male and Female|2003
0.4|0.7|0.5|44|VIb Renal carcinomas|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|VIc Unspecified malignant renal tumors|81425816|0-19|All Races|Male and Female|2003
9.6|11.0|10.3|849|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|81425816|0-19|All Races|Male and Female|2003
16.3|18.1|17.1|1418|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|81425816|0-19|All Races|Male and Female|2003
0.9|1.4|1.1|93|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|81425816|0-19|All Races|Male and Female|2003
0.4|0.7|0.5|45|XIIa Other specified malignant tumors|81425816|0-19|All Races|Male and Female|2003
0.4|0.8|0.6|48|XIIb Other unspecified malignant tumors|81425816|0-19|All Races|Male and Female|2003
0.1|0.4|0.2|20|XIa Adrenocortical carcinomas|81425816|0-19|All Races|Male and Female|2003
5.7|6.8|6.2|514|XIb Thyroid carcinomas|81425816|0-19|All Races|Male and Female|2003
0.5|0.9|0.7|54|XIc Nasopharyngeal carcinomas|81425816|0-19|All Races|Male and Female|2003
5.4|6.5|5.9|489|XId Malignant melanomas|81425816|0-19|All Races|Male and Female|2003
~|~|~|~|XIe Skin carcinomas|81425816|0-19|All Races|Male and Female|2003
3.6|4.5|4.0|331|XIf Other and unspecified carcinomas|81425816|0-19|All Races|Male and Female|2003
1.1|1.6|1.3|111|Xa Intracranial and intraspinal germ cell tumors|81425816|0-19|All Races|Male and Female|2003
1.2|1.7|1.5|120|Xb Malignant extracranial and extragonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003
6.2|7.3|6.7|557|Xc Malignant gonadal germ cell tumors|81425816|0-19|All Races|Male and Female|2003
0.2|0.5|0.3|28|Xd Gonadal carcinomas|81425816|0-19|All Races|Male and Female|2003
0.3|0.6|0.4|33|Xe Other and unspecified malignant gonadal tumors|81425816|0-19|All Races|Male and Female|2003
171.4|177.1|174.2|14315|All ICCC Groups Combined|81754354|0-19|All Races|Male and Female|2004
44.7|47.6|46.1|3762|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|81754354|0-19|All Races|Male and Female|2004
23.1|25.3|24.2|2001|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|81754354|0-19|All Races|Male and Female|2004
30.9|33.4|32.1|2616|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|81754354|0-19|All Races|Male and Female|2004
2.4|3.1|2.7|223|IIIa Ependymomas and choroid plexus tumor|81754354|0-19|All Races|Male and Female|2004
15.6|17.4|16.5|1343|IIIb Astrocytomas|81754354|0-19|All Races|Male and Female|2004
6.0|7.1|6.6|532|IIIc Intracranial and intraspinal embryonal tumors|81754354|0-19|All Races|Male and Female|2004
4.7|5.7|5.1|416|IIId Other gliomas|81754354|0-19|All Races|Male and Female|2004
0.5|0.9|0.7|59|IIIe Other specified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|43|IIIf Unspecified intracranial and intraspinal neoplasms|81754354|0-19|All Races|Male and Female|2004
11.2|12.6|11.9|991|IIa Hodgkin lymphomas|81754354|0-19|All Races|Male and Female|2004
7.9|9.2|8.5|705|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|81754354|0-19|All Races|Male and Female|2004
2.0|2.7|2.3|191|IIc Burkitt lymphoma|81754354|0-19|All Races|Male and Female|2004
0.9|1.3|1.1|87|IId Miscellaneous lymphoreticular neoplasms|81754354|0-19|All Races|Male and Female|2004
0.2|0.5|0.3|27|IIe Unspecified lymphomas|81754354|0-19|All Races|Male and Female|2004
7.9|9.1|8.5|696|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|81754354|0-19|All Races|Male and Female|2004
7.6|8.9|8.2|673|IVa Neuroblastoma and ganglioneuroblastoma|81754354|0-19|All Races|Male and Female|2004
0.2|0.4|0.3|23|IVb Other peripheral nervous cell tumors|81754354|0-19|All Races|Male and Female|2004
11.1|12.6|11.9|980|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|81754354|0-19|All Races|Male and Female|2004
3.7|4.6|4.2|341|IXa Rhabdomyosarcomas|81754354|0-19|All Races|Male and Female|2004
1.1|1.6|1.4|113|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|IXc Kaposi sarcoma|81754354|0-19|All Races|Male and Female|2004
4.6|5.6|5.1|424|IXd Other specified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004
1.0|1.4|1.2|98|IXe Unspecified soft tissue sarcomas|81754354|0-19|All Races|Male and Female|2004
31.9|34.4|33.1|2691|Ia Lymphoid leukemias|81754354|0-19|All Races|Male and Female|2004
7.7|8.9|8.3|680|Ib Acute myeloid leukemias|81754354|0-19|All Races|Male and Female|2004
1.9|2.6|2.2|184|Ic Chronic myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004
1.1|1.6|1.4|112|Id Myelodysplastic syndrome and other myeloproliferative diseases|81754354|0-19|All Races|Male and Female|2004
0.9|1.4|1.2|95|Ie Unspecified and other specified leukemias|81754354|0-19|All Races|Male and Female|2004
0.3|0.6|0.5|38|Not classified by ICCC|81754354|0-19|All Races|Male and Female|2004
2.8|3.6|3.2|265|V RETINOBLASTOMA|81754354|0-19|All Races|Male and Female|2004
5.9|7.0|6.5|526|VI RENAL TUMORS|81754354|0-19|All Races|Male and Female|2004
2.2|2.9|2.6|210|VII HEPATIC TUMORS|81754354|0-19|All Races|Male and Female|2004
8.4|9.7|9.1|750|VIII MALIGNANT BONE TUMORS|81754354|0-19|All Races|Male and Female|2004
4.6|5.6|5.1|424|VIIIa Osteosarcomas|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|43|VIIIb Chondrosarcomas|81754354|0-19|All Races|Male and Female|2004
2.4|3.1|2.8|228|VIIIc Ewing tumor and related sarcomas of bone|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|VIIIe Unspecified malignant bone tumors|81754354|0-19|All Races|Male and Female|2004
1.6|2.3|1.9|158|VIIa Hepatoblastoma and mesenchymal tumors of liver|81754354|0-19|All Races|Male and Female|2004
0.4|0.8|0.6|48|VIIb Hepatic carcinomas|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|VIIc Unspecified malignant hepatic tumors|81754354|0-19|All Races|Male and Female|2004
5.3|6.4|5.9|476|VIa Nephroblastoma and other non-epithelial renal tumors|81754354|0-19|All Races|Male and Female|2004
0.4|0.8|0.6|47|VIb Renal carcinomas|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|VIc Unspecified malignant renal tumors|81754354|0-19|All Races|Male and Female|2004
10.4|11.9|11.1|928|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|81754354|0-19|All Races|Male and Female|2004
16.7|18.5|17.6|1467|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|81754354|0-19|All Races|Male and Female|2004
0.7|1.2|0.9|76|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|81754354|0-19|All Races|Male and Female|2004
0.3|0.6|0.4|34|XIIa Other specified malignant tumors|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|81754354|0-19|All Races|Male and Female|2004
0.1|0.4|0.2|19|XIa Adrenocortical carcinomas|81754354|0-19|All Races|Male and Female|2004
6.3|7.4|6.8|570|XIb Thyroid carcinomas|81754354|0-19|All Races|Male and Female|2004
0.4|0.7|0.5|46|XIc Nasopharyngeal carcinomas|81754354|0-19|All Races|Male and Female|2004
5.9|7.0|6.4|536|XId Malignant melanomas|81754354|0-19|All Races|Male and Female|2004
~|~|~|~|XIe Skin carcinomas|81754354|0-19|All Races|Male and Female|2004
3.1|3.9|3.5|288|XIf Other and unspecified carcinomas|81754354|0-19|All Races|Male and Female|2004
1.5|2.1|1.8|148|Xa Intracranial and intraspinal germ cell tumors|81754354|0-19|All Races|Male and Female|2004
1.1|1.6|1.3|110|Xb Malignant extracranial and extragonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004
6.8|8.0|7.3|614|Xc Malignant gonadal germ cell tumors|81754354|0-19|All Races|Male and Female|2004
0.2|0.5|0.4|30|Xd Gonadal carcinomas|81754354|0-19|All Races|Male and Female|2004
0.2|0.5|0.3|26|Xe Other and unspecified malignant gonadal tumors|81754354|0-19|All Races|Male and Female|2004
169.6|175.3|172.4|14250|All ICCC Groups Combined|82005260|0-19|All Races|Male and Female|2005
43.0|45.9|44.4|3639|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82005260|0-19|All Races|Male and Female|2005
24.6|26.8|25.7|2146|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82005260|0-19|All Races|Male and Female|2005
29.1|31.5|30.3|2471|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82005260|0-19|All Races|Male and Female|2005
2.6|3.4|3.0|243|IIIa Ependymomas and choroid plexus tumor|82005260|0-19|All Races|Male and Female|2005
14.7|16.4|15.5|1269|IIIb Astrocytomas|82005260|0-19|All Races|Male and Female|2005
5.4|6.4|5.9|476|IIIc Intracranial and intraspinal embryonal tumors|82005260|0-19|All Races|Male and Female|2005
4.4|5.4|4.9|395|IIId Other gliomas|82005260|0-19|All Races|Male and Female|2005
0.5|0.8|0.6|51|IIIe Other specified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005
0.3|0.6|0.5|37|IIIf Unspecified intracranial and intraspinal neoplasms|82005260|0-19|All Races|Male and Female|2005
12.0|13.5|12.7|1070|IIa Hodgkin lymphomas|82005260|0-19|All Races|Male and Female|2005
8.3|9.6|8.9|738|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82005260|0-19|All Races|Male and Female|2005
2.2|2.9|2.5|205|IIc Burkitt lymphoma|82005260|0-19|All Races|Male and Female|2005
1.0|1.5|1.3|104|IId Miscellaneous lymphoreticular neoplasms|82005260|0-19|All Races|Male and Female|2005
0.2|0.5|0.3|29|IIe Unspecified lymphomas|82005260|0-19|All Races|Male and Female|2005
8.5|9.8|9.1|748|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82005260|0-19|All Races|Male and Female|2005
8.2|9.5|8.9|729|IVa Neuroblastoma and ganglioneuroblastoma|82005260|0-19|All Races|Male and Female|2005
0.1|0.4|0.2|19|IVb Other peripheral nervous cell tumors|82005260|0-19|All Races|Male and Female|2005
11.5|13.0|12.2|1008|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82005260|0-19|All Races|Male and Female|2005
4.3|5.2|4.7|387|IXa Rhabdomyosarcomas|82005260|0-19|All Races|Male and Female|2005
1.2|1.7|1.4|118|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|IXc Kaposi sarcoma|82005260|0-19|All Races|Male and Female|2005
4.4|5.4|4.9|408|IXd Other specified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005
0.9|1.4|1.1|91|IXe Unspecified soft tissue sarcomas|82005260|0-19|All Races|Male and Female|2005
30.7|33.2|32.0|2606|Ia Lymphoid leukemias|82005260|0-19|All Races|Male and Female|2005
7.0|8.2|7.6|629|Ib Acute myeloid leukemias|82005260|0-19|All Races|Male and Female|2005
1.8|2.4|2.1|174|Ic Chronic myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005
1.3|1.9|1.6|131|Id Myelodysplastic syndrome and other myeloproliferative diseases|82005260|0-19|All Races|Male and Female|2005
1.0|1.5|1.2|99|Ie Unspecified and other specified leukemias|82005260|0-19|All Races|Male and Female|2005
0.3|0.6|0.5|38|Not classified by ICCC|82005260|0-19|All Races|Male and Female|2005
2.6|3.3|2.9|243|V RETINOBLASTOMA|82005260|0-19|All Races|Male and Female|2005
6.1|7.3|6.7|546|VI RENAL TUMORS|82005260|0-19|All Races|Male and Female|2005
1.8|2.5|2.2|178|VII HEPATIC TUMORS|82005260|0-19|All Races|Male and Female|2005
8.2|9.5|8.8|734|VIII MALIGNANT BONE TUMORS|82005260|0-19|All Races|Male and Female|2005
4.5|5.5|5.0|417|VIIIa Osteosarcomas|82005260|0-19|All Races|Male and Female|2005
0.2|0.4|0.3|24|VIIIb Chondrosarcomas|82005260|0-19|All Races|Male and Female|2005
2.5|3.3|2.9|240|VIIIc Ewing tumor and related sarcomas of bone|82005260|0-19|All Races|Male and Female|2005
0.3|0.6|0.4|37|VIIId Other specified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005
0.1|0.3|0.2|16|VIIIe Unspecified malignant bone tumors|82005260|0-19|All Races|Male and Female|2005
1.3|1.9|1.6|129|VIIa Hepatoblastoma and mesenchymal tumors of liver|82005260|0-19|All Races|Male and Female|2005
0.4|0.7|0.6|47|VIIb Hepatic carcinomas|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82005260|0-19|All Races|Male and Female|2005
5.5|6.6|6.0|492|VIa Nephroblastoma and other non-epithelial renal tumors|82005260|0-19|All Races|Male and Female|2005
0.4|0.8|0.6|50|VIb Renal carcinomas|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|VIc Unspecified malignant renal tumors|82005260|0-19|All Races|Male and Female|2005
10.7|12.2|11.4|963|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82005260|0-19|All Races|Male and Female|2005
16.3|18.1|17.2|1453|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82005260|0-19|All Races|Male and Female|2005
0.8|1.2|1.0|83|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82005260|0-19|All Races|Male and Female|2005
0.4|0.7|0.5|41|XIIa Other specified malignant tumors|82005260|0-19|All Races|Male and Female|2005
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|XIa Adrenocortical carcinomas|82005260|0-19|All Races|Male and Female|2005
5.7|6.7|6.2|524|XIb Thyroid carcinomas|82005260|0-19|All Races|Male and Female|2005
0.3|0.5|0.4|33|XIc Nasopharyngeal carcinomas|82005260|0-19|All Races|Male and Female|2005
6.0|7.1|6.5|547|XId Malignant melanomas|82005260|0-19|All Races|Male and Female|2005
~|~|~|~|XIe Skin carcinomas|82005260|0-19|All Races|Male and Female|2005
3.5|4.4|3.9|330|XIf Other and unspecified carcinomas|82005260|0-19|All Races|Male and Female|2005
1.3|1.9|1.6|133|Xa Intracranial and intraspinal germ cell tumors|82005260|0-19|All Races|Male and Female|2005
1.4|1.9|1.6|135|Xb Malignant extracranial and extragonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005
6.9|8.1|7.5|635|Xc Malignant gonadal germ cell tumors|82005260|0-19|All Races|Male and Female|2005
0.3|0.5|0.4|32|Xd Gonadal carcinomas|82005260|0-19|All Races|Male and Female|2005
0.2|0.5|0.3|28|Xe Other and unspecified malignant gonadal tumors|82005260|0-19|All Races|Male and Female|2005
170.5|176.2|173.3|14388|All ICCC Groups Combined|82324418|0-19|All Races|Male and Female|2006
45.4|48.4|46.9|3854|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82324418|0-19|All Races|Male and Female|2006
24.0|26.2|25.1|2106|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82324418|0-19|All Races|Male and Female|2006
30.2|32.7|31.4|2575|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82324418|0-19|All Races|Male and Female|2006
2.5|3.2|2.8|233|IIIa Ependymomas and choroid plexus tumor|82324418|0-19|All Races|Male and Female|2006
14.6|16.3|15.5|1270|IIIb Astrocytomas|82324418|0-19|All Races|Male and Female|2006
5.8|7.0|6.4|520|IIIc Intracranial and intraspinal embryonal tumors|82324418|0-19|All Races|Male and Female|2006
5.0|6.1|5.5|453|IIId Other gliomas|82324418|0-19|All Races|Male and Female|2006
0.4|0.8|0.6|48|IIIe Other specified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006
0.5|0.8|0.6|51|IIIf Unspecified intracranial and intraspinal neoplasms|82324418|0-19|All Races|Male and Female|2006
11.7|13.2|12.5|1056|IIa Hodgkin lymphomas|82324418|0-19|All Races|Male and Female|2006
8.1|9.4|8.7|729|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82324418|0-19|All Races|Male and Female|2006
2.1|2.8|2.4|199|IIc Burkitt lymphoma|82324418|0-19|All Races|Male and Female|2006
1.0|1.5|1.2|98|IId Miscellaneous lymphoreticular neoplasms|82324418|0-19|All Races|Male and Female|2006
0.2|0.4|0.3|24|IIe Unspecified lymphomas|82324418|0-19|All Races|Male and Female|2006
7.3|8.5|7.9|652|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82324418|0-19|All Races|Male and Female|2006
7.1|8.3|7.7|635|IVa Neuroblastoma and ganglioneuroblastoma|82324418|0-19|All Races|Male and Female|2006
0.1|0.3|0.2|17|IVb Other peripheral nervous cell tumors|82324418|0-19|All Races|Male and Female|2006
10.8|12.2|11.5|955|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82324418|0-19|All Races|Male and Female|2006
3.9|4.9|4.4|360|IXa Rhabdomyosarcomas|82324418|0-19|All Races|Male and Female|2006
1.1|1.6|1.3|109|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|IXc Kaposi sarcoma|82324418|0-19|All Races|Male and Female|2006
4.1|5.0|4.5|378|IXd Other specified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006
1.0|1.5|1.2|103|IXe Unspecified soft tissue sarcomas|82324418|0-19|All Races|Male and Female|2006
32.0|34.5|33.2|2717|Ia Lymphoid leukemias|82324418|0-19|All Races|Male and Female|2006
7.7|9.0|8.3|694|Ib Acute myeloid leukemias|82324418|0-19|All Races|Male and Female|2006
2.1|2.8|2.5|206|Ic Chronic myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006
1.4|2.0|1.7|139|Id Myelodysplastic syndrome and other myeloproliferative diseases|82324418|0-19|All Races|Male and Female|2006
1.0|1.4|1.2|98|Ie Unspecified and other specified leukemias|82324418|0-19|All Races|Male and Female|2006
0.3|0.6|0.4|36|Not classified by ICCC|82324418|0-19|All Races|Male and Female|2006
2.7|3.5|3.1|254|V RETINOBLASTOMA|82324418|0-19|All Races|Male and Female|2006
6.1|7.3|6.7|548|VI RENAL TUMORS|82324418|0-19|All Races|Male and Female|2006
2.3|3.0|2.6|215|VII HEPATIC TUMORS|82324418|0-19|All Races|Male and Female|2006
8.7|10.0|9.3|776|VIII MALIGNANT BONE TUMORS|82324418|0-19|All Races|Male and Female|2006
4.9|5.9|5.4|449|VIIIa Osteosarcomas|82324418|0-19|All Races|Male and Female|2006
0.1|0.3|0.2|18|VIIIb Chondrosarcomas|82324418|0-19|All Races|Male and Female|2006
2.7|3.4|3.0|251|VIIIc Ewing tumor and related sarcomas of bone|82324418|0-19|All Races|Male and Female|2006
0.4|0.7|0.5|44|VIIId Other specified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|VIIIe Unspecified malignant bone tumors|82324418|0-19|All Races|Male and Female|2006
1.6|2.2|1.9|157|VIIa Hepatoblastoma and mesenchymal tumors of liver|82324418|0-19|All Races|Male and Female|2006
0.5|0.8|0.6|54|VIIb Hepatic carcinomas|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82324418|0-19|All Races|Male and Female|2006
5.4|6.5|5.9|482|VIa Nephroblastoma and other non-epithelial renal tumors|82324418|0-19|All Races|Male and Female|2006
0.5|0.9|0.7|60|VIb Renal carcinomas|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|VIc Unspecified malignant renal tumors|82324418|0-19|All Races|Male and Female|2006
9.6|11.0|10.3|875|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82324418|0-19|All Races|Male and Female|2006
16.4|18.1|17.2|1465|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82324418|0-19|All Races|Male and Female|2006
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82324418|0-19|All Races|Male and Female|2006
0.4|0.7|0.6|46|XIIa Other specified malignant tumors|82324418|0-19|All Races|Male and Female|2006
0.3|0.5|0.4|31|XIIb Other unspecified malignant tumors|82324418|0-19|All Races|Male and Female|2006
0.1|0.3|0.2|16|XIa Adrenocortical carcinomas|82324418|0-19|All Races|Male and Female|2006
6.3|7.4|6.8|580|XIb Thyroid carcinomas|82324418|0-19|All Races|Male and Female|2006
0.5|0.8|0.6|54|XIc Nasopharyngeal carcinomas|82324418|0-19|All Races|Male and Female|2006
4.9|5.9|5.4|461|XId Malignant melanomas|82324418|0-19|All Races|Male and Female|2006
~|~|~|~|XIe Skin carcinomas|82324418|0-19|All Races|Male and Female|2006
3.7|4.5|4.1|346|XIf Other and unspecified carcinomas|82324418|0-19|All Races|Male and Female|2006
1.3|1.8|1.5|127|Xa Intracranial and intraspinal germ cell tumors|82324418|0-19|All Races|Male and Female|2006
1.3|1.8|1.5|130|Xb Malignant extracranial and extragonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006
5.9|7.0|6.4|547|Xc Malignant gonadal germ cell tumors|82324418|0-19|All Races|Male and Female|2006
0.4|0.7|0.5|42|Xd Gonadal carcinomas|82324418|0-19|All Races|Male and Female|2006
0.2|0.5|0.3|29|Xe Other and unspecified malignant gonadal tumors|82324418|0-19|All Races|Male and Female|2006
174.4|180.1|177.2|14811|All ICCC Groups Combined|82749431|0-19|All Races|Male and Female|2007
45.7|48.7|47.2|3901|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82749431|0-19|All Races|Male and Female|2007
23.9|26.1|25.0|2107|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82749431|0-19|All Races|Male and Female|2007
30.9|33.4|32.2|2647|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82749431|0-19|All Races|Male and Female|2007
2.2|2.9|2.5|210|IIIa Ependymomas and choroid plexus tumor|82749431|0-19|All Races|Male and Female|2007
15.4|17.2|16.3|1344|IIIb Astrocytomas|82749431|0-19|All Races|Male and Female|2007
5.9|7.0|6.4|527|IIIc Intracranial and intraspinal embryonal tumors|82749431|0-19|All Races|Male and Female|2007
5.3|6.3|5.8|472|IIId Other gliomas|82749431|0-19|All Races|Male and Female|2007
0.5|0.9|0.7|57|IIIe Other specified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.4|37|IIIf Unspecified intracranial and intraspinal neoplasms|82749431|0-19|All Races|Male and Female|2007
11.4|12.9|12.1|1038|IIa Hodgkin lymphomas|82749431|0-19|All Races|Male and Female|2007
8.1|9.4|8.8|732|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82749431|0-19|All Races|Male and Female|2007
2.3|3.0|2.6|213|IIc Burkitt lymphoma|82749431|0-19|All Races|Male and Female|2007
0.9|1.3|1.1|90|IId Miscellaneous lymphoreticular neoplasms|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.4|34|IIe Unspecified lymphomas|82749431|0-19|All Races|Male and Female|2007
8.4|9.7|9.0|753|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82749431|0-19|All Races|Male and Female|2007
8.2|9.5|8.8|734|IVa Neuroblastoma and ganglioneuroblastoma|82749431|0-19|All Races|Male and Female|2007
0.1|0.4|0.2|19|IVb Other peripheral nervous cell tumors|82749431|0-19|All Races|Male and Female|2007
11.7|13.3|12.5|1044|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82749431|0-19|All Races|Male and Female|2007
4.6|5.5|5.0|415|IXa Rhabdomyosarcomas|82749431|0-19|All Races|Male and Female|2007
1.1|1.7|1.4|117|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|IXc Kaposi sarcoma|82749431|0-19|All Races|Male and Female|2007
4.4|5.3|4.8|408|IXd Other specified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007
1.0|1.4|1.2|100|IXe Unspecified soft tissue sarcomas|82749431|0-19|All Races|Male and Female|2007
32.8|35.3|34.0|2796|Ia Lymphoid leukemias|82749431|0-19|All Races|Male and Female|2007
7.4|8.6|8.0|666|Ib Acute myeloid leukemias|82749431|0-19|All Races|Male and Female|2007
2.3|3.0|2.6|222|Ic Chronic myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007
1.2|1.8|1.5|125|Id Myelodysplastic syndrome and other myeloproliferative diseases|82749431|0-19|All Races|Male and Female|2007
0.9|1.4|1.1|92|Ie Unspecified and other specified leukemias|82749431|0-19|All Races|Male and Female|2007
0.2|0.5|0.3|28|Not classified by ICCC|82749431|0-19|All Races|Male and Female|2007
2.9|3.7|3.3|275|V RETINOBLASTOMA|82749431|0-19|All Races|Male and Female|2007
6.3|7.5|6.9|569|VI RENAL TUMORS|82749431|0-19|All Races|Male and Female|2007
2.1|2.8|2.5|206|VII HEPATIC TUMORS|82749431|0-19|All Races|Male and Female|2007
8.2|9.4|8.8|735|VIII MALIGNANT BONE TUMORS|82749431|0-19|All Races|Male and Female|2007
4.3|5.2|4.7|394|VIIIa Osteosarcomas|82749431|0-19|All Races|Male and Female|2007
0.3|0.5|0.4|32|VIIIb Chondrosarcomas|82749431|0-19|All Races|Male and Female|2007
2.7|3.5|3.1|256|VIIIc Ewing tumor and related sarcomas of bone|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.4|33|VIIId Other specified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007
0.1|0.4|0.2|20|VIIIe Unspecified malignant bone tumors|82749431|0-19|All Races|Male and Female|2007
1.6|2.2|1.9|155|VIIa Hepatoblastoma and mesenchymal tumors of liver|82749431|0-19|All Races|Male and Female|2007
0.4|0.8|0.6|51|VIIb Hepatic carcinomas|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82749431|0-19|All Races|Male and Female|2007
5.7|6.8|6.2|512|VIa Nephroblastoma and other non-epithelial renal tumors|82749431|0-19|All Races|Male and Female|2007
0.5|0.9|0.7|55|VIb Renal carcinomas|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|VIc Unspecified malignant renal tumors|82749431|0-19|All Races|Male and Female|2007
10.4|11.9|11.1|954|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82749431|0-19|All Races|Male and Female|2007
16.8|18.6|17.7|1522|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82749431|0-19|All Races|Male and Female|2007
0.6|1.0|0.8|70|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82749431|0-19|All Races|Male and Female|2007
0.3|0.5|0.4|31|XIIa Other specified malignant tumors|82749431|0-19|All Races|Male and Female|2007
0.3|0.6|0.5|39|XIIb Other unspecified malignant tumors|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|XIa Adrenocortical carcinomas|82749431|0-19|All Races|Male and Female|2007
6.9|8.1|7.5|644|XIb Thyroid carcinomas|82749431|0-19|All Races|Male and Female|2007
0.4|0.8|0.6|51|XIc Nasopharyngeal carcinomas|82749431|0-19|All Races|Male and Female|2007
4.9|5.9|5.4|461|XId Malignant melanomas|82749431|0-19|All Races|Male and Female|2007
~|~|~|~|XIe Skin carcinomas|82749431|0-19|All Races|Male and Female|2007
3.6|4.4|4.0|342|XIf Other and unspecified carcinomas|82749431|0-19|All Races|Male and Female|2007
1.3|1.9|1.6|131|Xa Intracranial and intraspinal germ cell tumors|82749431|0-19|All Races|Male and Female|2007
1.1|1.6|1.4|117|Xb Malignant extracranial and extragonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007
7.0|8.1|7.5|649|Xc Malignant gonadal germ cell tumors|82749431|0-19|All Races|Male and Female|2007
0.2|0.5|0.4|31|Xd Gonadal carcinomas|82749431|0-19|All Races|Male and Female|2007
0.2|0.4|0.3|26|Xe Other and unspecified malignant gonadal tumors|82749431|0-19|All Races|Male and Female|2007
176.3|182.0|179.1|15038|All ICCC Groups Combined|83118264|0-19|All Races|Male and Female|2008
47.3|50.3|48.8|4054|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83118264|0-19|All Races|Male and Female|2008
24.4|26.5|25.4|2151|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83118264|0-19|All Races|Male and Female|2008
31.3|33.8|32.5|2693|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83118264|0-19|All Races|Male and Female|2008
2.0|2.7|2.3|195|IIIa Ependymomas and choroid plexus tumor|83118264|0-19|All Races|Male and Female|2008
15.7|17.4|16.5|1370|IIIb Astrocytomas|83118264|0-19|All Races|Male and Female|2008
6.2|7.3|6.7|557|IIIc Intracranial and intraspinal embryonal tumors|83118264|0-19|All Races|Male and Female|2008
5.3|6.3|5.8|479|IIId Other gliomas|83118264|0-19|All Races|Male and Female|2008
0.5|0.9|0.7|60|IIIe Other specified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008
0.3|0.5|0.4|32|IIIf Unspecified intracranial and intraspinal neoplasms|83118264|0-19|All Races|Male and Female|2008
12.2|13.7|12.9|1104|IIa Hodgkin lymphomas|83118264|0-19|All Races|Male and Female|2008
8.1|9.4|8.7|731|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83118264|0-19|All Races|Male and Female|2008
2.2|2.9|2.6|212|IIc Burkitt lymphoma|83118264|0-19|All Races|Male and Female|2008
0.7|1.2|0.9|78|IId Miscellaneous lymphoreticular neoplasms|83118264|0-19|All Races|Male and Female|2008
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83118264|0-19|All Races|Male and Female|2008
7.8|9.1|8.4|705|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83118264|0-19|All Races|Male and Female|2008
7.5|8.7|8.1|676|IVa Neuroblastoma and ganglioneuroblastoma|83118264|0-19|All Races|Male and Female|2008
0.2|0.5|0.3|29|IVb Other peripheral nervous cell tumors|83118264|0-19|All Races|Male and Female|2008
11.5|13.0|12.2|1027|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83118264|0-19|All Races|Male and Female|2008
4.5|5.5|5.0|414|IXa Rhabdomyosarcomas|83118264|0-19|All Races|Male and Female|2008
0.9|1.4|1.2|97|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|IXc Kaposi sarcoma|83118264|0-19|All Races|Male and Female|2008
4.2|5.1|4.6|389|IXd Other specified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008
1.2|1.8|1.5|125|IXe Unspecified soft tissue sarcomas|83118264|0-19|All Races|Male and Female|2008
33.6|36.2|34.9|2886|Ia Lymphoid leukemias|83118264|0-19|All Races|Male and Female|2008
7.8|9.1|8.4|707|Ib Acute myeloid leukemias|83118264|0-19|All Races|Male and Female|2008
2.5|3.2|2.8|241|Ic Chronic myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008
1.3|1.9|1.6|134|Id Myelodysplastic syndrome and other myeloproliferative diseases|83118264|0-19|All Races|Male and Female|2008
0.8|1.3|1.0|86|Ie Unspecified and other specified leukemias|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|34|Not classified by ICCC|83118264|0-19|All Races|Male and Female|2008
2.8|3.6|3.2|269|V RETINOBLASTOMA|83118264|0-19|All Races|Male and Female|2008
6.6|7.8|7.2|599|VI RENAL TUMORS|83118264|0-19|All Races|Male and Female|2008
2.1|2.7|2.4|201|VII HEPATIC TUMORS|83118264|0-19|All Races|Male and Female|2008
8.2|9.5|8.8|739|VIII MALIGNANT BONE TUMORS|83118264|0-19|All Races|Male and Female|2008
4.5|5.4|4.9|414|VIIIa Osteosarcomas|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|36|VIIIb Chondrosarcomas|83118264|0-19|All Races|Male and Female|2008
2.4|3.2|2.8|232|VIIIc Ewing tumor and related sarcomas of bone|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|35|VIIId Other specified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008
0.2|0.4|0.3|22|VIIIe Unspecified malignant bone tumors|83118264|0-19|All Races|Male and Female|2008
1.6|2.2|1.8|155|VIIa Hepatoblastoma and mesenchymal tumors of liver|83118264|0-19|All Races|Male and Female|2008
0.4|0.7|0.5|45|VIIb Hepatic carcinomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83118264|0-19|All Races|Male and Female|2008
5.9|7.0|6.5|536|VIa Nephroblastoma and other non-epithelial renal tumors|83118264|0-19|All Races|Male and Female|2008
0.5|0.9|0.7|61|VIb Renal carcinomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|VIc Unspecified malignant renal tumors|83118264|0-19|All Races|Male and Female|2008
10.3|11.7|11.0|944|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83118264|0-19|All Races|Male and Female|2008
17.2|19.0|18.0|1555|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83118264|0-19|All Races|Male and Female|2008
0.6|1.0|0.8|67|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83118264|0-19|All Races|Male and Female|2008
0.3|0.6|0.4|35|XIIa Other specified malignant tumors|83118264|0-19|All Races|Male and Female|2008
0.3|0.5|0.4|32|XIIb Other unspecified malignant tumors|83118264|0-19|All Races|Male and Female|2008
0.1|0.4|0.2|20|XIa Adrenocortical carcinomas|83118264|0-19|All Races|Male and Female|2008
7.6|8.8|8.2|708|XIb Thyroid carcinomas|83118264|0-19|All Races|Male and Female|2008
0.4|0.7|0.5|46|XIc Nasopharyngeal carcinomas|83118264|0-19|All Races|Male and Female|2008
4.4|5.3|4.8|416|XId Malignant melanomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|XIe Skin carcinomas|83118264|0-19|All Races|Male and Female|2008
3.8|4.6|4.2|360|XIf Other and unspecified carcinomas|83118264|0-19|All Races|Male and Female|2008
1.5|2.0|1.7|146|Xa Intracranial and intraspinal germ cell tumors|83118264|0-19|All Races|Male and Female|2008
1.2|1.7|1.4|124|Xb Malignant extracranial and extragonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008
6.7|7.8|7.2|629|Xc Malignant gonadal germ cell tumors|83118264|0-19|All Races|Male and Female|2008
0.2|0.5|0.3|30|Xd Gonadal carcinomas|83118264|0-19|All Races|Male and Female|2008
~|~|~|~|Xe Other and unspecified malignant gonadal tumors|83118264|0-19|All Races|Male and Female|2008
175.7|181.4|178.5|14999|All ICCC Groups Combined|83280391|0-19|All Races|Male and Female|2009
45.9|48.9|47.4|3947|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83280391|0-19|All Races|Male and Female|2009
24.3|26.5|25.4|2150|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83280391|0-19|All Races|Male and Female|2009
31.1|33.6|32.3|2679|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83280391|0-19|All Races|Male and Female|2009
2.1|2.8|2.4|203|IIIa Ependymomas and choroid plexus tumor|83280391|0-19|All Races|Male and Female|2009
15.6|17.3|16.4|1364|IIIb Astrocytomas|83280391|0-19|All Races|Male and Female|2009
5.8|6.9|6.4|526|IIIc Intracranial and intraspinal embryonal tumors|83280391|0-19|All Races|Male and Female|2009
5.6|6.7|6.1|504|IIId Other gliomas|83280391|0-19|All Races|Male and Female|2009
0.4|0.7|0.6|47|IIIe Other specified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009
0.3|0.6|0.4|35|IIIf Unspecified intracranial and intraspinal neoplasms|83280391|0-19|All Races|Male and Female|2009
11.9|13.5|12.7|1087|IIa Hodgkin lymphomas|83280391|0-19|All Races|Male and Female|2009
8.2|9.4|8.8|739|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83280391|0-19|All Races|Male and Female|2009
1.9|2.6|2.2|184|IIc Burkitt lymphoma|83280391|0-19|All Races|Male and Female|2009
1.1|1.6|1.4|114|IId Miscellaneous lymphoreticular neoplasms|83280391|0-19|All Races|Male and Female|2009
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83280391|0-19|All Races|Male and Female|2009
7.7|9.0|8.3|693|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83280391|0-19|All Races|Male and Female|2009
7.4|8.7|8.0|668|IVa Neuroblastoma and ganglioneuroblastoma|83280391|0-19|All Races|Male and Female|2009
0.2|0.4|0.3|25|IVb Other peripheral nervous cell tumors|83280391|0-19|All Races|Male and Female|2009
11.4|12.9|12.1|1016|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83280391|0-19|All Races|Male and Female|2009
3.8|4.6|4.2|349|IXa Rhabdomyosarcomas|83280391|0-19|All Races|Male and Female|2009
1.3|1.9|1.6|135|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|IXc Kaposi sarcoma|83280391|0-19|All Races|Male and Female|2009
4.4|5.3|4.8|409|IXd Other specified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009
1.1|1.7|1.4|116|IXe Unspecified soft tissue sarcomas|83280391|0-19|All Races|Male and Female|2009
33.4|36.0|34.7|2879|Ia Lymphoid leukemias|83280391|0-19|All Races|Male and Female|2009
7.1|8.3|7.7|643|Ib Acute myeloid leukemias|83280391|0-19|All Races|Male and Female|2009
2.1|2.8|2.4|205|Ic Chronic myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009
1.3|1.9|1.6|132|Id Myelodysplastic syndrome and other myeloproliferative diseases|83280391|0-19|All Races|Male and Female|2009
0.8|1.3|1.1|88|Ie Unspecified and other specified leukemias|83280391|0-19|All Races|Male and Female|2009
0.3|0.5|0.4|33|Not classified by ICCC|83280391|0-19|All Races|Male and Female|2009
3.0|3.8|3.4|285|V RETINOBLASTOMA|83280391|0-19|All Races|Male and Female|2009
6.8|8.0|7.4|616|VI RENAL TUMORS|83280391|0-19|All Races|Male and Female|2009
1.8|2.5|2.1|180|VII HEPATIC TUMORS|83280391|0-19|All Races|Male and Female|2009
8.4|9.7|9.0|757|VIII MALIGNANT BONE TUMORS|83280391|0-19|All Races|Male and Female|2009
4.6|5.6|5.1|424|VIIIa Osteosarcomas|83280391|0-19|All Races|Male and Female|2009
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|83280391|0-19|All Races|Male and Female|2009
2.6|3.3|2.9|246|VIIIc Ewing tumor and related sarcomas of bone|83280391|0-19|All Races|Male and Female|2009
0.3|0.7|0.5|41|VIIId Other specified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009
0.1|0.3|0.2|17|VIIIe Unspecified malignant bone tumors|83280391|0-19|All Races|Male and Female|2009
1.3|1.8|1.5|129|VIIa Hepatoblastoma and mesenchymal tumors of liver|83280391|0-19|All Races|Male and Female|2009
0.4|0.8|0.6|49|VIIb Hepatic carcinomas|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83280391|0-19|All Races|Male and Female|2009
6.0|7.2|6.6|547|VIa Nephroblastoma and other non-epithelial renal tumors|83280391|0-19|All Races|Male and Female|2009
0.6|1.0|0.8|68|VIb Renal carcinomas|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|VIc Unspecified malignant renal tumors|83280391|0-19|All Races|Male and Female|2009
10.9|12.3|11.6|995|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83280391|0-19|All Races|Male and Female|2009
17.3|19.1|18.2|1565|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83280391|0-19|All Races|Male and Female|2009
0.8|1.2|1.0|83|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83280391|0-19|All Races|Male and Female|2009
0.3|0.6|0.5|39|XIIa Other specified malignant tumors|83280391|0-19|All Races|Male and Female|2009
0.4|0.7|0.5|44|XIIb Other unspecified malignant tumors|83280391|0-19|All Races|Male and Female|2009
0.2|0.4|0.3|22|XIa Adrenocortical carcinomas|83280391|0-19|All Races|Male and Female|2009
7.8|9.0|8.4|723|XIb Thyroid carcinomas|83280391|0-19|All Races|Male and Female|2009
0.5|0.9|0.7|59|XIc Nasopharyngeal carcinomas|83280391|0-19|All Races|Male and Female|2009
3.9|4.8|4.4|376|XId Malignant melanomas|83280391|0-19|All Races|Male and Female|2009
~|~|~|~|XIe Skin carcinomas|83280391|0-19|All Races|Male and Female|2009
3.9|4.8|4.4|374|XIf Other and unspecified carcinomas|83280391|0-19|All Races|Male and Female|2009
1.4|2.0|1.7|142|Xa Intracranial and intraspinal germ cell tumors|83280391|0-19|All Races|Male and Female|2009
1.1|1.6|1.4|116|Xb Malignant extracranial and extragonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009
7.0|8.2|7.6|658|Xc Malignant gonadal germ cell tumors|83280391|0-19|All Races|Male and Female|2009
0.4|0.8|0.6|51|Xd Gonadal carcinomas|83280391|0-19|All Races|Male and Female|2009
0.2|0.5|0.3|28|Xe Other and unspecified malignant gonadal tumors|83280391|0-19|All Races|Male and Female|2009
179.9|185.7|182.8|15310|All ICCC Groups Combined|83224734|0-19|All Races|Male and Female|2010
47.2|50.2|48.7|4052|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83224734|0-19|All Races|Male and Female|2010
27.0|29.3|28.1|2370|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83224734|0-19|All Races|Male and Female|2010
31.6|34.1|32.8|2719|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83224734|0-19|All Races|Male and Female|2010
2.5|3.2|2.9|238|IIIa Ependymomas and choroid plexus tumor|83224734|0-19|All Races|Male and Female|2010
16.4|18.2|17.2|1431|IIIb Astrocytomas|83224734|0-19|All Races|Male and Female|2010
5.6|6.6|6.1|503|IIIc Intracranial and intraspinal embryonal tumors|83224734|0-19|All Races|Male and Female|2010
5.2|6.2|5.7|470|IIId Other gliomas|83224734|0-19|All Races|Male and Female|2010
0.5|0.8|0.6|51|IIIe Other specified intracranial and intraspinal neoplasms|83224734|0-19|All Races|Male and Female|2010
0.2|0.5|0.3|26|IIIf Unspecified intracranial and intraspinal neoplasms|83224734|0-19|All Races|Male and Female|2010
11.4|12.9|12.1|1036|IIa Hodgkin lymphomas|83224734|0-19|All Races|Male and Female|2010
8.5|9.8|9.1|766|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83224734|0-19|All Races|Male and Female|2010
2.1|2.7|2.4|198|IIc Burkitt lymphoma|83224734|0-19|All Races|Male and Female|2010
3.7|4.6|4.1|339|IId Miscellaneous lymphoreticular neoplasms|83224734|0-19|All Races|Male and Female|2010
0.2|0.5|0.4|31|IIe Unspecified lymphomas|83224734|0-19|All Races|Male and Female|2010
8.0|9.3|8.6|717|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83224734|0-19|All Races|Male and Female|2010
7.8|9.1|8.4|698|IVa Neuroblastoma and ganglioneuroblastoma|83224734|0-19|All Races|Male and Female|2010
0.1|0.4|0.2|19|IVb Other peripheral nervous cell tumors|83224734|0-19|All Races|Male and Female|2010
11.7|13.2|12.4|1039|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83224734|0-19|All Races|Male and Female|2010
4.6|5.5|5.0|419|IXa Rhabdomyosarcomas|83224734|0-19|All Races|Male and Female|2010
0.8|1.3|1.1|89|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83224734|0-19|All Races|Male and Female|2010
~|~|~|~|IXc Kaposi sarcoma|83224734|0-19|All Races|Male and Female|2010
4.1|5.0|4.6|383|IXd Other specified soft tissue sarcomas|83224734|0-19|All Races|Male and Female|2010
1.4|2.0|1.7|144|IXe Unspecified soft tissue sarcomas|83224734|0-19|All Races|Male and Female|2010
33.4|36.0|34.7|2878|Ia Lymphoid leukemias|83224734|0-19|All Races|Male and Female|2010
7.9|9.2|8.5|713|Ib Acute myeloid leukemias|83224734|0-19|All Races|Male and Female|2010
2.4|3.1|2.7|229|Ic Chronic myeloproliferative diseases|83224734|0-19|All Races|Male and Female|2010
1.5|2.1|1.8|152|Id Myelodysplastic syndrome and other myeloproliferative diseases|83224734|0-19|All Races|Male and Female|2010
0.8|1.2|1.0|80|Ie Unspecified and other specified leukemias|83224734|0-19|All Races|Male and Female|2010
0.3|0.5|0.4|32|Not classified by ICCC|83224734|0-19|All Races|Male and Female|2010
3.0|3.8|3.4|282|V RETINOBLASTOMA|83224734|0-19|All Races|Male and Female|2010
6.1|7.2|6.6|553|VI RENAL TUMORS|83224734|0-19|All Races|Male and Female|2010
2.6|3.4|3.0|249|VII HEPATIC TUMORS|83224734|0-19|All Races|Male and Female|2010
7.8|9.0|8.4|703|VIII MALIGNANT BONE TUMORS|83224734|0-19|All Races|Male and Female|2010
4.3|5.2|4.7|397|VIIIa Osteosarcomas|83224734|0-19|All Races|Male and Female|2010
0.3|0.6|0.4|34|VIIIb Chondrosarcomas|83224734|0-19|All Races|Male and Female|2010
2.3|3.0|2.6|219|VIIIc Ewing tumor and related sarcomas of bone|83224734|0-19|All Races|Male and Female|2010
0.3|0.6|0.5|38|VIIId Other specified malignant bone tumors|83224734|0-19|All Races|Male and Female|2010
~|~|~|~|VIIIe Unspecified malignant bone tumors|83224734|0-19|All Races|Male and Female|2010
1.9|2.6|2.3|187|VIIa Hepatoblastoma and mesenchymal tumors of liver|83224734|0-19|All Races|Male and Female|2010
0.5|0.9|0.7|60|VIIb Hepatic carcinomas|83224734|0-19|All Races|Male and Female|2010
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83224734|0-19|All Races|Male and Female|2010
5.6|6.7|6.1|510|VIa Nephroblastoma and other non-epithelial renal tumors|83224734|0-19|All Races|Male and Female|2010
0.4|0.7|0.5|42|VIb Renal carcinomas|83224734|0-19|All Races|Male and Female|2010
~|~|~|~|VIc Unspecified malignant renal tumors|83224734|0-19|All Races|Male and Female|2010
10.9|12.3|11.6|986|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83224734|0-19|All Races|Male and Female|2010
17.1|18.9|17.9|1537|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83224734|0-19|All Races|Male and Female|2010
0.7|1.1|0.8|71|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83224734|0-19|All Races|Male and Female|2010
0.4|0.7|0.5|46|XIIa Other specified malignant tumors|83224734|0-19|All Races|Male and Female|2010
0.2|0.4|0.3|25|XIIb Other unspecified malignant tumors|83224734|0-19|All Races|Male and Female|2010
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|83224734|0-19|All Races|Male and Female|2010
8.1|9.3|8.7|744|XIb Thyroid carcinomas|83224734|0-19|All Races|Male and Female|2010
0.4|0.7|0.6|48|XIc Nasopharyngeal carcinomas|83224734|0-19|All Races|Male and Female|2010
3.7|4.5|4.1|348|XId Malignant melanomas|83224734|0-19|All Races|Male and Female|2010
~|~|~|~|XIe Skin carcinomas|83224734|0-19|All Races|Male and Female|2010
3.8|4.7|4.3|366|XIf Other and unspecified carcinomas|83224734|0-19|All Races|Male and Female|2010
1.7|2.3|2.0|167|Xa Intracranial and intraspinal germ cell tumors|83224734|0-19|All Races|Male and Female|2010
1.1|1.6|1.3|112|Xb Malignant extracranial and extragonadal germ cell tumors|83224734|0-19|All Races|Male and Female|2010
6.8|7.9|7.3|631|Xc Malignant gonadal germ cell tumors|83224734|0-19|All Races|Male and Female|2010
0.4|0.7|0.5|42|Xd Gonadal carcinomas|83224734|0-19|All Races|Male and Female|2010
0.3|0.6|0.4|34|Xe Other and unspecified malignant gonadal tumors|83224734|0-19|All Races|Male and Female|2010
181.4|187.2|184.3|15390|All ICCC Groups Combined|83041095|0-19|All Races|Male and Female|2011
47.3|50.3|48.8|4050|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83041095|0-19|All Races|Male and Female|2011
27.4|29.7|28.5|2390|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83041095|0-19|All Races|Male and Female|2011
32.3|34.8|33.5|2779|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83041095|0-19|All Races|Male and Female|2011
2.5|3.2|2.8|234|IIIa Ependymomas and choroid plexus tumor|83041095|0-19|All Races|Male and Female|2011
16.7|18.5|17.6|1459|IIIb Astrocytomas|83041095|0-19|All Races|Male and Female|2011
5.6|6.7|6.1|508|IIIc Intracranial and intraspinal embryonal tumors|83041095|0-19|All Races|Male and Female|2011
5.5|6.5|6.0|495|IIId Other gliomas|83041095|0-19|All Races|Male and Female|2011
0.4|0.8|0.6|50|IIIe Other specified intracranial and intraspinal neoplasms|83041095|0-19|All Races|Male and Female|2011
0.3|0.6|0.4|33|IIIf Unspecified intracranial and intraspinal neoplasms|83041095|0-19|All Races|Male and Female|2011
11.2|12.6|11.9|1007|IIa Hodgkin lymphomas|83041095|0-19|All Races|Male and Female|2011
8.3|9.6|8.9|747|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83041095|0-19|All Races|Male and Female|2011
2.2|2.9|2.5|207|IIc Burkitt lymphoma|83041095|0-19|All Races|Male and Female|2011
4.4|5.4|4.9|401|IId Miscellaneous lymphoreticular neoplasms|83041095|0-19|All Races|Male and Female|2011
0.2|0.5|0.3|28|IIe Unspecified lymphomas|83041095|0-19|All Races|Male and Female|2011
8.0|9.3|8.7|718|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83041095|0-19|All Races|Male and Female|2011
7.8|9.0|8.4|696|IVa Neuroblastoma and ganglioneuroblastoma|83041095|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|22|IVb Other peripheral nervous cell tumors|83041095|0-19|All Races|Male and Female|2011
11.1|12.6|11.9|991|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83041095|0-19|All Races|Male and Female|2011
4.0|5.0|4.5|373|IXa Rhabdomyosarcomas|83041095|0-19|All Races|Male and Female|2011
1.1|1.6|1.3|111|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83041095|0-19|All Races|Male and Female|2011
~|~|~|~|IXc Kaposi sarcoma|83041095|0-19|All Races|Male and Female|2011
4.3|5.2|4.7|394|IXd Other specified soft tissue sarcomas|83041095|0-19|All Races|Male and Female|2011
1.0|1.5|1.3|106|IXe Unspecified soft tissue sarcomas|83041095|0-19|All Races|Male and Female|2011
34.5|37.1|35.8|2965|Ia Lymphoid leukemias|83041095|0-19|All Races|Male and Female|2011
7.8|9.1|8.4|703|Ib Acute myeloid leukemias|83041095|0-19|All Races|Male and Female|2011
2.1|2.8|2.5|207|Ic Chronic myeloproliferative diseases|83041095|0-19|All Races|Male and Female|2011
1.0|1.5|1.3|106|Id Myelodysplastic syndrome and other myeloproliferative diseases|83041095|0-19|All Races|Male and Female|2011
0.6|1.1|0.8|69|Ie Unspecified and other specified leukemias|83041095|0-19|All Races|Male and Female|2011
0.3|0.6|0.4|37|Not classified by ICCC|83041095|0-19|All Races|Male and Female|2011
2.8|3.5|3.1|260|V RETINOBLASTOMA|83041095|0-19|All Races|Male and Female|2011
6.6|7.8|7.2|596|VI RENAL TUMORS|83041095|0-19|All Races|Male and Female|2011
2.5|3.3|2.9|238|VII HEPATIC TUMORS|83041095|0-19|All Races|Male and Female|2011
8.3|9.6|8.9|746|VIII MALIGNANT BONE TUMORS|83041095|0-19|All Races|Male and Female|2011
4.6|5.6|5.1|422|VIIIa Osteosarcomas|83041095|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|24|VIIIb Chondrosarcomas|83041095|0-19|All Races|Male and Female|2011
2.8|3.5|3.1|260|VIIIc Ewing tumor and related sarcomas of bone|83041095|0-19|All Races|Male and Female|2011
0.2|0.5|0.3|27|VIIId Other specified malignant bone tumors|83041095|0-19|All Races|Male and Female|2011
~|~|~|~|VIIIe Unspecified malignant bone tumors|83041095|0-19|All Races|Male and Female|2011
2.0|2.7|2.3|191|VIIa Hepatoblastoma and mesenchymal tumors of liver|83041095|0-19|All Races|Male and Female|2011
0.4|0.7|0.5|44|VIIb Hepatic carcinomas|83041095|0-19|All Races|Male and Female|2011
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83041095|0-19|All Races|Male and Female|2011
6.0|7.1|6.5|539|VIa Nephroblastoma and other non-epithelial renal tumors|83041095|0-19|All Races|Male and Female|2011
0.5|0.9|0.7|56|VIb Renal carcinomas|83041095|0-19|All Races|Male and Female|2011
~|~|~|~|VIc Unspecified malignant renal tumors|83041095|0-19|All Races|Male and Female|2011
10.1|11.5|10.8|915|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83041095|0-19|All Races|Male and Female|2011
18.0|19.9|18.9|1607|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83041095|0-19|All Races|Male and Female|2011
0.6|1.0|0.8|63|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83041095|0-19|All Races|Male and Female|2011
0.3|0.6|0.4|34|XIIa Other specified malignant tumors|83041095|0-19|All Races|Male and Female|2011
0.2|0.5|0.3|29|XIIb Other unspecified malignant tumors|83041095|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|83041095|0-19|All Races|Male and Female|2011
8.8|10.1|9.4|803|XIb Thyroid carcinomas|83041095|0-19|All Races|Male and Female|2011
0.5|0.8|0.6|52|XIc Nasopharyngeal carcinomas|83041095|0-19|All Races|Male and Female|2011
3.8|4.7|4.3|361|XId Malignant melanomas|83041095|0-19|All Races|Male and Female|2011
~|~|~|~|XIe Skin carcinomas|83041095|0-19|All Races|Male and Female|2011
3.8|4.7|4.2|361|XIf Other and unspecified carcinomas|83041095|0-19|All Races|Male and Female|2011
1.4|2.0|1.7|138|Xa Intracranial and intraspinal germ cell tumors|83041095|0-19|All Races|Male and Female|2011
1.2|1.7|1.4|117|Xb Malignant extracranial and extragonadal germ cell tumors|83041095|0-19|All Races|Male and Female|2011
6.6|7.8|7.2|614|Xc Malignant gonadal germ cell tumors|83041095|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|24|Xd Gonadal carcinomas|83041095|0-19|All Races|Male and Female|2011
0.2|0.4|0.3|22|Xe Other and unspecified malignant gonadal tumors|83041095|0-19|All Races|Male and Female|2011
182.4|188.2|185.3|15420|All ICCC Groups Combined|82866386|0-19|All Races|Male and Female|2012
45.7|48.7|47.2|3909|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82866386|0-19|All Races|Male and Female|2012
29.2|31.6|30.4|2539|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82866386|0-19|All Races|Male and Female|2012
31.3|33.8|32.5|2692|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82866386|0-19|All Races|Male and Female|2012
2.4|3.1|2.7|224|IIIa Ependymomas and choroid plexus tumor|82866386|0-19|All Races|Male and Female|2012
16.6|18.5|17.5|1450|IIIb Astrocytomas|82866386|0-19|All Races|Male and Female|2012
5.3|6.4|5.8|480|IIIc Intracranial and intraspinal embryonal tumors|82866386|0-19|All Races|Male and Female|2012
4.8|5.8|5.3|440|IIId Other gliomas|82866386|0-19|All Races|Male and Female|2012
0.4|0.7|0.6|46|IIIe Other specified intracranial and intraspinal neoplasms|82866386|0-19|All Races|Male and Female|2012
0.5|0.8|0.6|52|IIIf Unspecified intracranial and intraspinal neoplasms|82866386|0-19|All Races|Male and Female|2012
11.7|13.2|12.4|1048|IIa Hodgkin lymphomas|82866386|0-19|All Races|Male and Female|2012
9.6|11.0|10.3|861|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82866386|0-19|All Races|Male and Female|2012
2.0|2.7|2.3|191|IIc Burkitt lymphoma|82866386|0-19|All Races|Male and Female|2012
4.4|5.3|4.8|400|IId Miscellaneous lymphoreticular neoplasms|82866386|0-19|All Races|Male and Female|2012
0.3|0.6|0.5|39|IIe Unspecified lymphomas|82866386|0-19|All Races|Male and Female|2012
8.1|9.4|8.8|723|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82866386|0-19|All Races|Male and Female|2012
7.9|9.2|8.5|703|IVa Neuroblastoma and ganglioneuroblastoma|82866386|0-19|All Races|Male and Female|2012
0.1|0.4|0.2|20|IVb Other peripheral nervous cell tumors|82866386|0-19|All Races|Male and Female|2012
10.9|12.4|11.6|967|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82866386|0-19|All Races|Male and Female|2012
4.0|4.9|4.4|368|IXa Rhabdomyosarcomas|82866386|0-19|All Races|Male and Female|2012
1.0|1.5|1.2|102|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82866386|0-19|All Races|Male and Female|2012
~|~|~|~|IXc Kaposi sarcoma|82866386|0-19|All Races|Male and Female|2012
4.0|5.0|4.5|373|IXd Other specified soft tissue sarcomas|82866386|0-19|All Races|Male and Female|2012
1.2|1.7|1.4|119|IXe Unspecified soft tissue sarcomas|82866386|0-19|All Races|Male and Female|2012
32.8|35.3|34.1|2818|Ia Lymphoid leukemias|82866386|0-19|All Races|Male and Female|2012
7.3|8.5|7.9|655|Ib Acute myeloid leukemias|82866386|0-19|All Races|Male and Female|2012
2.3|3.0|2.6|221|Ic Chronic myeloproliferative diseases|82866386|0-19|All Races|Male and Female|2012
1.2|1.8|1.5|124|Id Myelodysplastic syndrome and other myeloproliferative diseases|82866386|0-19|All Races|Male and Female|2012
0.9|1.3|1.1|91|Ie Unspecified and other specified leukemias|82866386|0-19|All Races|Male and Female|2012
0.4|0.7|0.5|44|Not classified by ICCC|82866386|0-19|All Races|Male and Female|2012
2.9|3.7|3.3|271|V RETINOBLASTOMA|82866386|0-19|All Races|Male and Female|2012
6.4|7.6|7.0|579|VI RENAL TUMORS|82866386|0-19|All Races|Male and Female|2012
2.6|3.3|2.9|243|VII HEPATIC TUMORS|82866386|0-19|All Races|Male and Female|2012
8.4|9.7|9.0|752|VIII MALIGNANT BONE TUMORS|82866386|0-19|All Races|Male and Female|2012
4.7|5.7|5.2|430|VIIIa Osteosarcomas|82866386|0-19|All Races|Male and Female|2012
0.3|0.5|0.4|32|VIIIb Chondrosarcomas|82866386|0-19|All Races|Male and Female|2012
2.5|3.2|2.8|235|VIIIc Ewing tumor and related sarcomas of bone|82866386|0-19|All Races|Male and Female|2012
0.3|0.6|0.4|37|VIIId Other specified malignant bone tumors|82866386|0-19|All Races|Male and Female|2012
0.1|0.3|0.2|18|VIIIe Unspecified malignant bone tumors|82866386|0-19|All Races|Male and Female|2012
2.0|2.6|2.3|189|VIIa Hepatoblastoma and mesenchymal tumors of liver|82866386|0-19|All Races|Male and Female|2012
0.5|0.8|0.6|52|VIIb Hepatic carcinomas|82866386|0-19|All Races|Male and Female|2012
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82866386|0-19|All Races|Male and Female|2012
5.7|6.8|6.2|516|VIa Nephroblastoma and other non-epithelial renal tumors|82866386|0-19|All Races|Male and Female|2012
0.5|0.9|0.7|58|VIb Renal carcinomas|82866386|0-19|All Races|Male and Female|2012
~|~|~|~|VIc Unspecified malignant renal tumors|82866386|0-19|All Races|Male and Female|2012
10.9|12.4|11.7|982|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82866386|0-19|All Races|Male and Female|2012
18.5|20.3|19.4|1636|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82866386|0-19|All Races|Male and Female|2012
0.8|1.2|1.0|83|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82866386|0-19|All Races|Male and Female|2012
0.3|0.7|0.5|40|XIIa Other specified malignant tumors|82866386|0-19|All Races|Male and Female|2012
0.4|0.7|0.5|43|XIIb Other unspecified malignant tumors|82866386|0-19|All Races|Male and Female|2012
0.2|0.4|0.3|22|XIa Adrenocortical carcinomas|82866386|0-19|All Races|Male and Female|2012
9.0|10.4|9.7|820|XIb Thyroid carcinomas|82866386|0-19|All Races|Male and Female|2012
0.3|0.6|0.5|38|XIc Nasopharyngeal carcinomas|82866386|0-19|All Races|Male and Female|2012
3.8|4.7|4.2|356|XId Malignant melanomas|82866386|0-19|All Races|Male and Female|2012
~|~|~|~|XIe Skin carcinomas|82866386|0-19|All Races|Male and Female|2012
4.2|5.1|4.6|391|XIf Other and unspecified carcinomas|82866386|0-19|All Races|Male and Female|2012
1.3|1.9|1.6|130|Xa Intracranial and intraspinal germ cell tumors|82866386|0-19|All Races|Male and Female|2012
1.4|2.0|1.7|143|Xb Malignant extracranial and extragonadal germ cell tumors|82866386|0-19|All Races|Male and Female|2012
7.1|8.2|7.6|647|Xc Malignant gonadal germ cell tumors|82866386|0-19|All Races|Male and Female|2012
0.3|0.6|0.4|35|Xd Gonadal carcinomas|82866386|0-19|All Races|Male and Female|2012
0.2|0.5|0.3|27|Xe Other and unspecified malignant gonadal tumors|82866386|0-19|All Races|Male and Female|2012
181.5|187.4|184.4|15303|All ICCC Groups Combined|82797930|0-19|All Races|Male and Female|2013
44.9|47.9|46.4|3836|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82797930|0-19|All Races|Male and Female|2013
27.7|30.0|28.8|2399|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82797930|0-19|All Races|Male and Female|2013
32.2|34.7|33.4|2759|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82797930|0-19|All Races|Male and Female|2013
2.3|3.1|2.7|221|IIIa Ependymomas and choroid plexus tumor|82797930|0-19|All Races|Male and Female|2013
17.1|18.9|18.0|1487|IIIb Astrocytomas|82797930|0-19|All Races|Male and Female|2013
5.2|6.3|5.7|472|IIIc Intracranial and intraspinal embryonal tumors|82797930|0-19|All Races|Male and Female|2013
5.3|6.3|5.8|476|IIId Other gliomas|82797930|0-19|All Races|Male and Female|2013
0.6|0.9|0.7|61|IIIe Other specified intracranial and intraspinal neoplasms|82797930|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|42|IIIf Unspecified intracranial and intraspinal neoplasms|82797930|0-19|All Races|Male and Female|2013
10.8|12.3|11.5|967|IIa Hodgkin lymphomas|82797930|0-19|All Races|Male and Female|2013
8.9|10.2|9.5|792|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82797930|0-19|All Races|Male and Female|2013
2.0|2.7|2.3|192|IIc Burkitt lymphoma|82797930|0-19|All Races|Male and Female|2013
4.6|5.6|5.1|419|IId Miscellaneous lymphoreticular neoplasms|82797930|0-19|All Races|Male and Female|2013
0.2|0.5|0.3|29|IIe Unspecified lymphomas|82797930|0-19|All Races|Male and Female|2013
8.7|10.0|9.4|769|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82797930|0-19|All Races|Male and Female|2013
8.4|9.7|9.0|742|IVa Neuroblastoma and ganglioneuroblastoma|82797930|0-19|All Races|Male and Female|2013
0.2|0.5|0.3|27|IVb Other peripheral nervous cell tumors|82797930|0-19|All Races|Male and Female|2013
10.9|12.4|11.7|968|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82797930|0-19|All Races|Male and Female|2013
4.2|5.1|4.6|383|IXa Rhabdomyosarcomas|82797930|0-19|All Races|Male and Female|2013
1.0|1.5|1.3|104|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82797930|0-19|All Races|Male and Female|2013
~|~|~|~|IXc Kaposi sarcoma|82797930|0-19|All Races|Male and Female|2013
4.1|5.0|4.5|377|IXd Other specified soft tissue sarcomas|82797930|0-19|All Races|Male and Female|2013
1.0|1.5|1.2|103|IXe Unspecified soft tissue sarcomas|82797930|0-19|All Races|Male and Female|2013
31.4|33.9|32.6|2695|Ia Lymphoid leukemias|82797930|0-19|All Races|Male and Female|2013
7.8|9.0|8.4|696|Ib Acute myeloid leukemias|82797930|0-19|All Races|Male and Female|2013
2.1|2.8|2.5|206|Ic Chronic myeloproliferative diseases|82797930|0-19|All Races|Male and Female|2013
1.4|2.0|1.7|138|Id Myelodysplastic syndrome and other myeloproliferative diseases|82797930|0-19|All Races|Male and Female|2013
1.0|1.5|1.2|101|Ie Unspecified and other specified leukemias|82797930|0-19|All Races|Male and Female|2013
0.3|0.6|0.4|34|Not classified by ICCC|82797930|0-19|All Races|Male and Female|2013
2.8|3.6|3.2|264|V RETINOBLASTOMA|82797930|0-19|All Races|Male and Female|2013
6.7|7.9|7.3|602|VI RENAL TUMORS|82797930|0-19|All Races|Male and Female|2013
2.3|3.0|2.6|214|VII HEPATIC TUMORS|82797930|0-19|All Races|Male and Female|2013
8.5|9.8|9.1|760|VIII MALIGNANT BONE TUMORS|82797930|0-19|All Races|Male and Female|2013
4.5|5.4|4.9|412|VIIIa Osteosarcomas|82797930|0-19|All Races|Male and Female|2013
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|82797930|0-19|All Races|Male and Female|2013
2.8|3.5|3.1|260|VIIIc Ewing tumor and related sarcomas of bone|82797930|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|45|VIIId Other specified malignant bone tumors|82797930|0-19|All Races|Male and Female|2013
~|~|~|~|VIIIe Unspecified malignant bone tumors|82797930|0-19|All Races|Male and Female|2013
1.6|2.3|1.9|159|VIIa Hepatoblastoma and mesenchymal tumors of liver|82797930|0-19|All Races|Male and Female|2013
0.5|0.8|0.6|53|VIIb Hepatic carcinomas|82797930|0-19|All Races|Male and Female|2013
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82797930|0-19|All Races|Male and Female|2013
5.9|7.0|6.4|528|VIa Nephroblastoma and other non-epithelial renal tumors|82797930|0-19|All Races|Male and Female|2013
0.7|1.1|0.8|71|VIb Renal carcinomas|82797930|0-19|All Races|Male and Female|2013
~|~|~|~|VIc Unspecified malignant renal tumors|82797930|0-19|All Races|Male and Female|2013
11.1|12.6|11.8|989|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82797930|0-19|All Races|Male and Female|2013
18.5|20.4|19.4|1632|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82797930|0-19|All Races|Male and Female|2013
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82797930|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|43|XIIa Other specified malignant tumors|82797930|0-19|All Races|Male and Female|2013
0.3|0.6|0.4|34|XIIb Other unspecified malignant tumors|82797930|0-19|All Races|Male and Female|2013
~|~|~|~|XIa Adrenocortical carcinomas|82797930|0-19|All Races|Male and Female|2013
8.7|10.1|9.4|790|XIb Thyroid carcinomas|82797930|0-19|All Races|Male and Female|2013
0.5|0.8|0.6|52|XIc Nasopharyngeal carcinomas|82797930|0-19|All Races|Male and Female|2013
3.8|4.7|4.2|356|XId Malignant melanomas|82797930|0-19|All Races|Male and Female|2013
~|~|~|~|XIe Skin carcinomas|82797930|0-19|All Races|Male and Female|2013
4.5|5.5|5.0|418|XIf Other and unspecified carcinomas|82797930|0-19|All Races|Male and Female|2013
1.7|2.3|1.9|161|Xa Intracranial and intraspinal germ cell tumors|82797930|0-19|All Races|Male and Female|2013
1.1|1.6|1.4|113|Xb Malignant extracranial and extragonadal germ cell tumors|82797930|0-19|All Races|Male and Female|2013
7.0|8.1|7.5|635|Xc Malignant gonadal germ cell tumors|82797930|0-19|All Races|Male and Female|2013
0.4|0.7|0.5|45|Xd Gonadal carcinomas|82797930|0-19|All Races|Male and Female|2013
0.3|0.6|0.4|35|Xe Other and unspecified malignant gonadal tumors|82797930|0-19|All Races|Male and Female|2013
187.2|193.1|190.1|15782|All ICCC Groups Combined|82828260|0-19|All Races|Male and Female|2014
46.1|49.1|47.6|3937|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82828260|0-19|All Races|Male and Female|2014
30.4|32.8|31.6|2630|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82828260|0-19|All Races|Male and Female|2014
32.3|34.8|33.5|2772|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82828260|0-19|All Races|Male and Female|2014
2.5|3.2|2.8|235|IIIa Ependymomas and choroid plexus tumor|82828260|0-19|All Races|Male and Female|2014
17.0|18.8|17.9|1481|IIIb Astrocytomas|82828260|0-19|All Races|Male and Female|2014
5.5|6.6|6.0|498|IIIc Intracranial and intraspinal embryonal tumors|82828260|0-19|All Races|Male and Female|2014
4.9|5.9|5.4|447|IIId Other gliomas|82828260|0-19|All Races|Male and Female|2014
0.6|1.1|0.8|69|IIIe Other specified intracranial and intraspinal neoplasms|82828260|0-19|All Races|Male and Female|2014
0.4|0.7|0.5|42|IIIf Unspecified intracranial and intraspinal neoplasms|82828260|0-19|All Races|Male and Female|2014
11.1|12.5|11.8|989|IIa Hodgkin lymphomas|82828260|0-19|All Races|Male and Female|2014
10.5|12.0|11.2|935|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82828260|0-19|All Races|Male and Female|2014
2.3|3.0|2.6|219|IIc Burkitt lymphoma|82828260|0-19|All Races|Male and Female|2014
5.0|6.0|5.5|453|IId Miscellaneous lymphoreticular neoplasms|82828260|0-19|All Races|Male and Female|2014
0.3|0.6|0.4|34|IIe Unspecified lymphomas|82828260|0-19|All Races|Male and Female|2014
8.7|10.0|9.3|769|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82828260|0-19|All Races|Male and Female|2014
8.3|9.6|9.0|738|IVa Neuroblastoma and ganglioneuroblastoma|82828260|0-19|All Races|Male and Female|2014
0.3|0.5|0.4|31|IVb Other peripheral nervous cell tumors|82828260|0-19|All Races|Male and Female|2014
11.3|12.8|12.1|1003|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82828260|0-19|All Races|Male and Female|2014
3.8|4.7|4.2|346|IXa Rhabdomyosarcomas|82828260|0-19|All Races|Male and Female|2014
1.3|1.8|1.5|126|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82828260|0-19|All Races|Male and Female|2014
~|~|~|~|IXc Kaposi sarcoma|82828260|0-19|All Races|Male and Female|2014
4.5|5.4|4.9|411|IXd Other specified soft tissue sarcomas|82828260|0-19|All Races|Male and Female|2014
1.1|1.7|1.4|115|IXe Unspecified soft tissue sarcomas|82828260|0-19|All Races|Male and Female|2014
32.3|34.8|33.6|2771|Ia Lymphoid leukemias|82828260|0-19|All Races|Male and Female|2014
8.0|9.3|8.6|716|Ib Acute myeloid leukemias|82828260|0-19|All Races|Male and Female|2014
2.3|3.0|2.6|217|Ic Chronic myeloproliferative diseases|82828260|0-19|All Races|Male and Female|2014
1.3|1.9|1.6|129|Id Myelodysplastic syndrome and other myeloproliferative diseases|82828260|0-19|All Races|Male and Female|2014
1.0|1.5|1.3|104|Ie Unspecified and other specified leukemias|82828260|0-19|All Races|Male and Female|2014
0.4|0.7|0.5|41|Not classified by ICCC|82828260|0-19|All Races|Male and Female|2014
2.8|3.6|3.2|265|V RETINOBLASTOMA|82828260|0-19|All Races|Male and Female|2014
6.7|7.8|7.2|596|VI RENAL TUMORS|82828260|0-19|All Races|Male and Female|2014
2.4|3.1|2.7|224|VII HEPATIC TUMORS|82828260|0-19|All Races|Male and Female|2014
8.6|10.0|9.3|772|VIII MALIGNANT BONE TUMORS|82828260|0-19|All Races|Male and Female|2014
4.6|5.6|5.1|426|VIIIa Osteosarcomas|82828260|0-19|All Races|Male and Female|2014
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|82828260|0-19|All Races|Male and Female|2014
2.6|3.4|3.0|250|VIIIc Ewing tumor and related sarcomas of bone|82828260|0-19|All Races|Male and Female|2014
0.4|0.7|0.6|46|VIIId Other specified malignant bone tumors|82828260|0-19|All Races|Male and Female|2014
0.2|0.4|0.3|21|VIIIe Unspecified malignant bone tumors|82828260|0-19|All Races|Male and Female|2014
1.9|2.5|2.2|179|VIIa Hepatoblastoma and mesenchymal tumors of liver|82828260|0-19|All Races|Male and Female|2014
0.4|0.7|0.5|44|VIIb Hepatic carcinomas|82828260|0-19|All Races|Male and Female|2014
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82828260|0-19|All Races|Male and Female|2014
6.0|7.2|6.6|541|VIa Nephroblastoma and other non-epithelial renal tumors|82828260|0-19|All Races|Male and Female|2014
0.5|0.8|0.6|53|VIb Renal carcinomas|82828260|0-19|All Races|Male and Female|2014
~|~|~|~|VIc Unspecified malignant renal tumors|82828260|0-19|All Races|Male and Female|2014
10.5|11.9|11.2|935|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82828260|0-19|All Races|Male and Female|2014
20.2|22.2|21.1|1775|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82828260|0-19|All Races|Male and Female|2014
0.6|1.0|0.8|63|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82828260|0-19|All Races|Male and Female|2014
0.3|0.6|0.4|35|XIIa Other specified malignant tumors|82828260|0-19|All Races|Male and Female|2014
0.2|0.5|0.3|28|XIIb Other unspecified malignant tumors|82828260|0-19|All Races|Male and Female|2014
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|82828260|0-19|All Races|Male and Female|2014
10.0|11.4|10.7|900|XIb Thyroid carcinomas|82828260|0-19|All Races|Male and Female|2014
0.2|0.5|0.4|30|XIc Nasopharyngeal carcinomas|82828260|0-19|All Races|Male and Female|2014
3.7|4.6|4.1|343|XId Malignant melanomas|82828260|0-19|All Races|Male and Female|2014
~|~|~|~|XIe Skin carcinomas|82828260|0-19|All Races|Male and Female|2014
5.1|6.2|5.6|473|XIf Other and unspecified carcinomas|82828260|0-19|All Races|Male and Female|2014
1.4|1.9|1.6|137|Xa Intracranial and intraspinal germ cell tumors|82828260|0-19|All Races|Male and Female|2014
1.4|2.0|1.7|138|Xb Malignant extracranial and extragonadal germ cell tumors|82828260|0-19|All Races|Male and Female|2014
6.4|7.6|7.0|586|Xc Malignant gonadal germ cell tumors|82828260|0-19|All Races|Male and Female|2014
0.3|0.6|0.5|40|Xd Gonadal carcinomas|82828260|0-19|All Races|Male and Female|2014
0.3|0.6|0.4|34|Xe Other and unspecified malignant gonadal tumors|82828260|0-19|All Races|Male and Female|2014
192.4|198.4|195.3|16256|All ICCC Groups Combined|82974459|0-19|All Races|Male and Female|2015
48.2|51.3|49.7|4119|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82974459|0-19|All Races|Male and Female|2015
30.2|32.6|31.4|2620|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82974459|0-19|All Races|Male and Female|2015
31.5|33.9|32.7|2705|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82974459|0-19|All Races|Male and Female|2015
2.4|3.1|2.7|226|IIIa Ependymomas and choroid plexus tumor|82974459|0-19|All Races|Male and Female|2015
15.8|17.5|16.6|1376|IIIb Astrocytomas|82974459|0-19|All Races|Male and Female|2015
5.6|6.7|6.1|503|IIIc Intracranial and intraspinal embryonal tumors|82974459|0-19|All Races|Male and Female|2015
5.5|6.5|6.0|496|IIId Other gliomas|82974459|0-19|All Races|Male and Female|2015
0.6|1.0|0.8|68|IIIe Other specified intracranial and intraspinal neoplasms|82974459|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|36|IIIf Unspecified intracranial and intraspinal neoplasms|82974459|0-19|All Races|Male and Female|2015
11.5|13.0|12.2|1029|IIa Hodgkin lymphomas|82974459|0-19|All Races|Male and Female|2015
9.9|11.3|10.5|880|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82974459|0-19|All Races|Male and Female|2015
2.1|2.8|2.5|203|IIc Burkitt lymphoma|82974459|0-19|All Races|Male and Female|2015
5.2|6.3|5.7|473|IId Miscellaneous lymphoreticular neoplasms|82974459|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|35|IIe Unspecified lymphomas|82974459|0-19|All Races|Male and Female|2015
8.9|10.2|9.5|788|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82974459|0-19|All Races|Male and Female|2015
8.6|9.9|9.2|761|IVa Neuroblastoma and ganglioneuroblastoma|82974459|0-19|All Races|Male and Female|2015
0.2|0.5|0.3|27|IVb Other peripheral nervous cell tumors|82974459|0-19|All Races|Male and Female|2015
11.4|12.9|12.1|1009|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82974459|0-19|All Races|Male and Female|2015
4.1|5.0|4.5|377|IXa Rhabdomyosarcomas|82974459|0-19|All Races|Male and Female|2015
1.1|1.7|1.4|116|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82974459|0-19|All Races|Male and Female|2015
~|~|~|~|IXc Kaposi sarcoma|82974459|0-19|All Races|Male and Female|2015
4.2|5.1|4.6|388|IXd Other specified soft tissue sarcomas|82974459|0-19|All Races|Male and Female|2015
1.2|1.8|1.5|124|IXe Unspecified soft tissue sarcomas|82974459|0-19|All Races|Male and Female|2015
34.5|37.1|35.8|2961|Ia Lymphoid leukemias|82974459|0-19|All Races|Male and Female|2015
7.9|9.1|8.5|707|Ib Acute myeloid leukemias|82974459|0-19|All Races|Male and Female|2015
2.5|3.2|2.8|235|Ic Chronic myeloproliferative diseases|82974459|0-19|All Races|Male and Female|2015
1.2|1.8|1.5|123|Id Myelodysplastic syndrome and other myeloproliferative diseases|82974459|0-19|All Races|Male and Female|2015
0.9|1.4|1.1|93|Ie Unspecified and other specified leukemias|82974459|0-19|All Races|Male and Female|2015
0.3|0.5|0.4|31|Not classified by ICCC|82974459|0-19|All Races|Male and Female|2015
3.3|4.2|3.7|307|V RETINOBLASTOMA|82974459|0-19|All Races|Male and Female|2015
7.3|8.5|7.9|651|VI RENAL TUMORS|82974459|0-19|All Races|Male and Female|2015
2.7|3.5|3.1|256|VII HEPATIC TUMORS|82974459|0-19|All Races|Male and Female|2015
8.5|9.8|9.1|760|VIII MALIGNANT BONE TUMORS|82974459|0-19|All Races|Male and Female|2015
4.4|5.3|4.8|404|VIIIa Osteosarcomas|82974459|0-19|All Races|Male and Female|2015
0.3|0.6|0.4|33|VIIIb Chondrosarcomas|82974459|0-19|All Races|Male and Female|2015
2.7|3.5|3.1|258|VIIIc Ewing tumor and related sarcomas of bone|82974459|0-19|All Races|Male and Female|2015
0.4|0.7|0.6|46|VIIId Other specified malignant bone tumors|82974459|0-19|All Races|Male and Female|2015
0.1|0.4|0.2|19|VIIIe Unspecified malignant bone tumors|82974459|0-19|All Races|Male and Female|2015
2.1|2.8|2.4|198|VIIa Hepatoblastoma and mesenchymal tumors of liver|82974459|0-19|All Races|Male and Female|2015
0.5|0.9|0.7|56|VIIb Hepatic carcinomas|82974459|0-19|All Races|Male and Female|2015
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82974459|0-19|All Races|Male and Female|2015
6.5|7.7|7.1|582|VIa Nephroblastoma and other non-epithelial renal tumors|82974459|0-19|All Races|Male and Female|2015
0.6|1.0|0.8|67|VIb Renal carcinomas|82974459|0-19|All Races|Male and Female|2015
~|~|~|~|VIc Unspecified malignant renal tumors|82974459|0-19|All Races|Male and Female|2015
10.9|12.3|11.6|975|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82974459|0-19|All Races|Male and Female|2015
22.2|24.3|23.2|1959|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82974459|0-19|All Races|Male and Female|2015
0.7|1.1|0.9|76|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82974459|0-19|All Races|Male and Female|2015
0.5|0.8|0.6|51|XIIa Other specified malignant tumors|82974459|0-19|All Races|Male and Female|2015
0.2|0.4|0.3|25|XIIb Other unspecified malignant tumors|82974459|0-19|All Races|Male and Female|2015
~|~|~|~|XIa Adrenocortical carcinomas|82974459|0-19|All Races|Male and Female|2015
10.1|11.5|10.8|913|XIb Thyroid carcinomas|82974459|0-19|All Races|Male and Female|2015
0.4|0.8|0.6|51|XIc Nasopharyngeal carcinomas|82974459|0-19|All Races|Male and Female|2015
3.5|4.3|3.9|325|XId Malignant melanomas|82974459|0-19|All Races|Male and Female|2015
~|~|~|~|XIe Skin carcinomas|82974459|0-19|All Races|Male and Female|2015
7.2|8.4|7.7|652|XIf Other and unspecified carcinomas|82974459|0-19|All Races|Male and Female|2015
1.6|2.2|1.8|153|Xa Intracranial and intraspinal germ cell tumors|82974459|0-19|All Races|Male and Female|2015
1.2|1.7|1.4|116|Xb Malignant extracranial and extragonadal germ cell tumors|82974459|0-19|All Races|Male and Female|2015
7.0|8.1|7.5|637|Xc Malignant gonadal germ cell tumors|82974459|0-19|All Races|Male and Female|2015
0.3|0.6|0.5|39|Xd Gonadal carcinomas|82974459|0-19|All Races|Male and Female|2015
0.2|0.5|0.4|30|Xe Other and unspecified malignant gonadal tumors|82974459|0-19|All Races|Male and Female|2015
190.2|196.1|193.1|16116|All ICCC Groups Combined|83184415|0-19|All Races|Male and Female|2016
48.2|51.3|49.7|4127|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83184415|0-19|All Races|Male and Female|2016
29.4|31.7|30.5|2560|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83184415|0-19|All Races|Male and Female|2016
30.6|33.1|31.8|2639|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83184415|0-19|All Races|Male and Female|2016
2.2|2.8|2.5|206|IIIa Ependymomas and choroid plexus tumor|83184415|0-19|All Races|Male and Female|2016
15.1|16.9|16.0|1325|IIIb Astrocytomas|83184415|0-19|All Races|Male and Female|2016
5.0|6.1|5.5|458|IIIc Intracranial and intraspinal embryonal tumors|83184415|0-19|All Races|Male and Female|2016
5.8|6.9|6.4|527|IIId Other gliomas|83184415|0-19|All Races|Male and Female|2016
0.7|1.2|0.9|78|IIIe Other specified intracranial and intraspinal neoplasms|83184415|0-19|All Races|Male and Female|2016
0.4|0.7|0.5|45|IIIf Unspecified intracranial and intraspinal neoplasms|83184415|0-19|All Races|Male and Female|2016
11.6|13.1|12.3|1043|IIa Hodgkin lymphomas|83184415|0-19|All Races|Male and Female|2016
10.1|11.5|10.7|899|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83184415|0-19|All Races|Male and Female|2016
2.1|2.8|2.5|204|IIc Burkitt lymphoma|83184415|0-19|All Races|Male and Female|2016
4.2|5.1|4.6|381|IId Miscellaneous lymphoreticular neoplasms|83184415|0-19|All Races|Male and Female|2016
0.3|0.5|0.4|33|IIe Unspecified lymphomas|83184415|0-19|All Races|Male and Female|2016
8.2|9.5|8.9|731|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83184415|0-19|All Races|Male and Female|2016
8.1|9.4|8.7|717|IVa Neuroblastoma and ganglioneuroblastoma|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|IVb Other peripheral nervous cell tumors|83184415|0-19|All Races|Male and Female|2016
11.5|13.0|12.2|1018|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83184415|0-19|All Races|Male and Female|2016
4.5|5.4|4.9|410|IXa Rhabdomyosarcomas|83184415|0-19|All Races|Male and Female|2016
0.9|1.4|1.1|92|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|IXc Kaposi sarcoma|83184415|0-19|All Races|Male and Female|2016
4.2|5.2|4.7|392|IXd Other specified soft tissue sarcomas|83184415|0-19|All Races|Male and Female|2016
1.2|1.7|1.5|122|IXe Unspecified soft tissue sarcomas|83184415|0-19|All Races|Male and Female|2016
34.4|37.0|35.7|2958|Ia Lymphoid leukemias|83184415|0-19|All Races|Male and Female|2016
8.0|9.2|8.6|716|Ib Acute myeloid leukemias|83184415|0-19|All Races|Male and Female|2016
2.5|3.3|2.9|240|Ic Chronic myeloproliferative diseases|83184415|0-19|All Races|Male and Female|2016
1.2|1.8|1.5|122|Id Myelodysplastic syndrome and other myeloproliferative diseases|83184415|0-19|All Races|Male and Female|2016
0.9|1.3|1.1|91|Ie Unspecified and other specified leukemias|83184415|0-19|All Races|Male and Female|2016
0.2|0.5|0.3|27|Not classified by ICCC|83184415|0-19|All Races|Male and Female|2016
2.8|3.6|3.2|260|V RETINOBLASTOMA|83184415|0-19|All Races|Male and Female|2016
6.3|7.5|6.9|570|VI RENAL TUMORS|83184415|0-19|All Races|Male and Female|2016
2.5|3.3|2.9|239|VII HEPATIC TUMORS|83184415|0-19|All Races|Male and Female|2016
9.1|10.4|9.8|817|VIII MALIGNANT BONE TUMORS|83184415|0-19|All Races|Male and Female|2016
4.7|5.7|5.2|435|VIIIa Osteosarcomas|83184415|0-19|All Races|Male and Female|2016
0.2|0.4|0.3|25|VIIIb Chondrosarcomas|83184415|0-19|All Races|Male and Female|2016
3.1|3.9|3.5|291|VIIIc Ewing tumor and related sarcomas of bone|83184415|0-19|All Races|Male and Female|2016
0.5|0.8|0.6|54|VIIId Other specified malignant bone tumors|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|VIIIe Unspecified malignant bone tumors|83184415|0-19|All Races|Male and Female|2016
2.1|2.8|2.4|199|VIIa Hepatoblastoma and mesenchymal tumors of liver|83184415|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|37|VIIb Hepatic carcinomas|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83184415|0-19|All Races|Male and Female|2016
5.5|6.6|6.1|500|VIa Nephroblastoma and other non-epithelial renal tumors|83184415|0-19|All Races|Male and Female|2016
0.6|1.0|0.8|67|VIb Renal carcinomas|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|VIc Unspecified malignant renal tumors|83184415|0-19|All Races|Male and Female|2016
10.5|12.0|11.2|947|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83184415|0-19|All Races|Male and Female|2016
23.5|25.7|24.6|2081|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83184415|0-19|All Races|Male and Female|2016
1.0|1.5|1.2|100|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83184415|0-19|All Races|Male and Female|2016
0.5|0.9|0.7|58|XIIa Other specified malignant tumors|83184415|0-19|All Races|Male and Female|2016
0.4|0.7|0.5|42|XIIb Other unspecified malignant tumors|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|XIa Adrenocortical carcinomas|83184415|0-19|All Races|Male and Female|2016
10.4|11.8|11.1|943|XIb Thyroid carcinomas|83184415|0-19|All Races|Male and Female|2016
0.2|0.5|0.3|28|XIc Nasopharyngeal carcinomas|83184415|0-19|All Races|Male and Female|2016
3.4|4.2|3.8|321|XId Malignant melanomas|83184415|0-19|All Races|Male and Female|2016
~|~|~|~|XIe Skin carcinomas|83184415|0-19|All Races|Male and Female|2016
8.4|9.7|9.0|762|XIf Other and unspecified carcinomas|83184415|0-19|All Races|Male and Female|2016
1.7|2.4|2.0|169|Xa Intracranial and intraspinal germ cell tumors|83184415|0-19|All Races|Male and Female|2016
1.1|1.6|1.3|107|Xb Malignant extracranial and extragonadal germ cell tumors|83184415|0-19|All Races|Male and Female|2016
6.5|7.7|7.1|600|Xc Malignant gonadal germ cell tumors|83184415|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|36|Xd Gonadal carcinomas|83184415|0-19|All Races|Male and Female|2016
0.3|0.6|0.4|35|Xe Other and unspecified malignant gonadal tumors|83184415|0-19|All Races|Male and Female|2016
185.5|191.4|188.4|15739|All ICCC Groups Combined|83308218|0-19|All Races|Male and Female|2017
45.2|48.1|46.6|3878|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83308218|0-19|All Races|Male and Female|2017
29.3|31.7|30.5|2561|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83308218|0-19|All Races|Male and Female|2017
32.7|35.2|34.0|2820|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83308218|0-19|All Races|Male and Female|2017
2.5|3.3|2.9|239|IIIa Ependymomas and choroid plexus tumor|83308218|0-19|All Races|Male and Female|2017
16.8|18.6|17.7|1472|IIIb Astrocytomas|83308218|0-19|All Races|Male and Female|2017
5.2|6.2|5.7|471|IIIc Intracranial and intraspinal embryonal tumors|83308218|0-19|All Races|Male and Female|2017
6.0|7.1|6.5|542|IIId Other gliomas|83308218|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|48|IIIe Other specified intracranial and intraspinal neoplasms|83308218|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|48|IIIf Unspecified intracranial and intraspinal neoplasms|83308218|0-19|All Races|Male and Female|2017
11.3|12.7|12.0|1016|IIa Hodgkin lymphomas|83308218|0-19|All Races|Male and Female|2017
9.5|10.9|10.2|856|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83308218|0-19|All Races|Male and Female|2017
2.1|2.8|2.5|205|IIc Burkitt lymphoma|83308218|0-19|All Races|Male and Female|2017
5.1|6.1|5.5|458|IId Miscellaneous lymphoreticular neoplasms|83308218|0-19|All Races|Male and Female|2017
0.2|0.5|0.3|26|IIe Unspecified lymphomas|83308218|0-19|All Races|Male and Female|2017
7.9|9.2|8.5|699|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83308218|0-19|All Races|Male and Female|2017
7.7|9.0|8.3|683|IVa Neuroblastoma and ganglioneuroblastoma|83308218|0-19|All Races|Male and Female|2017
0.1|0.3|0.2|16|IVb Other peripheral nervous cell tumors|83308218|0-19|All Races|Male and Female|2017
11.6|13.1|12.3|1028|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83308218|0-19|All Races|Male and Female|2017
4.4|5.3|4.8|402|IXa Rhabdomyosarcomas|83308218|0-19|All Races|Male and Female|2017
0.9|1.3|1.1|92|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83308218|0-19|All Races|Male and Female|2017
~|~|~|~|IXc Kaposi sarcoma|83308218|0-19|All Races|Male and Female|2017
4.1|5.0|4.5|378|IXd Other specified soft tissue sarcomas|83308218|0-19|All Races|Male and Female|2017
1.6|2.2|1.8|154|IXe Unspecified soft tissue sarcomas|83308218|0-19|All Races|Male and Female|2017
32.5|35.0|33.8|2802|Ia Lymphoid leukemias|83308218|0-19|All Races|Male and Female|2017
7.3|8.6|7.9|662|Ib Acute myeloid leukemias|83308218|0-19|All Races|Male and Female|2017
2.3|3.0|2.7|224|Ic Chronic myeloproliferative diseases|83308218|0-19|All Races|Male and Female|2017
1.0|1.5|1.2|99|Id Myelodysplastic syndrome and other myeloproliferative diseases|83308218|0-19|All Races|Male and Female|2017
0.9|1.3|1.1|91|Ie Unspecified and other specified leukemias|83308218|0-19|All Races|Male and Female|2017
0.3|0.5|0.4|33|Not classified by ICCC|83308218|0-19|All Races|Male and Female|2017
2.7|3.5|3.1|253|V RETINOBLASTOMA|83308218|0-19|All Races|Male and Female|2017
6.2|7.3|6.7|556|VI RENAL TUMORS|83308218|0-19|All Races|Male and Female|2017
2.3|3.0|2.7|221|VII HEPATIC TUMORS|83308218|0-19|All Races|Male and Female|2017
8.7|10.0|9.3|787|VIII MALIGNANT BONE TUMORS|83308218|0-19|All Races|Male and Female|2017
4.9|5.9|5.3|450|VIIIa Osteosarcomas|83308218|0-19|All Races|Male and Female|2017
0.2|0.5|0.4|30|VIIIb Chondrosarcomas|83308218|0-19|All Races|Male and Female|2017
2.5|3.3|2.9|242|VIIIc Ewing tumor and related sarcomas of bone|83308218|0-19|All Races|Male and Female|2017
0.4|0.7|0.5|42|VIIId Other specified malignant bone tumors|83308218|0-19|All Races|Male and Female|2017
0.2|0.4|0.3|23|VIIIe Unspecified malignant bone tumors|83308218|0-19|All Races|Male and Female|2017
1.7|2.4|2.0|168|VIIa Hepatoblastoma and mesenchymal tumors of liver|83308218|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|49|VIIb Hepatic carcinomas|83308218|0-19|All Races|Male and Female|2017
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83308218|0-19|All Races|Male and Female|2017
5.5|6.6|6.0|498|VIa Nephroblastoma and other non-epithelial renal tumors|83308218|0-19|All Races|Male and Female|2017
0.5|0.9|0.7|56|VIb Renal carcinomas|83308218|0-19|All Races|Male and Female|2017
~|~|~|~|VIc Unspecified malignant renal tumors|83308218|0-19|All Races|Male and Female|2017
10.5|11.9|11.2|942|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83308218|0-19|All Races|Male and Female|2017
21.0|23.0|22.0|1870|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83308218|0-19|All Races|Male and Female|2017
0.9|1.3|1.1|91|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83308218|0-19|All Races|Male and Female|2017
0.5|0.8|0.7|54|XIIa Other specified malignant tumors|83308218|0-19|All Races|Male and Female|2017
0.3|0.6|0.4|37|XIIb Other unspecified malignant tumors|83308218|0-19|All Races|Male and Female|2017
~|~|~|~|XIa Adrenocortical carcinomas|83308218|0-19|All Races|Male and Female|2017
9.5|10.8|10.1|861|XIb Thyroid carcinomas|83308218|0-19|All Races|Male and Female|2017
0.3|0.7|0.5|41|XIc Nasopharyngeal carcinomas|83308218|0-19|All Races|Male and Female|2017
2.6|3.3|2.9|249|XId Malignant melanomas|83308218|0-19|All Races|Male and Female|2017
~|~|~|~|XIe Skin carcinomas|83308218|0-19|All Races|Male and Female|2017
7.6|8.8|8.2|693|XIf Other and unspecified carcinomas|83308218|0-19|All Races|Male and Female|2017
1.8|2.4|2.1|177|Xa Intracranial and intraspinal germ cell tumors|83308218|0-19|All Races|Male and Female|2017
1.1|1.6|1.3|110|Xb Malignant extracranial and extragonadal germ cell tumors|83308218|0-19|All Races|Male and Female|2017
6.3|7.4|6.8|577|Xc Malignant gonadal germ cell tumors|83308218|0-19|All Races|Male and Female|2017
0.2|0.5|0.4|30|Xd Gonadal carcinomas|83308218|0-19|All Races|Male and Female|2017
0.4|0.8|0.6|48|Xe Other and unspecified malignant gonadal tumors|83308218|0-19|All Races|Male and Female|2017
187.0|192.9|189.9|15865|All ICCC Groups Combined|83321994|0-19|All Races|Male and Female|2018
47.5|50.5|49.0|4069|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83321994|0-19|All Races|Male and Female|2018
28.7|31.1|29.9|2513|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83321994|0-19|All Races|Male and Female|2018
29.4|31.8|30.6|2539|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83321994|0-19|All Races|Male and Female|2018
2.1|2.8|2.4|202|IIIa Ependymomas and choroid plexus tumor|83321994|0-19|All Races|Male and Female|2018
14.4|16.1|15.2|1265|IIIb Astrocytomas|83321994|0-19|All Races|Male and Female|2018
4.9|5.9|5.4|442|IIIc Intracranial and intraspinal embryonal tumors|83321994|0-19|All Races|Male and Female|2018
5.8|6.9|6.3|527|IIId Other gliomas|83321994|0-19|All Races|Male and Female|2018
0.5|0.9|0.7|58|IIIe Other specified intracranial and intraspinal neoplasms|83321994|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|45|IIIf Unspecified intracranial and intraspinal neoplasms|83321994|0-19|All Races|Male and Female|2018
11.5|13.0|12.2|1039|IIa Hodgkin lymphomas|83321994|0-19|All Races|Male and Female|2018
9.8|11.2|10.5|884|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83321994|0-19|All Races|Male and Female|2018
1.9|2.5|2.2|180|IIc Burkitt lymphoma|83321994|0-19|All Races|Male and Female|2018
4.2|5.2|4.7|385|IId Miscellaneous lymphoreticular neoplasms|83321994|0-19|All Races|Male and Female|2018
0.2|0.4|0.3|25|IIe Unspecified lymphomas|83321994|0-19|All Races|Male and Female|2018
8.4|9.7|9.1|738|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83321994|0-19|All Races|Male and Female|2018
8.2|9.5|8.8|716|IVa Neuroblastoma and ganglioneuroblastoma|83321994|0-19|All Races|Male and Female|2018
0.2|0.4|0.3|22|IVb Other peripheral nervous cell tumors|83321994|0-19|All Races|Male and Female|2018
10.9|12.3|11.6|969|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83321994|0-19|All Races|Male and Female|2018
3.9|4.8|4.3|359|IXa Rhabdomyosarcomas|83321994|0-19|All Races|Male and Female|2018
1.0|1.5|1.2|99|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83321994|0-19|All Races|Male and Female|2018
~|~|~|~|IXc Kaposi sarcoma|83321994|0-19|All Races|Male and Female|2018
4.2|5.2|4.7|393|IXd Other specified soft tissue sarcomas|83321994|0-19|All Races|Male and Female|2018
1.1|1.6|1.4|115|IXe Unspecified soft tissue sarcomas|83321994|0-19|All Races|Male and Female|2018
34.8|37.4|36.1|2994|Ia Lymphoid leukemias|83321994|0-19|All Races|Male and Female|2018
7.4|8.7|8.0|670|Ib Acute myeloid leukemias|83321994|0-19|All Races|Male and Female|2018
2.0|2.7|2.3|196|Ic Chronic myeloproliferative diseases|83321994|0-19|All Races|Male and Female|2018
0.9|1.4|1.2|95|Id Myelodysplastic syndrome and other myeloproliferative diseases|83321994|0-19|All Races|Male and Female|2018
1.1|1.6|1.4|114|Ie Unspecified and other specified leukemias|83321994|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|44|Not classified by ICCC|83321994|0-19|All Races|Male and Female|2018
2.7|3.5|3.1|251|V RETINOBLASTOMA|83321994|0-19|All Races|Male and Female|2018
6.4|7.6|7.0|573|VI RENAL TUMORS|83321994|0-19|All Races|Male and Female|2018
2.6|3.3|2.9|239|VII HEPATIC TUMORS|83321994|0-19|All Races|Male and Female|2018
9.0|10.4|9.7|818|VIII MALIGNANT BONE TUMORS|83321994|0-19|All Races|Male and Female|2018
4.8|5.8|5.2|444|VIIIa Osteosarcomas|83321994|0-19|All Races|Male and Female|2018
0.3|0.6|0.4|34|VIIIb Chondrosarcomas|83321994|0-19|All Races|Male and Female|2018
2.9|3.7|3.3|277|VIIIc Ewing tumor and related sarcomas of bone|83321994|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|43|VIIId Other specified malignant bone tumors|83321994|0-19|All Races|Male and Female|2018
0.1|0.4|0.2|20|VIIIe Unspecified malignant bone tumors|83321994|0-19|All Races|Male and Female|2018
1.9|2.6|2.2|180|VIIa Hepatoblastoma and mesenchymal tumors of liver|83321994|0-19|All Races|Male and Female|2018
0.5|0.8|0.7|55|VIIb Hepatic carcinomas|83321994|0-19|All Races|Male and Female|2018
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83321994|0-19|All Races|Male and Female|2018
5.7|6.8|6.2|508|VIa Nephroblastoma and other non-epithelial renal tumors|83321994|0-19|All Races|Male and Female|2018
0.5|0.9|0.7|60|VIb Renal carcinomas|83321994|0-19|All Races|Male and Female|2018
~|~|~|~|VIc Unspecified malignant renal tumors|83321994|0-19|All Races|Male and Female|2018
9.8|11.2|10.5|888|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83321994|0-19|All Races|Male and Female|2018
24.0|26.1|25.1|2134|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83321994|0-19|All Races|Male and Female|2018
0.9|1.3|1.1|90|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83321994|0-19|All Races|Male and Female|2018
0.4|0.7|0.6|47|XIIa Other specified malignant tumors|83321994|0-19|All Races|Male and Female|2018
0.4|0.7|0.5|43|XIIb Other unspecified malignant tumors|83321994|0-19|All Races|Male and Female|2018
0.2|0.5|0.4|30|XIa Adrenocortical carcinomas|83321994|0-19|All Races|Male and Female|2018
11.3|12.8|12.1|1030|XIb Thyroid carcinomas|83321994|0-19|All Races|Male and Female|2018
0.3|0.6|0.4|35|XIc Nasopharyngeal carcinomas|83321994|0-19|All Races|Male and Female|2018
2.9|3.7|3.3|280|XId Malignant melanomas|83321994|0-19|All Races|Male and Female|2018
~|~|~|~|XIe Skin carcinomas|83321994|0-19|All Races|Male and Female|2018
8.2|9.5|8.8|750|XIf Other and unspecified carcinomas|83321994|0-19|All Races|Male and Female|2018
1.3|1.9|1.6|131|Xa Intracranial and intraspinal germ cell tumors|83321994|0-19|All Races|Male and Female|2018
1.2|1.7|1.4|117|Xb Malignant extracranial and extragonadal germ cell tumors|83321994|0-19|All Races|Male and Female|2018
6.1|7.2|6.7|567|Xc Malignant gonadal germ cell tumors|83321994|0-19|All Races|Male and Female|2018
0.3|0.6|0.5|40|Xd Gonadal carcinomas|83321994|0-19|All Races|Male and Female|2018
0.3|0.5|0.4|33|Xe Other and unspecified malignant gonadal tumors|83321994|0-19|All Races|Male and Female|2018
183.2|185.8|184.5|76428|All ICCC Groups Combined|413514777|0-19|All Races|Male and Female|2018-2022
46.9|48.2|47.5|19505|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|413514777|0-19|All Races|Male and Female|2018-2022
28.0|29.0|28.5|11954|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|413514777|0-19|All Races|Male and Female|2018-2022
28.7|29.7|29.2|11995|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|413514777|0-19|All Races|Male and Female|2018-2022
2.2|2.5|2.4|973|IIIa Ependymomas and choroid plexus tumor|413514777|0-19|All Races|Male and Female|2018-2022
12.9|13.6|13.2|5465|IIIb Astrocytomas|413514777|0-19|All Races|Male and Female|2018-2022
5.0|5.5|5.2|2126|IIIc Intracranial and intraspinal embryonal tumors|413514777|0-19|All Races|Male and Female|2018-2022
6.9|7.4|7.1|2946|IIId Other gliomas|413514777|0-19|All Races|Male and Female|2018-2022
0.5|0.7|0.6|251|IIIe Other specified intracranial and intraspinal neoplasms|413514777|0-19|All Races|Male and Female|2018-2022
0.5|0.6|0.6|234|IIIf Unspecified intracranial and intraspinal neoplasms|413514777|0-19|All Races|Male and Female|2018-2022
11.8|12.4|12.1|5140|IIa Hodgkin lymphomas|413514777|0-19|All Races|Male and Female|2018-2022
10.0|10.6|10.3|4316|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|413514777|0-19|All Races|Male and Female|2018-2022
2.5|2.8|2.6|1078|IIc Burkitt lymphoma|413514777|0-19|All Races|Male and Female|2018-2022
3.1|3.4|3.2|1306|IId Miscellaneous lymphoreticular neoplasms|413514777|0-19|All Races|Male and Female|2018-2022
0.2|0.3|0.3|114|IIe Unspecified lymphomas|413514777|0-19|All Races|Male and Female|2018-2022
8.8|9.4|9.1|3626|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|413514777|0-19|All Races|Male and Female|2018-2022
8.4|9.0|8.7|3457|IVa Neuroblastoma and ganglioneuroblastoma|413514777|0-19|All Races|Male and Female|2018-2022
0.3|0.5|0.4|169|IVb Other peripheral nervous cell tumors|413514777|0-19|All Races|Male and Female|2018-2022
11.7|12.4|12.0|5001|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|413514777|0-19|All Races|Male and Female|2018-2022
4.5|4.9|4.7|1913|IXa Rhabdomyosarcomas|413514777|0-19|All Races|Male and Female|2018-2022
1.0|1.2|1.1|436|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|413514777|0-19|All Races|Male and Female|2018-2022
0.0|0.1|0.0|21|IXc Kaposi sarcoma|413514777|0-19|All Races|Male and Female|2018-2022
4.4|4.8|4.6|1947|IXd Other specified soft tissue sarcomas|413514777|0-19|All Races|Male and Female|2018-2022
1.5|1.8|1.6|684|IXe Unspecified soft tissue sarcomas|413514777|0-19|All Races|Male and Female|2018-2022
34.6|35.8|35.2|14391|Ia Lymphoid leukemias|413514777|0-19|All Races|Male and Female|2018-2022
7.6|8.1|7.9|3249|Ib Acute myeloid leukemias|413514777|0-19|All Races|Male and Female|2018-2022
2.0|2.2|2.1|888|Ic Chronic myeloproliferative diseases|413514777|0-19|All Races|Male and Female|2018-2022
1.1|1.3|1.2|500|Id Myelodysplastic syndrome and other myeloproliferative diseases|413514777|0-19|All Races|Male and Female|2018-2022
1.1|1.3|1.2|477|Ie Unspecified and other specified leukemias|413514777|0-19|All Races|Male and Female|2018-2022
0.5|0.6|0.5|226|Not classified by ICCC|413514777|0-19|All Races|Male and Female|2018-2022
2.8|3.1|3.0|1167|V RETINOBLASTOMA|413514777|0-19|All Races|Male and Female|2018-2022
6.7|7.2|7.0|2819|VI RENAL TUMORS|413514777|0-19|All Races|Male and Female|2018-2022
2.9|3.2|3.1|1235|VII HEPATIC TUMORS|413514777|0-19|All Races|Male and Female|2018-2022
9.0|9.6|9.3|3933|VIII MALIGNANT BONE TUMORS|413514777|0-19|All Races|Male and Female|2018-2022
5.0|5.5|5.2|2212|VIIIa Osteosarcomas|413514777|0-19|All Races|Male and Female|2018-2022
0.3|0.4|0.4|152|VIIIb Chondrosarcomas|413514777|0-19|All Races|Male and Female|2018-2022
2.8|3.1|3.0|1240|VIIIc Ewing tumor and related sarcomas of bone|413514777|0-19|All Races|Male and Female|2018-2022
0.4|0.6|0.5|215|VIIId Other specified malignant bone tumors|413514777|0-19|All Races|Male and Female|2018-2022
0.2|0.3|0.3|114|VIIIe Unspecified malignant bone tumors|413514777|0-19|All Races|Male and Female|2018-2022
2.2|2.5|2.3|930|VIIa Hepatoblastoma and mesenchymal tumors of liver|413514777|0-19|All Races|Male and Female|2018-2022
0.6|0.8|0.7|291|VIIb Hepatic carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
~|~|~|~|VIIc Unspecified malignant hepatic tumors|413514777|0-19|All Races|Male and Female|2018-2022
5.9|6.4|6.1|2463|VIa Nephroblastoma and other non-epithelial renal tumors|413514777|0-19|All Races|Male and Female|2018-2022
0.7|0.9|0.8|337|VIb Renal carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
0.0|0.1|0.0|19|VIc Unspecified malignant renal tumors|413514777|0-19|All Races|Male and Female|2018-2022
10.7|11.3|11.0|4632|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|413514777|0-19|All Races|Male and Female|2018-2022
22.8|23.8|23.3|9916|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|413514777|0-19|All Races|Male and Female|2018-2022
0.9|1.1|1.0|419|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|413514777|0-19|All Races|Male and Female|2018-2022
0.4|0.6|0.5|211|XIIa Other specified malignant tumors|413514777|0-19|All Races|Male and Female|2018-2022
0.4|0.6|0.5|208|XIIb Other unspecified malignant tumors|413514777|0-19|All Races|Male and Female|2018-2022
0.2|0.3|0.2|103|XIa Adrenocortical carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
10.2|10.8|10.5|4500|XIb Thyroid carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
0.3|0.5|0.4|166|XIc Nasopharyngeal carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
2.8|3.2|3.0|1264|XId Malignant melanomas|413514777|0-19|All Races|Male and Female|2018-2022
0.1|0.1|0.1|35|XIe Skin carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
8.8|9.3|9.0|3848|XIf Other and unspecified carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
1.6|1.8|1.7|713|Xa Intracranial and intraspinal germ cell tumors|413514777|0-19|All Races|Male and Female|2018-2022
1.2|1.5|1.3|542|Xb Malignant extracranial and extragonadal germ cell tumors|413514777|0-19|All Races|Male and Female|2018-2022
6.8|7.3|7.0|2989|Xc Malignant gonadal germ cell tumors|413514777|0-19|All Races|Male and Female|2018-2022
0.4|0.5|0.5|200|Xd Gonadal carcinomas|413514777|0-19|All Races|Male and Female|2018-2022
0.4|0.5|0.4|188|Xe Other and unspecified malignant gonadal tumors|413514777|0-19|All Races|Male and Female|2018-2022
183.7|189.6|186.7|15567|All ICCC Groups Combined|83213818|0-19|All Races|Male and Female|2019
45.4|48.4|46.9|3883|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|83213818|0-19|All Races|Male and Female|2019
28.5|30.9|29.7|2499|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|83213818|0-19|All Races|Male and Female|2019
28.0|30.4|29.2|2416|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|83213818|0-19|All Races|Male and Female|2019
2.2|2.9|2.5|209|IIIa Ependymomas and choroid plexus tumor|83213818|0-19|All Races|Male and Female|2019
13.4|15.0|14.2|1180|IIIb Astrocytomas|83213818|0-19|All Races|Male and Female|2019
4.5|5.5|5.0|409|IIIc Intracranial and intraspinal embryonal tumors|83213818|0-19|All Races|Male and Female|2019
5.9|7.0|6.5|536|IIId Other gliomas|83213818|0-19|All Races|Male and Female|2019
0.4|0.7|0.5|45|IIIe Other specified intracranial and intraspinal neoplasms|83213818|0-19|All Races|Male and Female|2019
0.3|0.6|0.5|37|IIIf Unspecified intracranial and intraspinal neoplasms|83213818|0-19|All Races|Male and Female|2019
11.6|13.1|12.3|1047|IIa Hodgkin lymphomas|83213818|0-19|All Races|Male and Female|2019
9.7|11.0|10.3|868|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|83213818|0-19|All Races|Male and Female|2019
1.9|2.5|2.2|182|IIc Burkitt lymphoma|83213818|0-19|All Races|Male and Female|2019
4.2|5.2|4.7|382|IId Miscellaneous lymphoreticular neoplasms|83213818|0-19|All Races|Male and Female|2019
0.1|0.4|0.2|20|IIe Unspecified lymphomas|83213818|0-19|All Races|Male and Female|2019
8.7|10.0|9.3|754|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|83213818|0-19|All Races|Male and Female|2019
8.4|9.7|9.0|731|IVa Neuroblastoma and ganglioneuroblastoma|83213818|0-19|All Races|Male and Female|2019
0.2|0.4|0.3|23|IVb Other peripheral nervous cell tumors|83213818|0-19|All Races|Male and Female|2019
12.1|13.6|12.9|1074|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|83213818|0-19|All Races|Male and Female|2019
4.0|4.9|4.4|366|IXa Rhabdomyosarcomas|83213818|0-19|All Races|Male and Female|2019
1.1|1.6|1.3|107|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|83213818|0-19|All Races|Male and Female|2019
~|~|~|~|IXc Kaposi sarcoma|83213818|0-19|All Races|Male and Female|2019
4.8|5.8|5.2|442|IXd Other specified soft tissue sarcomas|83213818|0-19|All Races|Male and Female|2019
1.6|2.2|1.8|154|IXe Unspecified soft tissue sarcomas|83213818|0-19|All Races|Male and Female|2019
32.9|35.4|34.1|2819|Ia Lymphoid leukemias|83213818|0-19|All Races|Male and Female|2019
7.5|8.7|8.1|670|Ib Acute myeloid leukemias|83213818|0-19|All Races|Male and Female|2019
2.0|2.6|2.3|192|Ic Chronic myeloproliferative diseases|83213818|0-19|All Races|Male and Female|2019
1.0|1.5|1.3|103|Id Myelodysplastic syndrome and other myeloproliferative diseases|83213818|0-19|All Races|Male and Female|2019
1.0|1.4|1.2|99|Ie Unspecified and other specified leukemias|83213818|0-19|All Races|Male and Female|2019
0.4|0.7|0.5|43|Not classified by ICCC|83213818|0-19|All Races|Male and Female|2019
2.7|3.4|3.0|243|V RETINOBLASTOMA|83213818|0-19|All Races|Male and Female|2019
6.0|7.2|6.6|538|VI RENAL TUMORS|83213818|0-19|All Races|Male and Female|2019
2.6|3.4|3.0|244|VII HEPATIC TUMORS|83213818|0-19|All Races|Male and Female|2019
8.6|9.9|9.2|777|VIII MALIGNANT BONE TUMORS|83213818|0-19|All Races|Male and Female|2019
4.7|5.7|5.2|436|VIIIa Osteosarcomas|83213818|0-19|All Races|Male and Female|2019
0.2|0.5|0.3|28|VIIIb Chondrosarcomas|83213818|0-19|All Races|Male and Female|2019
2.5|3.3|2.9|244|VIIIc Ewing tumor and related sarcomas of bone|83213818|0-19|All Races|Male and Female|2019
0.3|0.7|0.5|41|VIIId Other specified malignant bone tumors|83213818|0-19|All Races|Male and Female|2019
0.2|0.5|0.3|28|VIIIe Unspecified malignant bone tumors|83213818|0-19|All Races|Male and Female|2019
2.0|2.6|2.3|185|VIIa Hepatoblastoma and mesenchymal tumors of liver|83213818|0-19|All Races|Male and Female|2019
0.5|0.8|0.6|54|VIIb Hepatic carcinomas|83213818|0-19|All Races|Male and Female|2019
~|~|~|~|VIIc Unspecified malignant hepatic tumors|83213818|0-19|All Races|Male and Female|2019
5.2|6.3|5.7|466|VIa Nephroblastoma and other non-epithelial renal tumors|83213818|0-19|All Races|Male and Female|2019
0.6|1.0|0.8|70|VIb Renal carcinomas|83213818|0-19|All Races|Male and Female|2019
~|~|~|~|VIc Unspecified malignant renal tumors|83213818|0-19|All Races|Male and Female|2019
10.1|11.5|10.8|914|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|83213818|0-19|All Races|Male and Female|2019
23.7|25.9|24.8|2112|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|83213818|0-19|All Races|Male and Female|2019
0.7|1.1|0.8|70|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|83213818|0-19|All Races|Male and Female|2019
0.3|0.6|0.5|38|XIIa Other specified malignant tumors|83213818|0-19|All Races|Male and Female|2019
0.3|0.5|0.4|32|XIIb Other unspecified malignant tumors|83213818|0-19|All Races|Male and Female|2019
~|~|~|~|XIa Adrenocortical carcinomas|83213818|0-19|All Races|Male and Female|2019
11.0|12.4|11.7|999|XIb Thyroid carcinomas|83213818|0-19|All Races|Male and Female|2019
0.3|0.6|0.5|41|XIc Nasopharyngeal carcinomas|83213818|0-19|All Races|Male and Female|2019
2.8|3.6|3.2|272|XId Malignant melanomas|83213818|0-19|All Races|Male and Female|2019
~|~|~|~|XIe Skin carcinomas|83213818|0-19|All Races|Male and Female|2019
8.5|9.8|9.1|777|XIf Other and unspecified carcinomas|83213818|0-19|All Races|Male and Female|2019
1.6|2.2|1.9|157|Xa Intracranial and intraspinal germ cell tumors|83213818|0-19|All Races|Male and Female|2019
1.2|1.8|1.5|120|Xb Malignant extracranial and extragonadal germ cell tumors|83213818|0-19|All Races|Male and Female|2019
6.1|7.2|6.7|568|Xc Malignant gonadal germ cell tumors|83213818|0-19|All Races|Male and Female|2019
0.3|0.6|0.4|35|Xd Gonadal carcinomas|83213818|0-19|All Races|Male and Female|2019
0.3|0.6|0.4|34|Xe Other and unspecified malignant gonadal tumors|83213818|0-19|All Races|Male and Female|2019
177.0|182.8|179.9|14912|All ICCC Groups Combined|82873432|0-19|All Races|Male and Female|2020
46.0|49.0|47.5|3905|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82873432|0-19|All Races|Male and Female|2020
27.1|29.4|28.3|2372|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82873432|0-19|All Races|Male and Female|2020
27.1|29.4|28.3|2329|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82873432|0-19|All Races|Male and Female|2020
1.9|2.6|2.2|183|IIIa Ependymomas and choroid plexus tumor|82873432|0-19|All Races|Male and Female|2020
11.9|13.5|12.7|1048|IIIb Astrocytomas|82873432|0-19|All Races|Male and Female|2020
5.0|6.1|5.5|450|IIIc Intracranial and intraspinal embryonal tumors|82873432|0-19|All Races|Male and Female|2020
6.0|7.1|6.5|541|IIId Other gliomas|82873432|0-19|All Races|Male and Female|2020
0.5|0.9|0.7|55|IIIe Other specified intracranial and intraspinal neoplasms|82873432|0-19|All Races|Male and Female|2020
0.5|0.8|0.6|52|IIIf Unspecified intracranial and intraspinal neoplasms|82873432|0-19|All Races|Male and Female|2020
10.8|12.3|11.5|982|IIa Hodgkin lymphomas|82873432|0-19|All Races|Male and Female|2020
9.6|11.0|10.3|863|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82873432|0-19|All Races|Male and Female|2020
2.0|2.7|2.4|196|IIc Burkitt lymphoma|82873432|0-19|All Races|Male and Female|2020
3.4|4.3|3.8|309|IId Miscellaneous lymphoreticular neoplasms|82873432|0-19|All Races|Male and Female|2020
0.2|0.4|0.3|22|IIe Unspecified lymphomas|82873432|0-19|All Races|Male and Female|2020
8.4|9.7|9.0|721|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82873432|0-19|All Races|Male and Female|2020
8.2|9.5|8.9|705|IVa Neuroblastoma and ganglioneuroblastoma|82873432|0-19|All Races|Male and Female|2020
0.1|0.3|0.2|16|IVb Other peripheral nervous cell tumors|82873432|0-19|All Races|Male and Female|2020
11.3|12.8|12.0|998|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82873432|0-19|All Races|Male and Female|2020
4.3|5.3|4.8|395|IXa Rhabdomyosarcomas|82873432|0-19|All Races|Male and Female|2020
0.8|1.3|1.0|83|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82873432|0-19|All Races|Male and Female|2020
~|~|~|~|IXc Kaposi sarcoma|82873432|0-19|All Races|Male and Female|2020
4.1|5.0|4.5|381|IXd Other specified soft tissue sarcomas|82873432|0-19|All Races|Male and Female|2020
1.4|1.9|1.6|134|IXe Unspecified soft tissue sarcomas|82873432|0-19|All Races|Male and Female|2020
34.1|36.7|35.4|2901|Ia Lymphoid leukemias|82873432|0-19|All Races|Male and Female|2020
7.1|8.3|7.7|636|Ib Acute myeloid leukemias|82873432|0-19|All Races|Male and Female|2020
1.8|2.5|2.1|181|Ic Chronic myeloproliferative diseases|82873432|0-19|All Races|Male and Female|2020
1.0|1.4|1.2|97|Id Myelodysplastic syndrome and other myeloproliferative diseases|82873432|0-19|All Races|Male and Female|2020
0.9|1.4|1.1|90|Ie Unspecified and other specified leukemias|82873432|0-19|All Races|Male and Female|2020
0.4|0.7|0.5|42|Not classified by ICCC|82873432|0-19|All Races|Male and Female|2020
2.6|3.3|2.9|232|V RETINOBLASTOMA|82873432|0-19|All Races|Male and Female|2020
6.7|7.9|7.3|589|VI RENAL TUMORS|82873432|0-19|All Races|Male and Female|2020
2.6|3.4|3.0|240|VII HEPATIC TUMORS|82873432|0-19|All Races|Male and Female|2020
8.0|9.3|8.6|727|VIII MALIGNANT BONE TUMORS|82873432|0-19|All Races|Male and Female|2020
4.5|5.4|4.9|416|VIIIa Osteosarcomas|82873432|0-19|All Races|Male and Female|2020
0.2|0.5|0.3|29|VIIIb Chondrosarcomas|82873432|0-19|All Races|Male and Female|2020
2.4|3.2|2.8|234|VIIIc Ewing tumor and related sarcomas of bone|82873432|0-19|All Races|Male and Female|2020
0.2|0.5|0.3|27|VIIId Other specified malignant bone tumors|82873432|0-19|All Races|Male and Female|2020
0.2|0.4|0.2|21|VIIIe Unspecified malignant bone tumors|82873432|0-19|All Races|Male and Female|2020
2.0|2.6|2.3|183|VIIa Hepatoblastoma and mesenchymal tumors of liver|82873432|0-19|All Races|Male and Female|2020
0.5|0.9|0.7|56|VIIb Hepatic carcinomas|82873432|0-19|All Races|Male and Female|2020
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82873432|0-19|All Races|Male and Female|2020
5.9|7.1|6.5|521|VIa Nephroblastoma and other non-epithelial renal tumors|82873432|0-19|All Races|Male and Female|2020
0.6|1.0|0.8|66|VIb Renal carcinomas|82873432|0-19|All Races|Male and Female|2020
~|~|~|~|VIc Unspecified malignant renal tumors|82873432|0-19|All Races|Male and Female|2020
10.2|11.6|10.9|920|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82873432|0-19|All Races|Male and Female|2020
19.7|21.7|20.7|1760|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82873432|0-19|All Races|Male and Female|2020
0.7|1.2|0.9|77|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82873432|0-19|All Races|Male and Female|2020
0.3|0.6|0.5|38|XIIa Other specified malignant tumors|82873432|0-19|All Races|Male and Female|2020
0.3|0.6|0.5|39|XIIb Other unspecified malignant tumors|82873432|0-19|All Races|Male and Female|2020
0.2|0.4|0.3|21|XIa Adrenocortical carcinomas|82873432|0-19|All Races|Male and Female|2020
8.4|9.7|9.0|768|XIb Thyroid carcinomas|82873432|0-19|All Races|Male and Female|2020
0.2|0.4|0.3|24|XIc Nasopharyngeal carcinomas|82873432|0-19|All Races|Male and Female|2020
2.3|3.1|2.7|227|XId Malignant melanomas|82873432|0-19|All Races|Male and Female|2020
~|~|~|~|XIe Skin carcinomas|82873432|0-19|All Races|Male and Female|2020
7.8|9.0|8.4|713|XIf Other and unspecified carcinomas|82873432|0-19|All Races|Male and Female|2020
1.5|2.1|1.8|150|Xa Intracranial and intraspinal germ cell tumors|82873432|0-19|All Races|Male and Female|2020
0.9|1.4|1.1|88|Xb Malignant extracranial and extragonadal germ cell tumors|82873432|0-19|All Races|Male and Female|2020
6.6|7.8|7.2|610|Xc Malignant gonadal germ cell tumors|82873432|0-19|All Races|Male and Female|2020
0.3|0.6|0.4|37|Xd Gonadal carcinomas|82873432|0-19|All Races|Male and Female|2020
0.3|0.6|0.4|35|Xe Other and unspecified malignant gonadal tumors|82873432|0-19|All Races|Male and Female|2020
180.6|186.5|183.5|15094|All ICCC Groups Combined|82201873|0-19|All Races|Male and Female|2021
45.8|48.8|47.2|3848|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|82201873|0-19|All Races|Male and Female|2021
26.0|28.3|27.1|2269|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|82201873|0-19|All Races|Male and Female|2021
28.3|30.6|29.4|2403|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|82201873|0-19|All Races|Male and Female|2021
1.9|2.5|2.2|177|IIIa Ependymomas and choroid plexus tumor|82201873|0-19|All Races|Male and Female|2021
12.1|13.7|12.9|1056|IIIb Astrocytomas|82201873|0-19|All Races|Male and Female|2021
5.0|6.0|5.5|439|IIIc Intracranial and intraspinal embryonal tumors|82201873|0-19|All Races|Male and Female|2021
7.2|8.4|7.8|638|IIId Other gliomas|82201873|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|45|IIIe Other specified intracranial and intraspinal neoplasms|82201873|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|48|IIIf Unspecified intracranial and intraspinal neoplasms|82201873|0-19|All Races|Male and Female|2021
11.2|12.7|11.9|1015|IIa Hodgkin lymphomas|82201873|0-19|All Races|Male and Female|2021
9.3|10.7|10.0|834|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|82201873|0-19|All Races|Male and Female|2021
3.0|3.8|3.4|280|IIc Burkitt lymphoma|82201873|0-19|All Races|Male and Female|2021
1.3|1.8|1.5|120|IId Miscellaneous lymphoreticular neoplasms|82201873|0-19|All Races|Male and Female|2021
0.1|0.4|0.2|20|IIe Unspecified lymphomas|82201873|0-19|All Races|Male and Female|2021
8.6|10.0|9.3|730|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|82201873|0-19|All Races|Male and Female|2021
8.0|9.3|8.6|671|IVa Neuroblastoma and ganglioneuroblastoma|82201873|0-19|All Races|Male and Female|2021
0.5|0.9|0.7|59|IVb Other peripheral nervous cell tumors|82201873|0-19|All Races|Male and Female|2021
11.2|12.7|12.0|985|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|82201873|0-19|All Races|Male and Female|2021
4.4|5.4|4.9|395|IXa Rhabdomyosarcomas|82201873|0-19|All Races|Male and Female|2021
0.8|1.2|1.0|78|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|82201873|0-19|All Races|Male and Female|2021
~|~|~|~|IXc Kaposi sarcoma|82201873|0-19|All Races|Male and Female|2021
3.9|4.8|4.4|364|IXd Other specified soft tissue sarcomas|82201873|0-19|All Races|Male and Female|2021
1.5|2.1|1.7|144|IXe Unspecified soft tissue sarcomas|82201873|0-19|All Races|Male and Female|2021
33.7|36.3|35.0|2838|Ia Lymphoid leukemias|82201873|0-19|All Races|Male and Female|2021
7.1|8.3|7.7|632|Ib Acute myeloid leukemias|82201873|0-19|All Races|Male and Female|2021
1.8|2.4|2.1|175|Ic Chronic myeloproliferative diseases|82201873|0-19|All Races|Male and Female|2021
1.2|1.7|1.4|116|Id Myelodysplastic syndrome and other myeloproliferative diseases|82201873|0-19|All Races|Male and Female|2021
0.9|1.3|1.1|87|Ie Unspecified and other specified leukemias|82201873|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|50|Not classified by ICCC|82201873|0-19|All Races|Male and Female|2021
2.5|3.2|2.8|218|V RETINOBLASTOMA|82201873|0-19|All Races|Male and Female|2021
6.6|7.8|7.2|572|VI RENAL TUMORS|82201873|0-19|All Races|Male and Female|2021
2.8|3.7|3.2|256|VII HEPATIC TUMORS|82201873|0-19|All Races|Male and Female|2021
8.6|9.9|9.2|777|VIII MALIGNANT BONE TUMORS|82201873|0-19|All Races|Male and Female|2021
4.5|5.5|5.0|422|VIIIa Osteosarcomas|82201873|0-19|All Races|Male and Female|2021
0.2|0.5|0.3|27|VIIIb Chondrosarcomas|82201873|0-19|All Races|Male and Female|2021
2.6|3.4|3.0|252|VIIIc Ewing tumor and related sarcomas of bone|82201873|0-19|All Races|Male and Female|2021
0.5|0.8|0.6|51|VIIId Other specified malignant bone tumors|82201873|0-19|All Races|Male and Female|2021
0.2|0.4|0.3|25|VIIIe Unspecified malignant bone tumors|82201873|0-19|All Races|Male and Female|2021
2.2|2.9|2.5|195|VIIa Hepatoblastoma and mesenchymal tumors of liver|82201873|0-19|All Races|Male and Female|2021
0.5|0.9|0.7|58|VIIb Hepatic carcinomas|82201873|0-19|All Races|Male and Female|2021
~|~|~|~|VIIc Unspecified malignant hepatic tumors|82201873|0-19|All Races|Male and Female|2021
5.9|7.0|6.4|511|VIa Nephroblastoma and other non-epithelial renal tumors|82201873|0-19|All Races|Male and Female|2021
0.5|0.9|0.7|57|VIb Renal carcinomas|82201873|0-19|All Races|Male and Female|2021
~|~|~|~|VIc Unspecified malignant renal tumors|82201873|0-19|All Races|Male and Female|2021
10.6|12.0|11.3|943|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|82201873|0-19|All Races|Male and Female|2021
22.0|24.0|23.0|1952|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|82201873|0-19|All Races|Male and Female|2021
0.9|1.4|1.1|91|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|82201873|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|43|XIIa Other specified malignant tumors|82201873|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|48|XIIb Other unspecified malignant tumors|82201873|0-19|All Races|Male and Female|2021
0.2|0.4|0.2|20|XIa Adrenocortical carcinomas|82201873|0-19|All Races|Male and Female|2021
9.4|10.7|10.0|855|XIb Thyroid carcinomas|82201873|0-19|All Races|Male and Female|2021
0.4|0.7|0.5|42|XIc Nasopharyngeal carcinomas|82201873|0-19|All Races|Male and Female|2021
2.4|3.2|2.8|234|XId Malignant melanomas|82201873|0-19|All Races|Male and Female|2021
~|~|~|~|XIe Skin carcinomas|82201873|0-19|All Races|Male and Female|2021
8.7|10.1|9.4|796|XIf Other and unspecified carcinomas|82201873|0-19|All Races|Male and Female|2021
1.5|2.1|1.8|150|Xa Intracranial and intraspinal germ cell tumors|82201873|0-19|All Races|Male and Female|2021
1.3|1.8|1.5|120|Xb Malignant extracranial and extragonadal germ cell tumors|82201873|0-19|All Races|Male and Female|2021
6.3|7.5|6.9|584|Xc Malignant gonadal germ cell tumors|82201873|0-19|All Races|Male and Female|2021
0.4|0.8|0.6|50|Xd Gonadal carcinomas|82201873|0-19|All Races|Male and Female|2021
0.3|0.6|0.5|39|Xe Other and unspecified malignant gonadal tumors|82201873|0-19|All Races|Male and Female|2021
179.5|185.3|182.4|14990|All ICCC Groups Combined|81903660|0-19|All Races|Male and Female|2022
45.5|48.5|46.9|3800|I LEUKEMIAS, MYELOPROLIFERATIVE AND MYELODYSPLASTIC DISEASES|81903660|0-19|All Races|Male and Female|2022
26.3|28.6|27.5|2301|II LYMPHOMAS AND RETICULOENDOTHELIAL NEOPLASMS|81903660|0-19|All Races|Male and Female|2022
27.3|29.6|28.4|2308|III CNS AND MISCELLANEOUS INTRACRANIAL AND INTRASPINAL NEOPLASMS|81903660|0-19|All Races|Male and Female|2022
2.2|2.9|2.5|202|IIIa Ependymomas and choroid plexus tumor|81903660|0-19|All Races|Male and Female|2022
10.5|12.0|11.2|916|IIIb Astrocytomas|81903660|0-19|All Races|Male and Female|2022
4.4|5.3|4.8|386|IIIc Intracranial and intraspinal embryonal tumors|81903660|0-19|All Races|Male and Female|2022
8.0|9.3|8.6|704|IIId Other gliomas|81903660|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|48|IIIe Other specified intracranial and intraspinal neoplasms|81903660|0-19|All Races|Male and Female|2022
0.5|0.8|0.6|52|IIIf Unspecified intracranial and intraspinal neoplasms|81903660|0-19|All Races|Male and Female|2022
11.7|13.2|12.4|1057|IIa Hodgkin lymphomas|81903660|0-19|All Races|Male and Female|2022
9.7|11.1|10.4|867|IIb Non-Hodgkin lymphomas (except Burkitt lymphoma)|81903660|0-19|All Races|Male and Female|2022
2.6|3.3|2.9|240|IIc Burkitt lymphoma|81903660|0-19|All Races|Male and Female|2022
1.1|1.7|1.4|110|IId Miscellaneous lymphoreticular neoplasms|81903660|0-19|All Races|Male and Female|2022
0.2|0.5|0.3|27|IIe Unspecified lymphomas|81903660|0-19|All Races|Male and Female|2022
8.1|9.4|8.7|683|IV NEUROBLASTOMA AND OTHER PERIPHERAL NERVOUS CELL TUMORS|81903660|0-19|All Races|Male and Female|2022
7.5|8.8|8.1|634|IVa Neuroblastoma and ganglioneuroblastoma|81903660|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|49|IVb Other peripheral nervous cell tumors|81903660|0-19|All Races|Male and Female|2022
11.1|12.6|11.8|975|IX SOFT TISSUE AND OTHER EXTRAOSSEOUS SARCOMAS|81903660|0-19|All Races|Male and Female|2022
4.4|5.4|4.9|398|IXa Rhabdomyosarcomas|81903660|0-19|All Races|Male and Female|2022
0.6|1.1|0.8|69|IXb Fibrosarcomas, peripheral nerve sheath tumors and oth fibrous neoplasms|81903660|0-19|All Races|Male and Female|2022
~|~|~|~|IXc Kaposi sarcoma|81903660|0-19|All Races|Male and Female|2022
3.9|4.9|4.4|367|IXd Other specified soft tissue sarcomas|81903660|0-19|All Races|Male and Female|2022
1.4|2.0|1.7|137|IXe Unspecified soft tissue sarcomas|81903660|0-19|All Races|Male and Female|2022
34.0|36.6|35.3|2839|Ia Lymphoid leukemias|81903660|0-19|All Races|Male and Female|2022
7.2|8.4|7.8|641|Ib Acute myeloid leukemias|81903660|0-19|All Races|Male and Female|2022
1.4|2.0|1.7|144|Ic Chronic myeloproliferative diseases|81903660|0-19|All Races|Male and Female|2022
0.9|1.4|1.1|89|Id Myelodysplastic syndrome and other myeloproliferative diseases|81903660|0-19|All Races|Male and Female|2022
0.8|1.3|1.1|87|Ie Unspecified and other specified leukemias|81903660|0-19|All Races|Male and Female|2022
0.4|0.7|0.6|47|Not classified by ICCC|81903660|0-19|All Races|Male and Female|2022
2.5|3.3|2.9|223|V RETINOBLASTOMA|81903660|0-19|All Races|Male and Female|2022
6.3|7.5|6.9|547|VI RENAL TUMORS|81903660|0-19|All Races|Male and Female|2022
2.8|3.6|3.2|256|VII HEPATIC TUMORS|81903660|0-19|All Races|Male and Female|2022
9.3|10.6|9.9|834|VIII MALIGNANT BONE TUMORS|81903660|0-19|All Races|Male and Female|2022
5.4|6.4|5.9|494|VIIIa Osteosarcomas|81903660|0-19|All Races|Male and Female|2022
0.3|0.6|0.4|34|VIIIb Chondrosarcomas|81903660|0-19|All Races|Male and Female|2022
2.4|3.2|2.8|233|VIIIc Ewing tumor and related sarcomas of bone|81903660|0-19|All Races|Male and Female|2022
0.5|0.8|0.6|53|VIIId Other specified malignant bone tumors|81903660|0-19|All Races|Male and Female|2022
0.1|0.4|0.2|20|VIIIe Unspecified malignant bone tumors|81903660|0-19|All Races|Male and Female|2022
2.1|2.8|2.4|187|VIIa Hepatoblastoma and mesenchymal tumors of liver|81903660|0-19|All Races|Male and Female|2022
0.6|1.0|0.8|68|VIIb Hepatic carcinomas|81903660|0-19|All Races|Male and Female|2022
~|~|~|~|VIIc Unspecified malignant hepatic tumors|81903660|0-19|All Races|Male and Female|2022
5.3|6.4|5.8|457|VIa Nephroblastoma and other non-epithelial renal tumors|81903660|0-19|All Races|Male and Female|2022
0.8|1.2|1.0|84|VIb Renal carcinomas|81903660|0-19|All Races|Male and Female|2022
~|~|~|~|VIc Unspecified malignant renal tumors|81903660|0-19|All Races|Male and Female|2022
10.7|12.2|11.4|967|X GERM CELL TUMORS, TROPHOBLASTIC TUMORS AND NEOPLASMS OF GONADS|81903660|0-19|All Races|Male and Female|2022
21.9|24.0|22.9|1958|XI OTHER MALIGNANT EPITHELIAL NEOPLASMS AND MALIGNANT MELANOMAS|81903660|0-19|All Races|Male and Female|2022
0.9|1.4|1.1|91|XII OTHER AND UNSPECIFIED MALIGNANT NEOPLASMS|81903660|0-19|All Races|Male and Female|2022
0.4|0.7|0.6|45|XIIa Other specified malignant tumors|81903660|0-19|All Races|Male and Female|2022
0.4|0.8|0.6|46|XIIb Other unspecified malignant tumors|81903660|0-19|All Races|Male and Female|2022
0.1|0.3|0.2|17|XIa Adrenocortical carcinomas|81903660|0-19|All Races|Male and Female|2022
9.2|10.6|9.9|848|XIb Thyroid carcinomas|81903660|0-19|All Races|Male and Female|2022
0.2|0.4|0.3|24|XIc Nasopharyngeal carcinomas|81903660|0-19|All Races|Male and Female|2022
2.6|3.4|3.0|251|XId Malignant melanomas|81903660|0-19|All Races|Male and Female|2022
~|~|~|~|XIe Skin carcinomas|81903660|0-19|All Races|Male and Female|2022
8.9|10.2|9.5|812|XIf Other and unspecified carcinomas|81903660|0-19|All Races|Male and Female|2022
1.2|1.8|1.5|125|Xa Intracranial and intraspinal germ cell tumors|81903660|0-19|All Races|Male and Female|2022
1.0|1.5|1.2|97|Xb Malignant extracranial and extragonadal germ cell tumors|81903660|0-19|All Races|Male and Female|2022
7.1|8.3|7.7|660|Xc Malignant gonadal germ cell tumors|81903660|0-19|All Races|Male and Female|2022
0.3|0.6|0.4|38|Xd Gonadal carcinomas|81903660|0-19|All Races|Male and Female|2022
0.4|0.7|0.6|47|Xe Other and unspecified malignant gonadal tumors|81903660|0-19|All Races|Male and Female|2022
